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Throughout this thesis the word proteinase, although 
biochemically correct, has been substituted by protease to allow ease 
of quoting the literature which mostly uses the term protease.
Summary
'Vo cholerae extracellular pro teases were isolated, characterized 
and their role in adherence and as vaccine additives considered.
Gel filtration of the crude protease produced one large peak 
of pro tease activity quite distinct from the major protein band.
Isoelectric focussing of the crude protease or the pooled GlOO protease
peak (GlOO/P) yielded three peaks of pro tease activity. These were
phoretic heterogeneity.
termed IEF-1 which was a broad peak with a pi of 4,5 - 5,5 ^ 0,1, IEF-2 
with a pi of 6,5 ^ 0,1 and IEF-3 with a pi of 9,0 ^ 0,1,
The three lEF proteases were shown by peptide digest analysis 
to have distinct catalytic activities.
Gelatin-PAGE of the crude protease, GlOO/P, IEF-1, IEF-2 and 
IEF-3 showed that each preparation contained at least three areas of 
protease activity, suggesting either the presence of several proteases 
in each preparation or autocatalytic degradation of a single protease 
which had produced multiple activities on the PAGE gel.
Characterisation of the three lEF proteases by inhibitors 
revealed that IEF-1 was inhibited by metalloprotease and serine protease
.inhibitors, IEF-2 was inhibited by métallo, serine and thiol protease 
inhibitors and IEF-3 was inhibited by only metalloprotease inhibitors.
This suggested that more than one protease was present in IEF-1 and IEF-2 
as it is unusual for a single protease to be inhibited by more than one
class of protease inhibitor, IEF-3 was only inhibited by metallo- 
protease inhibitors but showed multiple protease activities in 
gelatin-PAGE suggesting either several metalloproteases or auto-
i
degradation of one metalloprotease which has then displayed electro-
The crude protease, GlOO/P and IEF-3 all showed muclnase and 
haemagglutinating activity,
Fibronectin and lactoferrin, two host substances that may be
ainvolved at the level of mucosal defence were tested for their g
susceptibility to V. cholerae proteases, Fibronectin was found to be 
digested after 1 h and further digestion occurred after 24 h. No 
digestion of lactoferrin was seen even after a 24 h incubation with 
V. cholerae proteases,
IgA is the main immunoglobulin present in mucosal secretions 
and so is the major antibody involved in mucosal defence, V, cholerae 
proteases were shown to digest IgA specifically with the loss of three 
peptide bands, Immunoelectrophoresis showed that the V, cholerae 
protease(s) was not a typical IgA pro tease as no distinct Fc and Fab 
fragments were produced. The antigenicity of the IgA remained but the 
single precipitin arc was shortened following protease treatment.
The binding of V. cholerae enterotoxin to ileal segments was
sfound not to be affected by. enzyme treatment of the tissue. However |î
it is interesting that treatment of the cholera enterotoxin with the h-Iprotease-containing mixture Gioo/P caused an increase in toxin activity, |
■ï\
peptide fragments with similar molecular weights to A^ and A^ following 3;
pro tease treatment.
The effect of V. cholerae proteases on the binding of the vibrios 
to ileal segments in vitro was assessed by a radioactive adherence assay, #
I'Three different types of tissue preparation were used. Experiments ||
5îwhich involved the use of tissue segments where both the mucosal and
i:"serosal surface of the ileum were present during the assay procedure 
showed no effect on the number of vibrios binding following enzyme 
treatment, V, cholerae was found to adhere to the serosal surface of I
the ileum and the numbers adhering to the serosal surface increased 
following protease treatment of the tissue segment. Adherence of 
V„ cholerae to the mucosal surface was found to decrease following 
pro tease treatment of the tissue segments and neuraminidase had no effect 
on the adherence of vibrios to either the mucosal or serosal surfaces.
The use of the protease-containing mixture' GlOO/pja vaccine to produce active protection 
against V, cholerae was tested in guinea-pigs. Initial experiments 
were done by giving guinea-pigs one parenteral vaccination. These 
guinea-pigs were found only to be significantly protected if given a 
vaccine containing both protease plus neuraminidase. Guinea-pigs 
given one parenteral vaccination and one parenteral booster dose with 
various concentrations of protease and neuraminidase were highly 
protected when the vaccine contained 80 pg of protease and 0.02 I.U, of 
neuraminidase,
A parenteral vaccination followed by an oral booster dose of 
80 pg of protease and 0,02 I,U, of neuraminidase significantly protected 
guinea-pigs and for the first time protease alone (80 pg) was a 
protective vaccine.
In conclusion, it is apparent that V. cholerae produces several 
proteases which play important roles in the pathogenesis of cholera.
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INTRODUCTION
lo GENERAL INTRODUCTION
The existence of cholera, or a similar disease, in the ancient 
civilizations of India and possibly China was suggested by Pollitzer 
(1959) in his definitive text on cholera.
During the London outbreak of cholera in 1854 an anaesthetist, 
John Snow "with a notebook, a map and his five senses", proved that many 
persons acquired the disease from "spoiled" water from the Broad Street 
pump. Boehm (1838) made the first claim to have seen the causative 
organism of cholera, a claim which was subsequently repeated by other 
workers including Pacini and Hassal (1854), Leyden (1866) and finally 
Kleb (1867) described intestinal organisms identical to Vibrio cholerae. 
Through the studies of Koch (1884) on cholera victims in Egypt and India 
it became generally accepted that V. cholerae was the causative organism. 
He reported the comma-shaped organism increased in number in the stools 
during infection and gradually disappeared on recovery. The bacteria 
were invariably present in the intestine of cholera victims and absent 
in patients suffering any other morbid disease (cited j  Pollitzer, 1959), 
Until the end of the 18th Century cholera as far as is known, was 
contained largely within India and neighbouring regions. From this time 
however, there have been a succession of cholera pandemics, the first 
six of which were described by Pollitzer (1959). The seventh pandemic 
of cholera began in 1961, after an absence of the disease from most of 
the world since the nineteen twenties. After 1961 the disease 
gradually spread over a large area of the world in several distinct 
phases
(i) 1961-1962: the disease was recognized in many countries of
south-east Asia, eg. Phillipines,
(ii) 1963-1969: the disease reached the countries of mainland Asia,
eg, Thailand,
(iii) 1970-1979; there was a significant rise in the incidence of 
cholera in the Middle East and parts of Africa and Europe,
In this seventh pandemic, the _el tor biovar of the cholera vibrio 
was more prevalent than the classical V, cholerae identified by Koch in 
1884, The tor biovar was first isolated in 1906 at the ^  tor 
quarantine station on the Gulf of Suez, Unlike the classical cholera 
vibrios, the ^  tor vibrio forms a soluble haemolysin (Gotschlich, 1906;
Moor, 1936; cited in Buchanan and Gibbons, 1974), and is unusual in its
phage susceptibility (Mukerjee, 1963), The el tor vibrios have a longer 
survival time in the environment and are more resistant to antibiotics 
than the classical vibrio strain (Gan and Tjia, 1963), It also causes 
a higher incidence of asymptomatic infection than the classical V. cholerae
(Bart _et a^, 1970). Consequently there are more undetected and
untreated cholera cases which preserve a reservoir of infection in ^  tor 
outbreaks.
The WoHoOo estimates that half of the world's population lives 
in or near the cholera endemic areas of Asia, so the disease obviously 
poses an immense public health problem. Because of the enormity of the 
problem, means of prevention and treatment of cholera have been sought. 
Treatment of the disease is now so well developed that infection with 
Vo cholerae need not be fatal.
Unfortunately, cholera is endemic in areas of high population 
density, and where restricted medical facilities hinder large-scale 
treatment. Until clean drinking water and proper sewage disposal 
systems become available, there is little hope of eradication of the 
disease. Emphasis should therefore be placed on the production of an 
effective vaccine which is capable of eliciting long-term protection 
against the disease.
2, CHOLERA, THE DISEASE
2.L Definition of cholera infection
Finkelstein (1975) defined cholera as an acute (frequently 
severe) dehydrating, diarrhoeal disease, usually occurring with epidemic 
incidence, caused by infection with cholera vibrios,
2.2 The causative organism
Cholera is caused by a Gram-negative uniflagellate, facultat­
ively anaerobic curved rod belonging to the family Vibrionaceae (Vernon, 
1965: see Buchanan and Gibbons 1974). It is contained in the genus
Vibrio (Pacini, 1854: see Buchanan and Gibbons, 1974), The species
Vibrio cholerae is subdivided into four biovars:
'i'
(i) Vo cholerae biovar cholerae
(ii) V, cholerae biovar el^  tor (Pribram, 1919)
(iii) V. cholerae biovar proteus (Buchner, 1885)
(iv) V, cholerae biovar albensis (Lehmann and Neumann, 1896)
Only biovars (i) and (ii) are associated with human cholera,
Biovar proteus causes gastroenteritis in human beings and biovar albensis 
is pathogenic only to certain animals, eg. guinea-pigs and pigeons.
All four biovars are intestinal pathogens (Buchanan and Gibbons, 1974),
2,2,1 Antigenic constitution
V. cholerae possesses both 'H' and 'O* antigens. The 'H'
antigens are non-specific, and are shared by all cholera vibrios. The
diagnosis of cholera is, therefore, dependent upon the use of 0-specific
antisera (Gardner and Venkatram, 1935), The majority of strains are
classified into six 0 antigenic groups, Serogroup "O", type 1 (0:1)
■
- ..
2,2,2 Serovars
1
contains the biovar cholerae and el_ tor, whereas protens and albensis 
biovars produce cell wall antigens other than the 0:1 antigen (Sakazaki 
et al, 1970).
Three antigenic factors A, B and G are used to sub-divide the
0:1 group into the serovars, Ogawa, Inaba and Hikojirtia (Kauffmann, 1950).
Table 1 depicts the combination of antigens found in serogroup 0:1.
Antigenic conversion among the serovars Ogawa, Inaba and
Hikojima can occur in both experimental animals and in natural infection 
(Kauffman, 1950; Sack and Miller, 1969). Serological conversion appears
to be related to the appearance of agglutinating antibody in the serum,
'Rough to smooth reversion was found with Inaba and Ogawa serotypes 
(Miller et al, 1972).
2.2.3 Somatic Antigens
The exact chemical structure of the O-somatic antigens of 
V o  cholerae are still unknown, despite the efforts of numerous research 
workers (Watanabe and Verwey, 1965; Verwey et al, 1965; Jackson and 
Redmond, 1971; Sur, Maiti and Chaterjee, 1974). Raziuddin and 
Kawasak (1976) presented detailed analyses of V. cholerae cell envelope 
lipopolysaccharide (IPS), The absence of 2-keto-3 deoxyoctonate (KDO), 
the typical linking sugar between the polysaccharide and lipid moieties 
in enterobacterial IPS was outstanding. In addition galactose, a 
typical core sugar in other Gram-negative bacteria was missing (Jackson 
and Redmond, 1971). Redmond (1975) discovered a highly-labile sugar, 
4-amino-4,6 dideoxy-D-mannose; this amounted to at least 6% in the LPS 
of V. cholerae 569B (inaba).
TABLE 1. Antigenic Determinants of Serogroup 0:1
SEROVAR 'O' FACTORS
Ogawa AB
Inaba AC
Hikojima ABC
saccharide preparations from V. cholerae 395 (inaba) inhibited adherence 
of two different Inaba strains to the intestinal mucous membrane. It 
was concluded that the somatic antigen may play a role in the adherence 
of V, cholerae to the intestinal mucosa.
2.3 Production of Clinical Disease
The events preceding the development of clinical cholera are: 
ingestion of viable V. cholerae, colonization of the small intestine and 
production of enterotoxin (Figure 1).
Recently Kabir (1982) characterized the LPS from V. cholerae
395 (Ogawa) and compared it with the LPS of the Inaba serovar and with 
the LPS of other species of the Enterobacteriaceae. The LPS of the
Ogawa 395 serovar also lacked KEK) but possessed an acid-labile amino 
sugar, 4-amino arabinose. This observation confirmed the earlier 
findings of Redmond (1975) who also detected 4-amino arabinose in the 
Ogawa serovar. Although this amino sugar was present in the LPS from
:several Gram-negative bacteria (Volk, Galanos and Ldderitz, 1970), the
Inaba serovar of V, cholerae does not possess this sugar. Thus, the
■
LPS from V. cholerae 395 (Ogawa) possesses both common and distinct 
features when compared with the LPS from enterobacterial species and
the Ogawa serovar.
The role of the somatic antigen of V. cholerae in the adherence 
of the vibrios to the intestinal epithelium was considered by Chitinis 
and his colleagues (Chitinis, Sharma and Kamat, 1982a,b). Lipopoly-
2.3,1 Ingestion of viable V, cholerae
Cholera infection is established via the orogastric route, the 
disease being dependent on the ingestion of live vibrios in food or water.
FIGURE 1 CHOLERA PATHOPHYSIOLOGY
(adapted from Nalin, 1975; Stephen and Pietrowski, 1981)
Inf eel ton Cokxxul'ion
EU)bor3tkxi
Adhesion
glucose 
arnioo acids Na^cr
HjO
: A W \ P
AG : adenylate cyclase H : specific hormone receptor
R ; component responsible for CTP-dependent regulation of enzyme 
activity,C : component responsible for enzymatic conversion of ATP to cAMP
Vo cholerae organisms are very acid-sensitive, so that protection from 
gastric acidity, eg„ within a bolus of food or ingestion of extremely 
large numbers of organisms is required for their safe passage into the 
small intestine* The organism grows well at the slightly alkaline pH 
(7oO-8oO) of the small intestine and is resistant to high bile salt 
concentrations, so that rapid multiplication may occur,
2*3,2 Colonization of the small intestine
Vo cholerae remains localized within the intestine during 
infection, and although no penetration of the tissue occurs, Freter (1969) 
demonstrated that 50% of the infecting vibrios in rabbit ileal loops 
adhered strongly to the intestinal lining. Cholera adherence seems to 
be necessary for colonization of the small intestine and appears to be 
a complex process involving several factors (see sections 4 and 5),
More than two decades ago Lankford (1960) suggested that cholera 
vibrios colonized the mucosa of the small intestine. This possibility was 
supported by the observations of Freter, Smith and Sweeney (1961) who 
concluded that because of the short transit time of fluid through the 
intestine of cholera patients and the inability of the contents of the 
lumen to support the growth of vibrios, the vibrios most probably 
colonized and grew on the intestinal mucosa.
Nelson, Clements and Finkelstein (1976) studied the colonization 
of the small intestine of infant and adult rabbits by V. cholerae, by 
scanning and transmission electron microscopy. They demonstrated a lag 
period of one hour before significant numbers of bacteria attached to the 
intestinal epithelium of adult animals. This lag was absent in the infant 
rabbit where colonization began immediately on infection, and where greater 
concentrations of vibrios accumulated than in the adult animal. It was
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suggested that natural differences in the susceptibility of the intestinal 
surface to bacterial attachment could be important in the different 
morbidity rates of infant and adult human beings for enteric diseases 
such as cholera.
Recent work has shown that a classical V* cholerae strain and 
mutants derived from it show significant differences in their abilities 
to colonize the infant mouse upper bowel and to induce diarrhoea:
(Baselski and Parker, 1978; Baselski, Upchurch and Parker, 1980;
Baselski, Medina and Parker, 1978 ; Sigel, Finkelstein and Parker, 1981), 
Differences in virulence were correlated with differences in the ability 
to multiply in the upper bowel and to evade normal host clearance 
mechanisms.
Sigel ejt £l (1980) found that the ability to multiply in the 
upper intestine appeared to be a preliminary determinant of virulence 
for V. cholerae strains and a good predictor for the ability to cause 
human disease, Srivastava, Shina and Srivastava (1980) found that if 
the intestine was exposed to an optimum number of vibrios, multiplication 
would not in itself have a role in the pathogenesis of cholera. However, 
multiplication of vibrios probably has a very important role in natural 
infection in man, in whom the infecting dose is likely to be small in 
relation to the number of vibrios needed to cause disease.
2.3.3 Production of enterotoxin
Growth of the cholera vibrios in the small intestine is 
accompanied by the production of an exo-enterotoxin. The enterotoxin 
of V» cholerae was first isolated and purified by Finkelstein and 
LoSpalluttoin 1969. This was 85 years after Koch first suggested that 
the symptoms of cholera were caused by a potent exotoxin secreted by the
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organism in the gut* Koch's ideas were not accepted till the late 1950s 
when De and his colleagues showed that injection of V, cholerae or sterile 
culture filtrates into ligated segments of rabbit ileal loops vivo led 
to rapid fluid accumulation in the lumen and consequent distention of 
the loop (De, 1959; De, Chose and Sen, 1960).
Guatre^casas, Parikh and Hollenberg (1973) stated that entero­
toxin from Vo cholerae was composed of two oligomeric subunits which were 
non-covalently linked, one of about 60 k.Dal* and another of approximately 
30 k.Dalo The 60 k.Dal* toxin unit, the B subunit, was found to be an 
aggregate of five 8-10 k.Dalo peptides. The 30 k.Dal. component, the 
A subunit, contained two disulphide linked peptides of unequal size, A^ 
and A^ with molecular weights of 28 and 5 k.Dal. respectively (Finkelstein 
et al, 1974), It was proposed that the B subunit was responsible for the 
initial interaction with the intestinal cell surface, while the A subunit 
represents the biologically active portion of the molecule (Figure 2;
Van Heyningen, 1974; Holmgren and hBnnroth, 1975; Finkelstein, 1975).
During purification of the enterotoxin Finkelstein and his 
colleagues also purified a protein that was immunologically identical to 
enterotoxin but was biologically inactive. This protein was named 
enterotoxoid or choleragenoid (Finkelstein and LoSpalluto, 1969).
The B subunit was common to both enterotoxin and enterotoxoid but the A 
subunit was absent in the latter (Finkelstein et al, 1974). This was 
in agreement with earlier work by Finkelstein, Fuji ta and LoSpalluto,
1971).
The functioning toxin binds specifically to GM^ ganglioside 
receptors on the intestinal cell surface by means of its B subunit 
(Holmgren, LÜnnroth and Svennerholm, 1973; Cuatre^cacas, 1973; Van 
Heyningen, 1974), The GM^ ganglioside is an acidic glycolipid containing
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FIGURE 2 PROPOSED MECHANISM OF ENTRY OF CHOLERA TOXIN 
FRAGMENT Al_______________ ___________________
(adapted from Stephen and Pietrowski, 1981) Î
(c)
Binding of B subunits to specific receptors (a) induces a 
conformational change in these sub-units and their insertion 
into the membrane (b) to create a hydrophilic channel through 
which the A sub-unit can diffuse into the cell (c). Here, thiol 
agents reduce the disulphide bond, allowing fragment A^ to diffuse 
into the cytoplasm and activate adenylate cyclase.
I
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sialic acid and a terminal galactose (Figure 3; Fishman and Brady,
1976). After B subunit attachment the A subunit is Inserted into the 
cell membrane resulting in activation of adenyl cyclase, which leads to 
increased levels of cyclic AMP and a net secretion of chloride ions into 
the bowel lumen and a net reduction in the adsorption of sodium (Figure 
4; Field, 1971; Strewler and Orloff, 1977).
The net fluid deficit which this produces in the body is 
responsible for the entire range of clinical manifestations of cholera 
(Carpenter, 1970; Carpenter, Greenough and Gordon, 1974), such as 
vomiting, diarrhoea and abdominal cramps and finally complete 
dehydration of the body,
2,4 Clinical Symptoms and Treatment
Pollitzer (1959), Pierce and Mondai (1974) and Mahalanabis, 
Watten and Wallace (1974) have comprehensively reviewed the clinical 
aspects of cholera.
Cholera has an incubation period varying from a few hours to 
five days with a mean of two to three days (Oseasohn ^  al, 1966;
Hornick e_t ad^ , 1971), The onset is abrupt, vomiting occurring in most 
patients shortly after the onset of severe diarrhoea. In severe cases 
the voluminous liquid ("rice-water") stools contain mucus, epithelial 
cells and large numbers of vibrios (lO^ml ^, or more). As the infection 
progresses fluid loss in the stool exceeds the ratio of readsorption by 
the colon, resulting in an overall deficit of isotonic fluid in the 
body. Fluid loss in severe cases approaches 15 to 20 litres per day.
In untreated cases the fatality rate was over 60% and higher rates were 
seen in children.
FIGURE 3,
14
The structure of monosialogariglioside CM
(van Heyningen, 1977)
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FIGURE 4.
Proposed mechanism for the regulation of adenylate cyclase 
activity and site of action of cholera toxin 
(adapted from Stephen and Pietrowski, 1981)
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Since the symptoms of cholera are entirely the result of water 
and electrolyte loss from the soft tissues and the blood into the gut,
replacement of this fluid can remedy the ill-effects of the toxin action,
/
Fluid replacement therapy reduces the mortality rate from 60% to less 
than l%o Methods of treatment of cholera were reviewed by Hirschhorn 
et al (1974) and outlined by Frost (1976), A suitable solution for oral 
rehydration of cholera patients was glucose 20,0 g, NaCl, 4o2g, NaHCO^, 
4.0g, KCl, 1.8g, dissolved in one litre of drinking water. Glucose is 
included in this solution as inclusion of 2% (w/v) glucose in oral 
fluids increases the absorptive capacity of the small intestine (Taylor 
et al, 1968), The fact that oral therapy can be administered by 
paramedical personnel is a significant advantage in rural areas of 
developing countries.
Tetracycline, chloramphenicol or furazolidene therapy 
significantly lowers the numbers of infecting organisms in the gut, and 
thereby reduces fluid loss (Carpenter, 1971; Gordon £t al, 1966), 
Antimicrobial therapy is, however, not a substitute for adequate fluid 
replacement. Antibiotic treatment does assist in the prevention of the 
carrier state, where the person harbours the cholera vibrios in the gall 
bladder and sheds them intermittently.
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3, DEVELOPMENT OF EFFICACIOUS V, cholerae VACCINE
3.1 Standard Vaccine
The standard cholera vaccine now in use is a saline suspension
9 -1containing 8 x 10 killed vibrios ml « The vaccine is bivalent,
containing equal numbers of Ogawa and Inaba serotypes.
Two doses of 0.5 ml and 1.0 ml are given to adults (0.1-0.3 ml 
for children under the age of 10 years) by the subcutaneous or intra­
muscular route. In epidemics, however, single 1.0 ml doses are used 
for mass immunization, and may be almost as effective as the two-dose 
regime in an endemic area.
The immunity induced by this vaccine is of short duration,
persisting for no longer than 6 months. The dosage cannot be increased
9 -1since concentrations greater than 8 x 10 cells ml tend to produce local 
tenderness, and less frequently lead to a slightly more severe reaction 
lasting for several days (Feeley and Gangerosa, 1980),
3.2 Prospective Cholera Vaccines
3.2.1 Cell Fractions
The possibility of cell fractions being effective immunogens 
against cholera infection was explored in several studies, Watanabe 
and Verwey (1965) isolated a lipopolysaccharide antigen from Ogawa cell super- 
nates which was protective against V.cholerae challenge in mice, Verwey 
et al (1965) also found Inaba lipopolysaccharide antigens to be 
protective in mice. From these studies an effective cholera vaccine 
could possibly be prepared from the outer envelope layers of V, cholerae.
3.2.2 Enterotoxin preparations
of disease, this toxin cannot be ignored as a potentially important 
immunogen (Finkelstein, 1969). Immunizing agents intended to prevent
Wliole cell cholera vaccine contains no enterotoxin (Feeley 
and Roberts, 1969); however due to its central role in the production
cholera by means of stimulating anti-toxic immunity include (i) formal­
dehyde-treated cholera toxin (Feeley and Roberts, 1969; Thomson, Walker 
and Knight, 1972), (ii) glutaraldehyde-treated cholera toxin (Rappaport 
et al, 1976; Levine e_t al, 1979), (iii) purified B-subunits (Svennerholm 
et al, 1982) and (iv) procholeragenoid (Finkelstein, Pujita and 
LoSpallutto, 1971). These immunizing agents are not capable of 
eliciting good protection against V. cholerae but may be useful in a 
combined vaccine with whole cells.
3,2,3 Attenuated V, cholerae vaccines I
IAn ideal cholera vaccine would be one which stimulated prolonged 
antibody production at the mucosal surface of the small intestine. 
Following the observation that clinical cholera infections in North 
American volunteers stimulated a high degree of protective immunity for 
at least 3 years (Levine £t al, 1981a,b) an immunological approach was 
taken to try to control cholera by means of attenuated non-enterotoxigenic 
Vo cholerae strains used as oral vaccines.
Naturally occurring non-toxigenic strains failed to provide 
protection in experimental challenge (Levine et al, 1982).
Honda and Finkelstein (1979) isolated a Vo cholerae mutant by 
mutagenesis with nitrosoguanadine which produced the immunogenic B-subunit 
but failed to produce detectable A-subunit. This mutant was termed 
Texas-Star SR, Texas-Star SR was extensively evaluated in volunteers
Î
_
:S:
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(Levine et al, 1981b; Levine et al, 1983) and was found to confer 
significant protection against V. cholerae challenge. However the Texas 
star strain suffers from certain•drawbacks ; - (a) the method of
■Iattenuation, mutagenesis with nitrosoguanadine, induces multiple ft
mutations, not all of which are necessarily recognized and (b) the 
precise genetic lesion presumed to be responsible for the attenuation 
of Texas Star is not known. Therefore, until this is clarified there iIalways remains the theoretical possibility of reversion to virulence,
ÎTo overcome these problems Kapar ejt aj^  (1984) developed an %
attenuated V. cholerae strain by techniques of recombinant DNA.
Mekalanos and his co-workers have also reported attenuated V, cholerae 
strains constructed by similar methods (Mekalanos £t a_l, 1983).
Attenuated V. cholerae vaccines constructed by this method eliminate 
some of the disadvantages of the previously tested attenuated strain,
Texas Star, A very specific method of mutagenesis was used so that no
.1
unexpected secondary mutations were present and the precise genetic Æ
lesion was known and in addition no possibility of reversion to ;§*
virulence existed. Volunteer studies are under way to evaluate the 
safety and efficiency of candidate vaccines produced by this method.
I
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4. BACTERIAL ADHERENCE TO MUCOSAL SURFACES
To induce disease, many pathogens must establish some degree of 
association with the mucosal surface. It seems likely that the extent 
to which a pathogen can attach to a surface influences colonization, and 
thus it may be related to virulence. Many pathogens have been observed 
to adhere to mucosal epithelium and a direct correlation between this 
ability and the initiation of infection exists.
The efficiency of the cleansing mechanisms operating on various 
mucosal surfaces to prevent colonization with bacteria was reviewed by 
Ofek and Beachy (1980) and Gibbons (1977), Briefly, the mucosal and 
endothelial surfaces are constantly bathed by mucous gels, blood flow or 
urine which together with mechanical anatomical mechanisms (sneezing, 
coughing, ciliary action and peristalsis) sweep such surfaces free of 
pathogenic bacteria. Therefore bacteria must adhere to host cells to 
counteract the normal cleansing mechanism. The importance of the 
initial colonization of mucosal surfaces is realized for a varied 
selection of pathogenic microbes, as shown in Table 2 (adapted from 
Mims , 1982).
Neisseria gonorrhoeae adherence to urethral mucosa cells has 
been studied by many workers (Ward and Watt, 1972; Swanson _et al, 1975; 
Pearce and Buchanan, 1978) and there is agreement that fimbriation 
facilitates gonococcal attachment to eukaryotic cells. By human fallopian 
tube organ culture (Ward, Watt and Robertson, 1974) which is highly relevant 
to the study of gonococcal adhesion, a four-fold increase in the adhesion 
of fimbriated gonococci to the mucosal surface occurred than found with 
a non-fimbriate variant of the same strain (Ward and Watt, 1980),
Fimbriate gonococci not only bind in greater numbers to human cells than
TABLE 2 Microorganisms whose attachment has a role in p
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athogenicity
(adapted from Mimms, 1982)
Microorganism Disease Attachment
site
Mechanism
Influenza virus Influenza Respiratory
epithelial
cells
H.A. reacts with 
neuraminic acid 
receptor on cell
Polio virus Poliomyelitis Susceptible 
tissue cell 
(neurone)
Viral capsid 
protein reacts 
with specific 
receptor on cell
Chlamydia Conjunctivitis Conjunctival
epithelium
Unknown-sialic 
acid receptor on 
epithelial cell
Mycoplasma Atypical Respiratory 'Foot® attaches
pneumoniae pneumonia epithelial
cells
to neuraminic 
acid receptor 
on cell
Neisseria
gonorrhoeae
Gonorrhoea Urethral
epithelium
Bacterial fimbriae 
involved and per­
haps outer membrane 
proteins
Vibrio
cholerae
Cholera Intestinal
epithelium
Receptor may be 
fucose or mannose
Escherichia
coli
Diarrhoea Intes tinal 
epithelium
Requires specific 
bacterial surface 
component ^  K88
Streptococcus 
mu tans
Dental caries Tooth Dextran 'glue' 
synthesised by 
bacteria
Bordetella
pertussis
Whooping cough Respiratory
epithelium
Evidence suggests 
involvement of 
bacterial fimbriae
Plasmodium
vivax
Malaria Erythrocyte of 
susceptible 
host sp.
Malarial merozoite 
attaches to 
antigen on erythro 
cyte surface
do non-fimbriate cells but also they show an increased rate of attachment. 
This may be critical in the transmission of the natural infection where 
flows of mucus or urine would tend to flush the bacterium from the mucosal 
surface, Buchanan, Pearce and Chen (1978) presented evidence for a 
carbohydrate containing receptor on Neisseria gonorrhoeae, somewhat 
resembling the carbohydrate moiety found on gangliosides,
However, as well as fimbriae, outer membrane proteins may play 
an important role in neisserial adhesion, Virji and Everson (1981) 
using variants of N. gonorrhoeae strain P9 which differs in its outer 
membrane proteins (Swanson, 1978; Lambden and Heckels, 1979), showed 
that one variant (P9-16) with no fimbriae but protein lib in the outer 
membrane, had high avidity of attachment, for a Chang conjunctiva cell 
line. They also found that protein II increased the final level of 
adhesion compared to the prototroph P9-1 which is non-fimbriate and 
lacks protein II in the outer membrane. The rate of attachment of 
these non-fimbriate variants however was slow compared to a variant 
such as P9-20 which was fimbriate and possessed protein II (Virji and 
Everson, 1981). Therefore, both fimbriae and outer membrane proteins 
play a role in adherence of N. gonorrhoeae.
Fimbriae have been shown to be important in E. coli adherence 
to the intestinal epithelium from as early as 1957 (Duguid and Gilles, 
1957). The fibrillar K antigen of E. coli, K88, was shown to be 
produced vivo and to be responsible for the colonization of pathogenic 
E. coli to the intestinal mucosa of neonatal piglets (Jones and Rutter,
1972). Bacteria without the antigen failed to adhere to the mucosa and 
hence failed to colonize and cause disease (Jones and Rutter, 1972).
Also, there is clear evidence that a similar mannose-resis tant adhesin, 
K99, promoted intestinal E. coli infection in calves and lambs (Orskov
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et al, 1975; Burrows, \ 1976). Ninety-eight percent of entero­
toxigenic strains of E. coli from human adults also have a mannose- 
resistant haemagglutinin, either Colonization Factor (CFA) I or II,
As the name suggests, these are also involved in colonization of the
was demonstrated in human volunteers given a virulent strain of E. coli
+  -  +  which was either CFA or CFA . Only those given CPA strains
I
Sellwood and Gibbons,
T
small intestine/Evans and Evans, 1978; Evans et al, 1975; Evans et al,
1978). The role of CFA/1 in the pathogenesis of diarrhoeal disease
contracted diarrhoea and showed prolonged excretion of bacteria.
Streptococcus pyogenes is thought to adhere to the pharyngeal
mucosa via the specific M protein surface layer (Ellen and Gibbons,
1974). Beachy and Ofek (1976) also suggested the involvement of
lipoteichoic acid in the adherence of Strep, pyogenes to eukaryotic cells
Ofek e_t al^  (1977) found that the new born animal had a low capacity to
bind streptococci and lipoteichoic acid to oral mucosal cells; this
ability increased a few days after birth. They suggested that a lipo- 
.teichoic acid specific site develops or is unmasked during this period,
:Mycoplasma pneumoniae is the causative organism of atypical 
pneumonia, although much smaller than bacteria, are also dependent upon 
attachment to the respiratory epithelium for production of the clinical
disease. Radestock and Bradt (1977) demonstrated that virulent
,,M. pneumoniae cells possessed a gliding motility and that an avirulent 
mutant was non-motile and showed reduced adherence. An adhesin present 
on the membrane of M. pneumoniae was identified as a high molecular 
weight protein (Gorski and Bredt, 1977). One receptor on eukaryotic 
cells for M. pneumoniae was demonstrated to be a sialic acid moiety 
(Razin, 1978),
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Bordetella pertussis infects the lower respiratory tract and 
is found mainly among the bronchial cilia (Mallory and Horner, 1912).
The specificity of the organisms for the ciliated cells is illustrated in 
scanning electron microscope pictures of organisms attached to the 
ciliated cells in tracheal organ cultures (Figure 5) (Muse, Collier and 
Baseman, 1977). Whether the sites of adhesion are on the cilia them­
selves (Muse, Collier and Baseman, 1977) or on the microvilli (Hopewell, 
Desombre and Holt, 1972) of the ciliated cells is unclear. The identity 
of filamentous haemagglutinins with the filamentous appendages was shown 
by the uniform attachment of specific anti-haemagglutinins antibody 
molecules to the bacterial fimbriae (Sato et al, 1979). Avirulent 
phase III organisms lacked fimbriae and did not attach to HeLa cells 
(Sato e_t al, 1979) nor to rabbit tracheal organ cultures (Matsuyama,
1977). Antibody to phase III organisms did not prevent phase I bacteria 
adhering to HeLa cells whereas homologous phase I antibody or antibody 
to isolated haemagglutinin largely prevented attachment (Sato £t al, 1979) 
The weight of evidence suggests that fimbriae play a part in the 
pathogenesis of B. pertussis by an involvement in the attachment of the 
organism to the mucosal surface although the possibility of other outer 
membrane proteins being involved in adhesion cannot be ruled out.
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FIGURE 5
Scanning electron micrograph of Bordetella pertussis infected
tissue
From,
Muse, Collier and Baseman (1977)
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5. ADHESIVE PROPERTIES OF V. cholerae
5o1 Association with and adhesion to the intestinal mucosa
V. cholerae interacts intimately with mucosal surfaces of the 
small intestine and this phenomenon is of prime importance in the patho­
genesis of cholera (Freter, 1969)o By definition, mucosae are 
epithelial layers moistened by mucus (Warwick and Williams, 1973), i
This term is collectively applied to two major categories:- j
(i) the inner habitat of the brush-border surface of the epithelial |j
cells. This consists of glycoproteins and glycolipids which appear |
to be synthesized by the epithelial cell (Bennet, 1963), The carbo- j
hydrate-rich surface layer formed in this manner is the glycocalyx I
(Ito, 1969) which consists of a fringe of polysaccharide fibres produced \
j
by the branching sugar chains on the glycoprotein molecules of the cell |
I
membrane ( Costerton, Greesey and Cheng, 1978), The oligosaccharide j
j
components of the glycoproteins tend to differ in composition not only \
at different positions along the intestine but also from the tips of |
I
the villi to the crypts of Lieberkllhn (Etzler and Branstrator, 1974); |
(ii) the outer habitat of the mucous gel. Specialized cells, goblet ;
cells, secrete glycoproteins which differ in various characteristics from |
those of the glycocalyx. The mucous gel can be of varying thickness over |
the epithelium, the classical work of Florey (1933) observed a rather I
patchy mucous blanket with areas of free villi. In contrast, Shrank “i
and Verwey (1976) suggested a continuous mucous blanket. The thickness I
of the mucous probably determines the degree and rate of penetration j
of the vibrios to the epithelium, j
As reviewed by Jones (1977), there is evidence that hetero- |i
saccharides of the glycocalyx act as receptors for bacterial adhesins. ,i
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The interaction of the vibrios with this mucosal surface is
decreased ability to kill suckling mice than wild type parents despite 
the fact that they produced enterotoxin. The lack of a flagellum and/or
of a complex nature and appears to involve more than one mechanism. 
These mechanisms include bacterial motility, chemotactic attraction,
penetration of the mucous gel on the intestinal villi, adhesion to 
receptors in the mucous gel, chemotaxis into deeper intervillous spaces, 
adherence of the organism to the epithelial surfaces and finally 
elaboration of an injurious toxin (Freter, 1978),
5,1.1 Motility
Vo cholerae was shown by several electron microscopy studies 
(Follet and Gordon, 1963; Barua and Chatterjee, 1964; Das and 
Chatterjee, 1966) to possess a polar monotrichous sheathed flagellum.
This is also true of other vibrio species (Glauert, Kerridge and Horne, 
1963).
Numerous reports suggested a correlation between the possession 
of a flagellum and adhesion to mucosal surfaces by cholera vibrios, 
Guentzel and Berry (1975) demonstrated a relationship between motility 
and virulence of V, cholerae, Non-motile V, cholerae mutants showed a
motility in these mutant strains greatly decreased their ability to 
to the mouse epithelium, Non-motile mutants were also less 
virulent for adult mice infected intra-peritoneally with the organisms 
suspended in hog gastric mucin than parental strains (Eubanks, Guentzel
■’i/and Berry, 1976),
Guentzal ^  aT (1977) found that motile organisms penetrated
in larger numbers into intervillous spaces and crypts of Lieberkllhn than 
.did non-motile strains.
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Jones and Freter (1976) and Freter and Jones (1976) found that 
non-flagellate mutant strains lacked the ability to adhere to brush- 
border membranes of rabbit intestine and that adherence of these motile 
strains could be inhibited by L-fucose and to a lesser extent by 
Dymannose,
By electron microscopy Nelson e_t al (197 7) demonstrated vibrios 
bound to the epithelial surface in a horizontal position with their 
flagella extending into the lumen of the intestine. It was suggested 
that since the cholera vibrio was propelled by a polar flagellum, its 
first contact with the intestinal surface would be via the "front-end”. 
After the initial binding the vibrio was thought to align in a position 
parallel to the surface to allow greater contact. During this sequence 
of events it is difficult to imagine how a binding site on the flagellum, 
which was not in contact with the epithelial cells, could be effective, 
as proposed by Jones and Freter (1976),
Freter ^  (1977) and Freter, O'Brien and Macsai (1978b) 
showed that not only were fewer non-motile bacteria present in the mucus, 
but that motile vibrios were more widely distributed and penetrated 
more deeply between the villi. Studies by Yancey and Berry (1978) and 
Yancey, Willis and Berry (1978) strengthened the earlier evidence that 
motility played a critical role in the pathogenicity of V, cholerae. 
These studies demonstrated that motility, or, as was suggested by the 
studies of Jones and Freter (1976), a motility related factor was 
required for the association with the ileal mucosa,
Yancey, Willis and Berry (1979) extended the original work of 
Eubanks, Guentzal and Berry (1976) on the use of a crude flagellar 
vaccine. The protection conferred by the crude flagellar immunization 
was superior to that of a commercial bivalent vaccine and also to that
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of glutaraldehyde-treated cholera toxoid. There is no definite
.explanation for the high degree of active protection afforded by immunity 
to the crude flagellar preparation. Bacterial motility is probably
5,1,2 Chemo taxi s
inhibited or the crude flagellar vaccine may contain vibrio surface 
components as contaminants. Neither assumption can, however, be 
confirmed until the specific antigenic components of the crude flagellar 
preparation are determined.
It is not clear at present whether the correlation between loss 
of motility and loss of virulence in cholera vibrios is actually a 
consequence of the loss of locomotion as such or whether this is simply 
related to the activity of some other virulence/adhesive factor which is 
phenotypicaily linked to the expression of motility. Recent work by 
Attridge and Rowley (1983a) suggested that motility was not the primary
4‘-role of the flagellum, but rather that this structure might act as a 
carrier of the adhesins responsible for attachment. Using a variety of 
assay systems they were unable to detect any adherence capacity 
associated with non-motile strains and this capacity was only obtained 
by the simultaneous acquisition of a functional flagellum.
1
Chemotaxis, which adds a directional component to microbial
motility, was suspected for many decades of being important in the 
localization of mammalian pathogens vivo. As reviewed by Weibull 
(1960) little was known about the chemotactic reactions of V, cholerae.
Guentzel e_t (1977) speculated on various possible virulence 
mechanisms of V, cholerae and listed chemotaxis among these, although no 
experimental data were given, Allweiss et al (1977) suggested that
I
chemotaxis might play a role in the initial attraction of cholera vibrios
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to the intestinal mucosa. A pepsin digest of rabbit intestinal mucosa 
neutralized a positive chemotactic response of V, cholerae, E, coli and
S. typhimurium to the villous surface of pieces of rabbit intestine.
Non-chemotactic motile mutants of the three bacterial strains had a 
significantly lower association with the mucosal tissue than the parent 
chemotactic strains. Mucosal extracts contained chemotactically active 
substances, or toxins, which apparently blocked the chemotactic 
attraction of cholera vibrios to the surface of the intestinal mucous 
gel (Freter et al, 1977), Additional work by Freter and others (Freter, 
O'Brien and Halstead, 1978; Freter, O'Brien and Macsai, 1979) using 
in vivo studies showed an increase in the mucosal association of chemo­
tactic vibrios, as compared to non-chemotactic strains.
The taxin gradients not only increased the efficiency of the 
initial contact between the vibrios and the mucosal surface but, in 
addition, appeared to extend some distance towards the crypts where the 
relative numbers of chemotactic vibrios far exceeded the number of 
non-chemotactic vibrios (Freter, O'Brien and Macsai, 1978a,b),
V, cholerae is attracted to twenty amino acids and several 
carbohydrates (Freter and O'Brien, 1981a), L-fucose inhibited the 
adhesion of V, cholerae to the brush border membrane but lacked taxin 
activity (Freter and O'Brien, 1981a,b). Recently, in vivo (Freter,
O'Brien and Macsai, 1981) and vitro studies (Freter e_t 1981) 
provided conclusive evidence that the toxin gradient which the vibrios 
follow extends deeply into the intervillous spaces of the intestinal 
mucosa.
From the various chemotactic studies with V, cholerae it would 
appear that chemotaxis aids in the initial association of the vibrios
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with the mucosa and also assists in their penetration through the mucous 
gel towards the base of the villi. Conceivably, the taxins which 
initially attract bacteria to the mucosal surface may differ from the 
taxins that attract the vibrios towards the base of the villi.
5.1,3 Association with the mucus
The mucous gel does not present an impenetrable barrier to 
vibrios (Freter ^  al, 1977) and indeed may provide a suitable habitat 
(Freter and Jones, 1976; Freter et al, 1977), The vibrios penetrate 
into and through the raucous gel for considerable distances in short 
periods of time (Freter, O'Brien and Macsai, 1978a,b). How this is 
achieved is not really known and is the subject of controversy.
The mucinase activity of the vibrios is likely to be of 
assistance (see Section 7J) although it was suggested that vibrios may 
move along tracts created within the gel as it flows from the epithelial 
surface to the lumen (Jones, Abrams and Freter, 1976), The migration 
of vibrios towards the tissue surface was suggested to be analogous 
to that proposed for migration of spermatazoa within cervical mucus 
(Gibbons and Sellwood, 1973), Schrank and Verwey (1976) suggested that 
vibrio interaction with the mucus was caused by entrapment within the 
mucus itself. Association of the vibrios to mucous receptors was 
suggested by Freter and Jones (1976), In both mouse and rabbit models 
V, cholerae populations are found within the mucous gel (Williams ejt al, 
1973; Schrank and Verwey, 1976; Freter et al, 1977), The apparent 
ease with which vibrios migrate through the mucus (Freter, O'Brien and 
Macasi, 1978a,b) suggests that little permanent attachment occurs in 
the mucous zone.
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5ol,4 Adhesion to the brush-border membrane of the epithelial cells
Cholera vibrios adhered to the brush-border surfaces of 
intestinal epithelium cells of the rabbit and accumulated there to form 
layers several cells deep (Nelson, Clements and Finkelstein, 1976), Work 
by Jones and his colleagues (Jones, Abrams and Freter, 1976; Jones and 
Freter, 1976) provided evidence that vibrios attached to brush-border 
membranes of both rabbit and mouse intestinal epithelial cells,
V, cholerae showed an apparent degree of selectivity in its 
attachment to the epithelial cells of the guinea-pig (LeBrec ^  al, 1965) 
and rabbit intestines (Hirschberger, Thalar and Mirelman, 1978). The 
unequal distribution of vibrios on adjacent villi, reported by Nelson, 
Clements and Finkelstein (1976), was probably due to an unequal distribution 
of mucus over the epithelium providing the vibrios with easier access to 
some areas compared to others. The absence of vibrios from the tips of 
the villi (Nelson, Clements and Finkelstein, 1976), although this site is 
readily accessible to the vibrios (Freter jet 1977), was probably due to 
lack of suitable receptors. It appears that V. cholerae cannot attach 
to the surfaces of all epithelial cells and that the attachment to eukary­
otic cells depends upon the presence of appropriate receptors.
The extent of adhesion of one vibrio strain to brush-border 
membranes vitro was directly related to the vibrio concentration and 
inversely related to the number of brush-border membranes present (Jones, 
Abrams and Freter, 1976). The adhesion was also both temperature and 
time dependent. At 4*^ C little or no adhesion occurred whereas marked 
adhesion occurred at 25°C and 37^C. The adhesion was not permanent at 
37^0 (Jones, Abrams and Freter, 1976) and the bacterium eventually 
dissociated. The membranes, after dissociation of the vibrios, remained
33
receptive to the attachment of fresh vibrio suspensions. Therefore,
ma rked enzymic destruction of the brush-border receptors was an unlikely,
but not excluded, reason for dissociation. Dissociation from brush 
borders ^  situ was accompanied by morphological changes in the micro­
villi (rough and patchy appearance) and perhaps increased mucous 
secretion (Nelson, Clements and Finkelstein, 1976), It may be that this 
movement of vibrios is the result of a reversed chemotactic gradient or 
enzymatic dissolution of the mucous gel.
The adherence of vibrios to the intact intestinal mucosal 
surface is a complicated process and the differences between the adhesive 
properties of the intact mucosa and the brush border membranes is 
quite distinct when inhibition studies are considered (see section 5.3),
5.2 V. cholerae adhesins
The forms taken by bacterial adhesins have been reviewed by 
Jones (1977).
5.2.1 Fimbriae
Unlike other bacteria such as E. coli and N. gonorrhoeae 
fimbriae have not been shown to play an important part in the adhesion 
of V. cholerae to the small intestinal mucosa,
.7,;.
3,'
Fimbriae have been observed on some vibrio species and unlike
the straight fimbriae of E. coli, those of V. cholerae are curved and up 
to 2.5 |im in length. The diameters of the fimbriae ranged from 6-8nm 
(Barua and Chatterjee, 1964) or approximately lOnm (Tweedy, Park and 
Hodgkiss, 1968), Only some 107. of the classical vibrios examined had 
fimbriae and there were 10 or less fimbriae per cell. In contrast 
almost half of the ^  tor vibrios examined produced up to 50 fimbriae
. J,.:
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per cell (Tweedy, Park and Hodgkiss, 1968), It seemed that el tor types
produced fimbriae more readily than the classical cholera vibrios and
.this may account for the greater adhesiveness of el tor vibrios.
.Several investigators have failed to find fimbriae on vibrio cells 
(Finkelstein and Mukherjee, 1963; Lankford and Legsomburana, 1965) and 
fimbriae have not been observed on vibrios attached to brush borders 
(Nelson, Clements and Finkelstein, 1976; Nelson et al, 1977).
Lateral strands have been observed on the surface of vibrios 
attached to mucosal surfaces (Nelson, Clements and Finkelstein, 1976). 
These are not unlike the lateral fimbriae of some vibrios (Tweedy,
Park and Hodgkiss, 1968). Whether these lateral strands are involved 
in V. cholerae adhesion is not known.
Barua and Chatterjee, 1964; Lankford and Legsomburana, 1965), Under 
the electron microscope the material appeared as a dense network of
5.2.2 Slime envelopes
Substances often called slime envelopes or slime agglutinin 
have been shown to be produced by V. cholerae (Bales and Lankford, 1961;
I.,.7-strands quite unlike fimbriae (Tweedy, Park and Hodgkiss, 1968),
Extracts believed to contain the slime material produced by cholera 
vibrios were proteinaceous (Lankford and Legsomburana, 1965), The 
slime envelope or agglutinin was not present in organisms harvested from 
agar plates. It was more stable on the surface of ^  tor vibrios 
(Lankford and Legsomburana, 1965). Chulasamaya and Lankford (1965) 
found no evidence that the slime envelope possessed adhesive properties. 
However, Attridge and Rowley (1983b) have correlated the production of
this slime agglutinin with the superior adherence of el tor strains to 
inert particles, erythrocytes and the serosal surface of murine intestine, .
J
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Similar levels of attachment were observed with vibrios of the classical 
biovar if these were cultured and assayed in conditions which support 
the development of slime agglutinin.
The slime agglutinin does not promote attachment to an intact 
mucosal surface, in vitro, and there is no evidence at present to suggest 
that the slime agglutinin plays a role in the pathogenesis of cholera.
5.2.3 Haemagglutinins
The haemagglutinating activity of V. cholerae was reviewed by 
Finkelstein (1973). Earlier studies on haemagglutinins were concerned 
with the haemagglutination test as a means of differentiating el tor 
and classical types for classification purposes. Haemagglutinating 
activity has been associated with the ability to adhere to the surface 
of epithelial cells (Jones and Freter, 1976). D-mannose may inhibit 
the haemagglutinins of V. cholerae completely (Barua and Mukherjee,
1965); partially (Barua and Mukherjee, 1965; Tweedy, Park and Hodgkiss, 
1968) or not at all (Jones and Freter, 1976; Shatterjee and Srivastava, 
1978). The haemagglutinins of some V. cholerae strains were also 
inhibited by L-fucose (Jones and Freter, 1976) but some strains were 
not inhibited by either D-mannose or L-fucose. From these carbohydrate 
inhibition studies there was good reason to believe that V, cholerae 
produces several haemagglutinins.
Finkelstein ejb ^  (1978) isolated a haemagglutinin from 
Vo cholerae which they termed "cholera lectin". This isolated 
haemagglutinin inhibited the attachment of heterologous and homologous 
vibrios to tissue in vivo and in vitro.
Four distinct V. cholerae haemagglutinins were described by 
Hanna and Finkelstein (1982),
-■ ' ■ ■ - - - -__
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(i) a cell-associated mannose-sensitive haemagglutinin (MSHA) was 
produced only by the e_l tor biovar. This haemagglutinin appeared to 
be responsible for the differentiation of ^  tor from the classical 
biovar V. cholerae. The MSHA was inhibited by D-mannose and L-fucose,
(ii) a cell-associated haemagglutinin inhibited by L-fucose (FSHA) 
which was present during the late logarithmic phase of growth.
(ill) a cell-associated haemagglutinin produced in late logarithmic 
to stationary phase that was not inhibited by either JD-mannose or 
L-fucose.
(iv) a "soluble" haemagglutinin was detected in late log phase
cultures of all strains tested. This soluble haemagglutinin is the 
"cholera lectin" reported earlier by Finkelstein ^  (1978), This 
particular haemagglutinin is discussed further in section 7.3,
The exact role, if any, of these haemagglutinins in colonization 
and adherence of V. cholerae to the intestinal mucosa is still uncertain.
5.3 Inhibition of V. cholerae adhesion and association
The interactions of vibrios with rabbit brush border membranes 
and with intact slices of rabbit intestinal mucosa were compared (Jones 
and Freter, 1976; Freter and Jones, 1976).
L-fucose inhibited the attachment of V. cholerae to the brush- 
border membranes of the rabbit. The L-isomer was inhibitory and the 
inhibition increased with increasing molecular size of the fucoside 
(Jones and Freter, 1975), ^-mannose also inhibited the attachment of 
some strains but to a lesser extent than L-fucose. The association 
of the vibrios with the intact intestinal mucosa appears to be quite 
different than to the isolated brush-border membranes as neither 
L-fucose nor D-mannose inhibited the attachment of vibrios to the intact
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mucosa (Freter and Jones, 1976). Bhattarjee and Srivastava (1978) 
in contrast to Freter and Jones (1976) found that D^mannose inhibited 
the association of el tor vibrio strains to intact slices of rabbit ÎÎ'
intestinal tissue.
The results obtained from these inhibition studies with D-mannose 
must be considered carefully as D-mannose is a chemo-attractant for 
V. cholerae. It is possible that the inhibition observed in these 
studies was a consequence of inhibition of adherence of the vibrios to
the brush-border membrane, but it is equally possible that the reduced 
association was a result of D-mannose interfering with normal chemotaxis. 
Unlike D-mannose, L-fucose was not a chemo-attractant for cholera vibrios, 
Pepsinised mucosal scrapings (Freter and Jones, 1976) 
inhibited both adherence to brush borders and association with mucosal 
slices. Fractionation of this crude mixture of substances revealed 
the presence of two activities one of which inhibited association with 
intact mucosa, possibly acting as a chemoattractant while the other 
inhibited adherence and possibly contained jL-fucose (Freter et al, 1977), 
Although there is no direct evidence that specific receptors 
exist, the evidence of selectivity with which vibrios attach to animal
cells and the inhibition of adhesion by some monosaccharides suggests 
that this may be so.
Evidence against the concept of host receptor structures being
.
required for attachment has recently been presented by Attridge and 
Rowley (1983a,b). They found that organisms selected for their 
capacity to adhere to inert substances simultaneously acquired the 
capacity to bind to intestinal tissues in vivo. Inhibition studies with 
monosaccharides, such as L-fucose, showed no decrease in the capacity
"I:
of cholerae to attach to the intestinal mucosal surface» They also 
found that V» cholerae showed undiminished binding to boiled tissue
segments
________
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6, PROTEASES
6»1 General Microbial Proteases
Extracellular protease activity has been noted in many 
eukaryotic microorganisms such as fungi, protozoa and slime moulds 
(North, 1982) and in many bacterial species (discussed below)» There 
have been correlations between protease activity and pathogenicity of 
eukaryotic and bacterial microorganisms» At the beginning of this 
study, since very little was known about V. cholerae protease(s), it 
was necessary to rely on studies with other bacterial proteases »
Pseudomonas aeruginosa, an important opportunistic pathogen, 
is known to produce several proteases (Jensen ej: al, 1980; Kessler, 
Kennah and Brown, 1977; Morihara and Tsuzuki, 1977), two of these 
proteases were isolated, purified and characterized» Both were metallo- 
proteases but they were immunologically distinct and differed in their 
molecular weights, substrate specificities and pH optima» One was 
designated alkaline protease because of its activity at alkaline pH, 
the other as elastase because it degraded elastin»
Another opportunistic pathogen, Serratia marcescens, was shown 
by Aiyappa and Harris (1976) to produce an extracellular metalloprotease. 
Unlike Ps. aeruginosa the Serratia protease was a neutral protease with 
maximum activity at pH 5»5-7»5» Lyerly and Kreger (1979) found that 
the purified Serratia protease although homogeneous by Ouchterlony double 
immunodiffusion showed three to four closely migrating bands in SDS- 
polyacrylamide gel electrophoresis» However, zymogram analysis of the
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patterns showed that protease activity was associated with each component, 
they therefore termed the protease 'microheterogeneous'. This 
characteristic of Serratia protease was also reported by McQuade and 
Crewther (1969), although their pro tease preparation was not rigorously 
examined for purity* Purified Ps. aeruginosa elastase was also reported 
to exhibit microheterogeneity (Kreger and Gray, 1978), so this 
observation was not unique to a single protease» In addition, 
preparations of crystalline bovine trypsin were found to contain variable 
quantities of at least five molecular weight species, which apparently
:resulted from partial autodigestion»
Pseudomonas proteases were implicated in the pathogenesis of 
several infections including keratitis and corneal ulcers (Kawaharajo 
et al, 1974; Hirao and Homma, 1978; Kreger and Gray, 1978) and in burned 
skin infections (Carney, Oyster and Jones, 1973; Ciomanec and Holder,
1979; Pavlovskis and Wretlind, 1979; Holder and Haidaris, 1979)»
Ps. aeruginosa is the major pathogen associated with persistent 
pulmonary infections in children and young adults with cystic fibrosis.
Data presented by dagger, Bahner and Warren (1983) suggested that 
protease production may be important in the initial colonization of 
the respiratory tract of cystic fibrosis patients by Ps. aeruginosa»
Protease activity was associated with the production of 
Serratia pneumonia by Lyerly and Kreger (1983), They showed that (i) 
a homogeneous Serratia protease preparation elicited gross lung damage 
in guinea-pigs and mice which was similar to that observed during 
experimental pneumonia, (ii) vaccination against this pro tease stimulated 
active immunity against experimental lethal pneumonia, and (iii) the
I
but all four had pH optima between 8*0 and 9,0, The finding that
• ■ ■
I
protease was produced situ during this type of pneumonia. These 
characteristics support the experimental evidence that this protease is 
involved in the pathogenesis of experimental Serratia pneumonia.
The viridans streptococci form the single most prevalent
group of bacteria causing subacute bacterial endocarditis» Strains of
■Streptococcus sanguis produced more than one type of proteolytic enzyme 
(Straus, Mattingly and Milligan, 1980)» Recently, Strep» sanguis 
isolated from a patient with subacute bacterial endocarditis (Straus,
1982) yielded four distinct proteases which were isolated and purified
from the supernatant fluids of stationary phase cultures» The four 
pro teases had different molecular weights and substrate specificities i
Strep, sanguis excreted potentially destructive enzymes when it was not 
actively multiplying may explain some of the damage it causes in heart 
tissue during subacute bacterial endocarditis.
The natural environment of Aeromonas hydrophile is surface 
fresh-water, including chlorinated drinking supplies (LeChevallier, 
Siedler and Evans, 1980)» A. hydrophile has been associated with wound 
infections, septicaemia (particularly in immunologically compromised 
patients) and with diarrhoea in human beings (Ljungh, Popoff and 
WadstrBm, 1977; Echeverria et al, 1981; Goodwin et al, 1983)»
A» hydrophile produces a number of surface lectin-like adhesins 
(Adams, Atkinson and Wood, 1983) and extracellular pro teases (Riddle,
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pathogenicity of A. hydrophile is unknown,
distributed among members of the family Micrococcaceae. According to
Graham and Ambaorski, 1981)» The role, if any, of the proteases, or *|:
their interaction with the surface lectins/haemagglutinins in the
The ability to hydrolyse casein or liquefy gelatin is widely si
■s5
Si
to Baird-Parker (1963), the majority of the staphylococcal strains -J
■|produce extracellular proteases» S» aureus produces at least three 
proteases, one which is EDTA-sensitive and two which are EDTA- 
insensitive; of the latter one is active at a neutral pH and the other
..Ïis an alkaline protease (Arvidson, 1973; Arvidson, Holme and Lindholm, |î
1973)» The function of the proteases from staphylococci and micro-
;
cocci is unknown but it has been suggested that they ensure a supply of
amino acids for growth and synthesis (McDonald and Chambers, 1966). v|l
#
ifi
;
Vibrio species other than cholera have been shown to produce g|
extracellular protease activity. Vibrio parahaemolyticus (Tanaka and 
luchi, 1983) produced four proteases separated by analytical poly- 
acrylamide gel electrophoresis, two of which were inhibited by serine
'Iprotease inhibitors and two which were inhibited by metalloprotease r'4
inhibitors. Vibrio alginolyticus produced alkaline proteases (Hare, %
Scott-Burden and Woods, 1983) which yielded five bands of protease 
activity in gelatin-PAGE» All five proteases were inhibited by both
serine and metalloprotease inhibitors»
wI
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Extracellular protease activity was found in many other
1971) and Proteus mirabilis (Hampson, Mills and Spencer, 1963) although
bacterial species including Bacillus subtilis (McGonn, Tsuru & Yasunobu,
1964), Bacillus megaterium (Keay et al, 1971), Bacillus cereus (Feder, ,:|
no relationship of the enzymes to pathogenesis was considered, y
Î
Therefore, protease activity appears to be widely distributed Iamong many microorganisms» The reason for this enzyme production is.
in some cases, unknown, in some organisms it is used to obtain amino
acids as a nutritional source and in many instances there is a correlation h
between protease production and the pathogenicity of the organism,
6,2 Microbial IgA Proteases iSI
In all mammals studied, secretions bathing mucous membranes
: :contain antibodies and the predominant isotype of antibody is IgA
(Tomasi and Grey, 1972), Mucosal IgA has binding specificity for
J'surface and secreted antigens of bacteria, viruses, microbial toxins and %
,1food antigens (Tomasi, 1976)» The precise mechanism by which antigen
Iclearance at mucosal sites takes place is unclear because secretory IgA
apparently does not utilize complement for disposal of antigen and is T
not opsonic (Wilson, 1972; Van Epps and Williams, 1976)» There is I*
§however evidence that secretory IgA functions by preventing adherence of
'bacteria to relevant tissues. Williams and Gibbons (1972) showed that 
preparations of secretory IgA specifically inhibited the adherence of -
'"llStreptococci to epithelial cells» Because such adherence is a 
prerequisite for colonization and disease, inhibition of this event
would apparently be an adequate means by which secretory IgA could function h
'
in mucosal defence.
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IgA is present in both serum and external secretions of the 
alimentary, respiratory and reproductive tracts. Serum IgA is 
primarily monomeric with a molecular weight of about 160 k.Dal, and 
composed of two light and two heavy chains characteristic of most 
immunoglobulins. In contrast IgA in secretions is mainly dimeric, 
composed of two covalently bound monomeric subunits of IgA, and is 
secreted in this form by the mucosal plasma cells» Each secreted IgA 
molecule also contains one J-chain, a polypeptide of molecular weight 
16 k.Dal, During transport of the IgA dimers through the mucosal 
epithelium to the lumen they bind to a glycoprotein, the secretory 
component, that is contributed by the epithelial cells» The molecular 
weight of the fully assembled secretory IgA (sIgA) is about 380 k.Dal,
Serum and sIgA contain two isotypes (subclasses) of IgA 
designated as IgAl and IgA2. The two isotypes are distributed unequally 
in human serum and secretions. Grey ^  (1968) in a careful analysis 
of the two isotypes in human colostrum found that 35-507» was of the 
IgA2 type but less than 10% of serum proteins were IgA2. The primary 
structure of IgAl and IgA2 are similar (Putman, Liu and Low, 1979), the 
only major difference in their amino acid sequence is in the hinge region 
peptides between Fab and Fc regions where IgA2 has a deletion of 13 amino 
acid residues (Figure 6).
IgA proteases are specific to human IgA and attack only proteins 
of the IgAl isotype, cleaving one of the peptide bonds within the hinge 
region of the heavy chain. Human IgA2 proteins are resistant to this 
enzyme because the hinge region of their heavy chains has a primary 
sequence deletion that involves most of the protease susceptible bonds 
found in IgAl.
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FIGURE 6
Structure of human immunoglobulin A 
(adapted from Kornfield and Plant, 1981)
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The IgAl protease-posilive bacteria so far identified include 
species that cause such human infections as meningitis, sinusitis, 
otitis media, bronchitis, pneumonitis, sexually transmitted diseases and 
bacterial endocarditis, IgAl protease was first clearly identified in 
S. sanguis, a species implicated in the early stages of dental caries 
(Gibbons and van Houte, 1975) and in causing endocarditis in persons 
with structural heart abnormalities (Genco, Plant and Mellering, 1975),
IgAl protease production by Neisseria gonorrhoeae is a constant 
feature of nearly all isolates of these organisms. Isolates harmlessly 
carried in the nasopharynx of normal persons and those obtained from 
cerebrospinal fluid of patients acutely ill with meningitis are all IgA 
protease positive (Plant et al, 1975; MuIks and Plant, 1978),
Haemophilus influenzae, a major respiratory, middle ear and 
meningeal pathogen was IgA protease positive in 95% of all strains 
(Hulks, Kornfield and Plant, 1980; Kilian et al, 1980), All clinical 
isolates of Streptococcus pneumoniae, which causes meningitis and 
pneumonia in man, were IgA protease positive (Male, 1979; Kilian,
Mestecky and Schrohenloher, 1979). Kilian and Holmgren (1981) reported
'
that several pathogens of the periodontal tissues have extracelluar 
proteolytic enzymes similar to IgAl proteases, IgAl specific enzymes 
were identified in Bacteroides melaninogenicus and Streptococcus mltior.
The extent to which IgA proteases become involved in the 
pathogenesis of infectious disease is not known because the mechanism by 
which limited proteolysis of IgA into Fab and Fc fragments may affect 
antibody function at secretory sites has not been determined. It is 
likely that the formation of single Fab fragments reduces the functional 
affinity of the antibody for its antigen by decreasing its raultivalency
f
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and binding efficiency (Hornick and Karush, 1972), Moreover, the 
separation of the antigen-binding Fab portion of the molecule from the 
Fc "effector" segment would be expected to interfere greatly with the 
disposal of antigen by IgA antibody,
6.3 Protease Inhibitors
Proteases can be placed in four wel1-characterized biochemical 
groups (Cohen, 1980; Laskowski and Kato, 1980,^
(i) proteases with a serine residue at the active site - serine proteases,
(ii) proteases with a nucleophilic cysteine residue at the active site -
sulphydryl(thiol) proteases,
(iii) metal-containing enzymes - metalloproteases,
(iv) proteases with an acid pH optimum - acidic (carboxyl) proteases.
By their reaction with enzyme inhibitors the proteases can be 
classified into one of these four groups (Table 3).
Alpha-2-macroglobulin (a2m) is a plasma protease inhibitor 
with a molecular weight of about 800 k.Dal, (Barrat and Starkey, 1973). 
a2m is quite unusual in being able to inhibit all four classes of 
proteases (Hartley, 1960), The mechanism by which oc2m causes inhibition 
is known as the "trap" mechanism (Barrat and Starkey, 1973). The protease 
hydrolyzes one or more particularly susceptible peptide bonds in a2m, and 
triggers a conformational change in a2m which traps the enzyme molecule. 
Proteases which are bound to a2m retain their ability to attack low 
molecular weight substances but are prevented from attacking high 
molecular weight substances due to stearic hindrance.
f
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TABLE 3
CLASSIFICATION OF PROTEASES INTO FOUR BIOCHEMICAL GROUPS
GROUP IDENTIFICATION
FUNCTIONALITY INHIBITORS
Serine Active serine
Metallo- Metal ion
Sulphydryl
Carboxyl
CySH
Acidic pH 
optimum
Soyabean^rypsin inhibitor 
Eggwhi te yfryp sin 
Anti-trypsin 
Phenylmethylsulphonyl 
fluoride
8-hydroxyquinoline 
Pho s pho rami don 
Ethylenediamijtetraacetic 
acid
Chelating agents 
Heavy metals
lodoacetate 
N'Ethylmaleimide 
Dithiothreitol
Peps tatin
Epoxy(p-nitrophenoxy) 
propane
I
I
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7o Vo cholerae EXTRACELLULAR ENZYMES
I7 o1 Mucinase j
Burnet and Stone (1947a) described an activity present in Icultures of V, cholerae that caused desquamation of guinea-pig !
iintestinal mucosa. They regarded this activity as enzymatic in nature |
and thought it might play a role in the pathogenesis of cholera; this j
new enzyme was referred to as mucinase, Burnet (1948, 1949) again 
drew attention to the existence of an enzyme or group of enzymes 
produced by V, cholerae that rapidly destroyed the viscosity and hence
I
the mechanical protective properties of intestinal mucus. It is j
significant that in these early papers Burnet had realised the |
possibility that there might be a mucinase complex containing a number of I
enzymes, including possibly mucinases, neuraminidases and proteases, |I
The immunological studies of Singer, Wei and Hoa (1948) i
showed that the mucinase activity could be neutralized by antiserum 
raised against products of V. cholerae in the culture filtrates, but in 
addition, they found that the activity was neutralized by antisera to 
the "0"-antigen of V. cholerae. On the other hand, Jensen (1953) showed 
that antisera to culture filtrates had a high neutralizing power but 
that "0"-antisera were ineffective, this confirmed the earlier work of 
Burnet (1947a). Narayanou, Devi and Menon (1953) and Singh and Ahuta 
(1953) also found mucolytic activity in V, cholerae cultures, and that 
some ej^  tor and non-agglutinating vibrio strains isolated from water also 
produced enzymes capable of desartquamating intestinal mucosa. The 
production of a mucinase enzyme by some non-pathogenic vibrios was 
also noted by Singh and Ahuja (1953), Lam and Mandle (1954) demonstrated
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that vibrio mucinase increased the permeability of isolated mouse 
intestinal Loops and they were able to neutralize this effect by active 
and passive immunization against the homologous mucinase,
Freter (1955) reported the presence of two serological types 
of mucinase occurring in varying combinations in V, cholerae strains.
The data he presented indicated that the titre and serological type of 
mucinase, produced ^  vitro, had no direct relation to virulenceo 
After a period of 35 years since Burnet's first paper on 
mucinase, Schneider and Parker (1982) reexamined the purification and 
characterization of V. cholerae mucinase. The mucinase possessed 
protease activity (discussed in section 7,3) but no neuraminidase 
activity was detected in this particular preparation. The lack of 
neuraminidase may have been due to the growth conditions and purification 
procedure, neither of which were optimal for neuraminidase production 
(Ada, French and Lind, 1961)o
The mucinase activity produced vitro appears to have only 
protease activity but whether this is the case vivo is not known.
It would seem more likely that the vivo mucinase is a complex of 
enzymes rather than one single enzyme,
7,2 Neuraminidase
Neuraminidases are enzymes with the common ability to hydrolyse 
the a-O-ketosidic bond between sialic acid residues and neighbouring 
carbohydrates (Figure 7), The existence of these enzymes was shown in 
viruses, bacteria, protozoa and vertebrates (Drzenaik, 1972; Gottschalk 
and Drzeneik, 1972),
The ability of culture fluids of Vo cholerae to render human
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FIGURE 7
Action o£ neuraminidase on bovine submaxillary gland 
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human red cells inagglutinable by influenza virus was first noticed by 
Burnet, McCrea and Stone (1946)o They described the active principle 
as the receptor-destroying enzyme (RDE) of V. cholerae (Burnet and 
Stone, 1947)o Gottschalk and Lind (1949) provided early evidence about 
the chemical activity of RDE but the enzyme was not characterized as a 
glycosidase until 1956 (Gottschalk, 1956; Heimer and Meyer, 1956),
The enzyme was originally named sialidase (Heimer and Meyer, 1956) but 
it is now more commonly known as neuraminidase (Gottschalk, 1957),
Early purification of RDE (Ada and French, 1950) was difficult 
and complex but some of these difficulties were overcome when it was 
found that the addition of N-acetyl neuramin-lactose to a simple medium 
greatly stimulated enzyme production (Ada and French, 1957; Ada and 
French, 1959a,b). Purification procedures and chemical and physical 
properties of the RDE were reported by various groups (Ada and French, 
1959b; Ada, French and Lind, 1961; Pye and Curtain, 1961),
Burnet (1949) reported that the mucinase and the RDE were 
different enzymes. Studies by Kusama and Craig (1970) supported this
:
statement since the time course for the production of the two enzymes 
was quite different.
Comparatively little is known about the function of bacterial 
neuraminidases although it is believed that one function may be to 
prepare the cell surface for attachment of pathogens particularly as more 
neuraminidase is excreted by pathogenic than non-pathogenic bacteria. 
Indeed only a few instances of non-pathogenic organisms which produce 
neuraminidase have been reported (Kunimoto e_t 1974), Therefore 
bacterial neuraminidase may "process" complex glycoproteins by removing
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removing those sialic acid residues joined to the backbone of the 
glycoprotein by susceptible chemical bonds (Hutchison and Kabyo, 1977),
Durihin, Popova and Kobrinskii (1976) found a high degree of 
correlation between synthesis of both enterotoxin and neuraminidase and 
it was suggested that these products acted cooperatively during the 
development of cholera. Neuraminidase was shown to increase the number 
of receptor sites on the epithelial membrane available for the binding 
of enterotoxin. This property of the enzyme, however, was rejected by 
Holmgren e_t al^  (1975), Holmgren (1981) found that neuraminidase 
treatment of intestinal epithelium tissue did not create new receptor 
sites for cholera enterotoxin.
Neuraminidase was implicated as a virulence factor not only in 
V. cholerae but also in streptococci (Milligan, Straus and Mattingly, , i
1977; Milligan et al, 1978; Davis, Mansoorbaig and Ayoub, 1979),
Pasteurella strains (Frank and Tabataki, 1981) and in other bacterial 
species that secrete or produce cell bound neuraminidase (Ray, 1977;
Smith, 1977 ; Pardo.e, 1974)
7,3 Proteases
Proteases are regarded as dégradative enzymes which are 
capable of cleaving proteins into small peptides and amino acids. This 
proteolytic activity is generally detected by digestion of proteins such 
as casein or gelatin.
Until 1981, very little work had been done on V, cholerae 
protease activity. Since then a number of workers have taken an 
interest in this area expanding the knowledge of extracellular pro tease 
activity in V, cholerae.
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A protease-type activity in the culture filtrates of 
V, cholerae was first noted by Burnet and Stone (1947a), Kusama and 
Craig (1970) suggested that the protease and lytic activity factor, also 
found in V, cholerae supernatant culture fluids, were the same enzyme. 
However, these were quite distinct from the neuraminidase,
Hsieh and Liu (1970) used a serological approach to study the 
protease activities of the so-called non-agglutinable (NAG) vibrios and 
those of V, cholerae. Proteases from the NAG vibrios were serologically 
indistinguishable from the enzymes produced by classical strains of 
V, cholerae, but were distinct from those produced by Vibrio metchritcovii 
and Aeromonas liquefaciens. Dahle and Sandvik (1971) also examined 
the serological characteristics of V. cholerae proteases. In contrast 
to Hsieh and Liu (1970), they found serological cross reactions between
I
i
protease fractions of Aeromonas liquefaciens and V. cholerae
Dahle and Sandvik (1971) used a zymogram technique to analyse 
the pro tease activity of V. cholerae. This technique involved the 
electrophoretic separation of proteases in polyacrylamide gels which 
were subsequently covered with a sodium caseinate gel allowing local-
'ization of the different proteases. Most of the strains examined 
produced more than one extracellular protease fraction, Sandvik and 
Dahle (1971) showed that some strains of V. cholerae produced two or
Imore serologically different proteases. These results suggested the
.idea of a complex pro tease system in V, cholerae,
Schneider, Sigel and Parker (1981) used a simple method, 
peptide digest analysis, to characterize the proteolytic activities 
of various V, cholerae isolates. This technique utilized the catalytic 
specificities of proteases as a basis for typing strains of V. cholerae,
s
 _
I
■ïi
A standard protein was used as the substrate for proteases found in 
culture supernatant fluids. The unique peptides generated by 
cleavage were separated on the basis of relative molecular weights by 
sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE),
The unique banding patterns generated in the gels were used as the 
basis for catalytic typing, V, cholerae supernatant culture fluids 
from most isolates revealed the presence of similar proteases as 
monitored by their peptide digest patterns and immunological 
reactivities. These observations agree with the earlier work of 
Hsieh and Liu (1970),
A genetical approach was used by Schneider and Parker (1978) 
to consider the role which extracellular enzymes may play in experimental 
infections with V, cholerae. Evidence was presented that most mutants 
deficient in proteolytic activity had reduced virulence for experimental 
animals. These authors suggested that a specific protease, rather than 
the total proteolytic activity, was involved in the virulence of 
V. cholerae as protease-deficient mutants showed no correlation between 
absolute protease levels and the LD^^ values. The protease(s) was 
thought to be involved in either maintenance or growth of the organisms 
in the gut. This work was done with pro tease-deficient mutants but 907, 
of these mutants were also neuraminidase-deficient, so this particular 
set of results should be interpreted with care as the neuraminidase 
deficiency may also be aiding in reducing the virulence of these mutant 
s trains,
Increased interest in V, cholerae proteases has been apparent 
during the course of my studies. Three major papers which support the 
experimental work to be described in this thesis have appeared in the
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literature during the past two years. Consequently, these will be
reviewed in'some detail. Table 3 summarizes the protease nomenclature 
used in these papers.
T
During studies on the role of the mucinase of V. cholerae CA401
in virulence, Schneider and Parker (1982) found the enzyme was an 
alkaline protease. Under the conditions used the mucinase was the 
only extracellular protease produced. The protease was purified by 
precipitation with 707. (w/v) ammonium sulphate and gel filtration on a 
column of either BioGel P-100 or Sephadex GlOO. The elution profiles
from these columns showed two peaks of protease activity. These were 
termed fraction 3 and fraction 4. The apparent molecular weights of 
fraction 3 and fraction 4 on Sephadex GlOO columns were 38 k.Dal. and 
22 k.Dal, respectively. The comparative peaks off BioGel PlOO columns
were 18 k.Dal and 10 k.Dal. SDS-PAGE and non-denaturing PAGE gels of 
fraction 3 showed a single band with a molecular weight of approximately 
36 k.Dal, Schneider and Parker suggested that the elution of the 
fractions from the BioGel PlOO was retarded, possibly due to an interaction 
with the gel matrix. Both molecular weight forms, fraction 3 and fraction 
4, exhibited similar properties, both were inhibited by (i) heavy metals 
but not by naturally occurring protease inhibitors and (ii) antiserum to 
purified mucinase. Antiserum to mucinase passively protected infant 
mice from diarrhoea caused by V. cholerae challenge.
A high protease-producing strain, V. cholerae el tor 1621 hip, 
was obtained by N-methyl-N -nitro-N-nitrosoguanadine mutagenesis of 
V. cholerae el tor 1621 (Young and Broadbent, 1982), Isoelectric
■:.:rfocussing of the culture filtrates showed the presence of at least three 
types of V, cholerae extracellular proteases. The wild type strain 
contained predominantly a protease with a pi of 4,2 which was sensitive
'.A:'.;
TABLE 4
Summary of Vo cholerae protease nomenclature
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Reference Strain Protease
Scheider and Vo cholerae Fraction 3
Parker (1982) CA401 Fraction 4
Young and V. cholerae I
Broadbent (1982) eltor 1621 II
Vo cholerae IIA
eltor 1621 hip IIB
IIIA
IIIB
Finkelstein and V. cholerae pi 6o 3
Hanne (1982) CA401 pi 5,3
pi 4.7
I
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to serine pro tease inhibitorSo This was termed type I protease. 
Activation of cholera toxin by limited proteolysis of the A subunit was 
also sensitive to serine protease inhibitors (Gill and Rapport, 1979; 
Makalanes, Collier and Romig, 1979) therefore Young and Broadbent 
suggested this may involve type I protease. No results have been shown 
to confirm this suggestion. The minor protease in the wild-type strain 
and the major protease in the mutant strain was termed protease IX, 
Protease II resembled the proteases described by Schneider and Parker 
(1982) as it was resistant to metalloprotease and serine protease 
inhibitors and possessed mucinase activity. Two peaks of type II
protease were found and differed by 1,2 pi units in isoelectric 
focussing point and by 1,5 k.Dal, in molecular weight; these were 
termed IIA and IIB. The mutant strain also contained a minor protease, 
proteaseXII, which was a typical metalloenzyme. Two peaks of
type III protease were found and differed by 0,3 pi units; these were 
termed IIIA and IIIB. Protease III was not detected in the wild-type 
s train.
The presence of four types of haemagglutinins in V. cholerae 
CA401 was described by Hanne and Finkelstein (1982), One of these 
haemagglutinins, the soluble haemagglutinin was purified to apparent 
homogeneity by a sequence of ammonium sulphate fractionations, gel 
filtration and preparative isoelectric focussing (Finkelstein and Hanne,
1982). The tremendous loss of activity during purification led to 
the observation that the soluble haemagglutinin was also a protease,
' ■
Analysis of protease activity after preparative isoelectric focussing
.revealed major regions of activity which focussed at pH 6,3 and in a 
broad area from 5.3 to 4.7, These corresponded almost exactly with
________
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the pis of the haemagglutinin activity. Antiserum raised against the j
purified haemagglutinin inhibited the protease activity and also :
inhibited attachment of V. cholerae to intestinal epithelium. However, |
I
further studies indicated that the two activities had different !
temperature requirements. The haemagglutinin titres were relatively |
constant over the temperature range 4° to 37°C, whereas 100-fold |
differences in protease activity were observed between 4° and 25^G, Î
These observations suggest that the haemagglutinin and protease I
activities may be independent functions of the same molecule.
This soluble haemagglutinin/protease was also found in a cell- 
associated form in. vivo (Finkelstein, Boesman;— Finkelstein and Holt,
1983). Finkelstein and his colleagues suggested that the purified 
haemagglutinin/protease was functionally identical to the mucinase 
described earlier by Burnet and Stone (1947a) and Burnet (1949), They 
came to this conclusion because (a) the haemagglutinin/protease degraded 
ovomucin and (b) antiserum against the purified haemagglutinin inhibited 
the mucinase activity. This correlation between mucinase and protease 
activity was noted previously by Schneider and Parker (1982) and Young 
and Broadbent (1982),
The haemagglutinin/protease hydrolysed fibronectin and lacto- 
ferrin (Finkelstein, Boesman^Finkelstein and Holt, 1983) two proteins 
that may participate in host defence against cholera, Fibronectin is 
an adhesive high molecular weight glycoprotein that is present on the 
surface of mammalian cells (Yamada and Olden, 1978) and has been shown 
to be synthesized by the crypt cells of the intestinal epithelium 
(Quaroni, Isselbacher and Ruoslahti, 1978), Fibronectin was reported 
to interfere with the adherence of Pseudomonas aeruginosa to epithelial
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cells (Woods et al, 1981). Lactoferrin has been assumed to play a 
major role in host defence by withholding essential iron and thus 
reducing its availability to microbes in mucosal secretions (Bullen,
1981).
Finkelstein, Boesman-Finkelstein and Holt (1983) found that 
the A subunit of the choleragen-related heat-labile enterotoxin of 
E. coli was nicked at a specific site by the haemagglutinin/protease.
It was suggested that this was the mechanism by which cholera enterotoxin 
is activated, although no work has been done as yet with cholera 
enterotoxin.
Recently the soluble haemagglutinin/protease was shown to be 
a zinc metalloenzyme by Booth, Boesman-Finkelstein and Finkelstein (1983), 
Both its haemagglutinating and protease functions were inhibited by 
chelating agents including a specially designed inhibitor of zinc 
metalloenzymes, Zincov (Nishino and Powers, 1979),
As mentioned above, the soluble haemagglutinin/protease was 
shown (Finkelstein, Boesman-Finkelstein and Holt, 1983) to nick the A 
subunit of the heat-labile enterotoxin of E. coli. Young and Broadbent 
(1982) suggest that this proteolytic activity would be sensitive to 
serine protease inhibitors, as was apparent with protease I isolated 
from culture supernatant fluids of V, cholerae el tor 1621, Both, 
Boesman-Finkelstein and Finkelstein (1983) have shown the haemagglutinin/ 
protease to be resistant to serine pro tease inhibitors but still capable 
of nicking the A-subunit of the heat-labile enterotoxin of E. coli.
By considering this recently published work it would appear 
that V, cholerae has numerous extracellular proteases. They differ in 
their molecular weights, their pi values and susceptibility to inhibitors
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There also appears to be a close relationship between protease, 
mucinase and the soluble haemagglutinin.
The work of Din and his colleagues (Din ^  al, 1981) showed 
that proteolytic enzymes altered the biochemical and biophysical nature 
of cervical mucus and so enhanced sperm migration through the mucus. 
Since V, cholerae must move through the mucus layer covering the mucosa 
the cholera proteases may be involved in this movement in a similar 
manner to the enhanced sperm migration through mucus gel treated with 
proteolytic enzymes. Protease activity was also shown to enhance the 
adherence of bacilli to human buccal epithelial cells by altering the 
epithelial cell surface (Woods et al, 1981), Cholera proteases may be 
involved in the adherence of vibrios to the epithelial cell surface by 
altering this surface in a manner that makes it more susceptible to 
vibrio attachment.
■ ,
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Object of Research
s
The main aim of this project was to determine the role of 
Vibrio cholerae extracellular protease(s) in the pathogenesis of 
cholera. Initially, the plan was to purify and characterize the 
proteases and to consider their role in adherence. Since existing 
vaccines for V, cholerae were shown to be ineffective in the duration of 
immunity induced the main objective was to examine the possible 
beneficial effects of adding the characterized protease(s) to 
experimental V. cholerae vaccines.
This thesis describes a variety of procedures used to prepare 
and purify the protease enzymes of V, cholerae, characterize the 
specific activities of these enzymes in an attempt to explain their role
in colonization, adherence and virulence of the organism. Finally
laboratory animals were immunized with vaccines containing the protease 
enzymes either alone or in conjunction with neuraminidase or enterotoxoid.
MATERIALS AND METHODS
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MATERIALS AND METHODS
1, Bacterial Strain
The organism used throughout these studies was Vibrio cholerae 
NCTC 10732, this is a classical biovar with Inaba serovar obtained from 
the National Collection of Type Cultures, Londono
2, Growth Media
Trypticase soy broth (TSB), Appendix lA from BBL (Becton,
Dickson & Co., Cockeysville, M.D.) was used to grow V. cholerae for the
production of proteases both in batch and fermenter-cultures.
A modified minimal medium syncase (Appendix 2, Finkelstein 
and Lankford, 1955) was used to grow V. cholerae for the radioactive 
adherence assays. This medium was modified by changing the carbon 
source from sucrose to glucose (Appendix 2B).
V. cholerae for use in ileal loop challenges was grown in
TU (w/v) protease peptone (Gibco Biocult Diagnostics).
Starter cultures of V. cholerae used to inoculate these media 
were grown on BBL trypticase soy agar (TSA) plates (Appendix IG).
3, Production of V. cholerae proteases
3.1 Batch Cultivation
Vo cholerae was grown overnight on TSA plates at 37°C, the 
growth was harvested by flooding the agar plate with sterile TSB. This 
cell suspension, 10 ml, was added to 500 ml of sterile TSB in 2 litre 
dimpled flasks. Six 2 litre flasks were inoculated for each batch and 
these were shaken on a rotary shaker at 150 rpm for 24 h at 37^C. The 
cultures were centrifuged at 9,000 rpm (7,000xg) for 20 min at 4°C in an
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MSE 21 High-spln centrifuge. The supernatant culture fluids were 
decanted and ammonium sulphate (BDH Chemicals, Poole, England, specially 
low in heavy metals) added slowly with stirring at 4°C to a final 
concentration of 85% saturation. The ammonium sulphate precipitates 
were stored at 4°C until required. The precipitate was removed by 
centrifugation at 9,000 rpm (7,000xg) for 15 min at 4°C in an MSE 21 
High-spin centrifuge. The supernatant fluid was decanted and the 
precipitate redissolved in a minimum volume of distilled water, this 
was extensively dialysed against distilled water for 48 h at 4°C to remove 
the ammonium salts,
3,2 Fermenter cultivation
V. cholerae was grown overnight in 500 ml TSB and this culture 
was added to 14.5 litres of sterile TSB in the fermenter vessel (L.H. 
Engineering Go, Ltd.). The stirrer was started at 500 rpm and the air
flow at 1 0  litre min after 2  h the stirrer and air flow were turned
down to 300 rpm and 2 litre min  ^ respectively. The antifoam used was 
silcolapse 5000 (Sigma Chemical Co. Ltd.). After 24 h, 1 g of 
merthiolate (Sigma) in 100 ml sterile distilled water was added and left 
for 1 h. The suspension of killed V. cholerae was removed from the 
fermenter vessel under positive air pressure. An attempt was made to 
precipitate the cells by adding 75 g of calcium chloride but this was not 
very effective. Therefore, the culture was centrifuged at 9,000 rpm 
(7,000xg) for 20 min at 4^C in an MSE 21 High-spin centrifuge > the 
supernatant decanted and ammonium sulphate added slowly with stirring at 
4°C to 857. saturation. The precipitate was removed by centrifugation 
at 9,000 rpm for 15 min at 4°C in an MSE 21 High-spin centrifuge. The
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precipitate was redissolved in a minimum volume of distilled water and 
dialysed for 48 h against distilled water at 4^G. Any precipitate not 
required immediately was stored at 4 ^0 .
4o Enzyme Assays
4.1 Protease Assays
4.1.1 Dimethylcasein assay
Proteolytic activity was measured by the method of Lin, Means 
and Feeny (1969) with N,N-dimethylcasein (DMC) as the substrate. This 
assay was used for all protease measurements unless otherwise stated.
Preparation of substrate
The substrate for the DMC assay was prepared by dissolving 1,5 g 
of casein (Sigma) in 150 ml of O.IM borate buffer, pH 9.0 by warming at 
37°C and subsequently cooling to 0°C. The slightly cloudy solution was 
rapidly stirred and 300 mg of sodium borohydride were added, A few 
drops of 2-octanol (B.D.H. Chemicals Ltd,) were added to prevent any 
subsequent tendency to foam. Formaldehyde, 3 ml, was added in 100 pi 
increments over a period of 30 min. Stirring was continued for a further
2-3 min and the solution acidified to pH 6.0 by the addition of 50% 
acetic acid. This solution was dialysed against distilled water for 
24 h at 4°C and the desalted protein was lyophilized and stored at -20°C 
as a fluffy white powder.
Assay procedure
The V, cholerae protease sample 0,1 ml was added to 1,0 ml of a 
solution of 0,1% (w/v) DMC at pH 9,0 and incubated for 30 min at 38°C,
The proteolytic reaction was stopped by heating the mixture briefly (1 min)
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in a boiling-water bath. After cooling, 1,0 ml of a solution of 0,17, j
(w/v) trinitrobenzene sulphonic acid (Sigma) and 1,0 ml of a 4% (w/v) |
sodium bicarbonate solution, pH 8,5, were added to each mixture. The !
Q y-r.îmixture was incubated in the dark for 30 min at 50 C, Subsequently, j
1.0 ml of 10% (w/v) sodium dodecylsulphate solution and 0,5 ml of IN HGl i
;
solution were added. The absorbance of the resultant yellow solution |
was read at 340 nm in a Unicam SP500 spectrophotometer. To measure ;Icell-associated protease activity, an overnight V, cholerae culture was I
washed twice in PBS and resuspended in PBS to give an absorption value |
of 0,4 at 600 nm. This V, cholerae suspension, 0,1 ml, was added to \
1.0 ml of 0,1% (w/v) DMC and incubated for 30 min at 37^C, Following |
I
incubation the samples were centrifuged to remove the vibrios, the I
supernatant removed, and the assay continued as explained previously, j
Calculation of enzyme activity I
I
The molar extinction coefficient is the absorbance of a IM Iisolution of the material of interest at the chosen wavelength and has |
1 " I  -the dimensions litre mol cm . The molar extinction coefficient |
values of various trinitrophenol a-amino acids have been determined by j
many workers (Okuyama and Satake, 1960; Satake ^  al, 1960; Ozols and
Strittmatter, 1966), These molar extinction coefficient values vary
slightly with different a-amino acids from 1,1 x 10^ to 1,5 x 10^, but \
have an average value of 1,3 x 1 0 ^, By using the value 1.3 x 1 0 ^, the I
results from the DMC assay can be expressed in terms of the number of
primary amino groups present irrespective of the peptide bond from which
they were derived (Lin, Means and Feeny, 1969), This allows the direct
expression of proteolytic activity in terms of the number of bonds split.
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The molar concentration of cleaved bonds can therefore be calculated 
from the relationship,
^340 nm
NH„-terminal
 ^ 1.3 X 10^
The enzyme activity is then calculated as
One enzyme unit (EU) = 1 pmol of free amino groups
-1 , -1generated min ml of protease
sample.
4.1.2 Azoalbumin Assay
The azoalbumin protease assay was modified from Tomareli,
Charney and Harding (1949) as used by Finkelstein and Hanne (1982),
Azoalbumin (Sigma Chemical Co.) 5 mgml  ^ in distilled water was the 
enzyme substrate. This substrate, 100 pi (0,5 mg) was mixed with 
50 pi of the cholera sample being tested, and incubated at 37^C. After 
1 h, 3 ml of 37o (w/v) trichloroacetic acid was added to precipitate 
undigested substrate. The mixtures were left at room temperature for 
20 rain and centrifuged at 900xg for 10 min in an MSE minor bench
■icentrifuge. The supernatant fluid, 2 ml, was decanted and added to 2 ml 
of 0.5M NaOH. The neutralized samples were agitated briefly and the
optical density at 440 nm was determined in a Unicam SP500 spectrophoto­
meter. A standard curve of digested substrate was generated by
.incubating different concentrations (0,05 mg - 0,5 mg) of the azoalbumin 
substrate with 1 mg of pronase (Sigma) per ml for 1 h to effect 
complete digestion. One unit of protease activity by this assay was 
defined as that which will digest 2 0 % of the substrate (ie, 0 , 1  mg) in 
1 h.
_______ ;   ' ’ I
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4,1.3 Digestion of casein
Casein plates were prepared by the method of Schneider and
Parker (1978). Trisodium citrate (4.41 g) was dissolved in 1 litre of
distilled water. Nutrient broth powder (8,0 g, Gibco), 5,0 g 
tryptone (Difco), 2,5 g yeast extract (Oxoid) and 1.0 g glucose (B.D.H.) 
were dissolved in 500 ml of the citrate solution. Sodium caseinate,
10,0 g (Difco) was dissolved in the remaining 500 ml. The two
solutions were combined, the pH was adjusted to 7,5 with IN NaOH and 20 ^
of purified agar (Oxoid) was added. After autoclaving for 15 min at 
121 psi the medium was cooled to 50°C, merthiolate was added to a final 
concentration of 0.0017, (w/v) and 1.0 ml of IM calcium chloride solution 
was added before the plates were poured. Casein agar (10 ml) was 
added to each petri-dish and when the medium was solid, walls were cut 
with a no,2 cork borer. Samples, 15 pi, were added to each well and 
the plates incubated at 37°C for 18 h. The diameter of the zone of 
precipitation was measured and this was compared with the zones of 
precipitation produced by trypsin (Sigma, type III) standards.
Ii
4,2 Neuraminidase Assay
Neuraminidase was measured by the method of Sedmqck and 
Gn^sberg (1973). Neuraminidase was measured by its hydrolysis of
2-(3methoxyphenol)-N-acetyl“OC neuraminic acid (MPN) which liberated
3-methoxyphenol (MP) (Figure 8 ), MP can combine with the diazonium 
salt of 4-amino 2, 5-dimethoxy-4-nitroazobenzene (DS.ADNB) to give a 
water soluble chromogen.
Assay procedure
The test sample (0.1 ml) was warmed to 37^C for 2-3 min and
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F I G U R E  8
Enzymatic hydrolysis of 2-(3*“methoxyphenyI)-N“ 
acetyl-alpha-neuraminic acid (MPN)o The enzyme 
hydrolyses the ketosidic|at"~C-2 of N-acetyl
Neuraminic acid
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One enzyme unit (EU) was defined as 1 (imol of methoxyphenyl
I
-2the reaction started by the addition of 0,1 ml of MPN (10 M in 0,1M
phosphate buffer, pH 5,9)o The mixture was incubated at 37°C and §
after 30 min the reaction was stopped by the addition of 25 pi of IM
tetra-sodium EDTA in 0,1M phosphate buffer, pH 5,9. The samples were
- 1immersed in ice and 0,2 ml of 6  mgml DS-ADNB (Koch Light, Fast black 
K salt) in 0.4M phosphate buffer, pH 7,0 was added. The precipitate 
which formed after 30 min at O^C was solubilized by the addition of 4 ml 
of 0,5N NaOH, The absorbance at 580 nt^ resultant blue solutions were 
read in a Pye-Unicam SP500 spectrophotometer,
Standard curve
I
A standard curve was obtained to determine the absorption of 
the solubilized chromogen formed from MP and the DS-ADNB, as a function 
of the concentration of MP,
Standard solutions of MP from 20-100 n,moles were prepared 
in 0,1M phosphate buffer, pH 5,9 containing 2 x 10 ^M GaCl^. The 
standard solutions were added to 0,1 ml of 0,1M phosphate buffer, pH 5,9
.t
and incubated at 37^C, After 30 min the reaction was stopped by the 
addition of 25 pi of IM tetra-sodium EDTA. The mixtures were immersed 
in ice and 0,2 ml of DS-ADNB added. After 30 min at 0°G the 
precipitates that formed were solubilized in 4 ml of 0.5N NaOH, The 
absorbance was measured at 580 nm in the SP500 spectrophotometer, |
Galculation of specific activity
-1 -1generated min ml of sample. This was read from the standard curve.
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4,3 Mucinase Assay
Ovomucin was prepared by the method of Kusama and Craig (1970)
■FÎs
Ï
3
The whites of 12 eggs were freed of chalazea and poured into 4 litres of 
distilled water at 4^C, The precipitate formed after 30 min of stirring 
was centrifuged off (7,000xg, 20 min) and dissolved in 10% NaCl, This 
was diluted with distilled water to a salt concentration of 0,85%» To 
the final preparation thiomersal was added to a final concentration of 
0,001% (w/v)o Serial two-fold dilutions of mucin in PBS in 1 ml amounts, 
were made and one drop of 1 % (w/v) cetyltrimethylammonium bromide was
added. The highest dilution which gave a characteristic fibrous clot 
was considered one clot forming unit.
Two clot forming doses in 0,5 ml were added to equal volumes
of serial two-fold dilutions of the protease samples being tested.
These mixtures were kept at 37 C for 1 h. One drop of 1% (w/v) cetyl- 
.trimethylammonium bromide (Sigma) was added to each sample to detect
undigested mucin. The reciprocal of the highest dilution of the
protease sample which prevented clot formation was taken as the number of
- 1units in the sample. All samples tested were standardized to 15 EU ml
■of protease activity before use in the assay,
5, Other Assays
5,1 Haemagglutination Assay
The samples being tested were diluted in serial two-fold 
dilutions in round-bottomed microtit(%_ plates in 25 pi of PBS, Red
:blood cells (rbc), either sheep or chicken, (1,5%) were added in 25pl, 
the plates were tapped to mix interactants, and rbcs were allowed to
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settle at 25°C for 30 min. The titre was defined as the reciprocal of 
the highest dilution in which haemagglutination was visible to the naked 
eye. For determination of cell-associated haemagglutination, vibrios 
were washed twice and suspended in PBS to give an absorption value of 
0,4 at 600 nm and the assay continued as described,
5,2 Limulus Amoebocyte Lysate Assay
The Limulus amoebocyte lysate (LAL) was used to rapidly detect
Gram-negative bacterial endotoxin. Single test vials were supplied by
MoA, Bioproducts, Maryland,
These single test vials contain a lysate prepared from the
circulating amoebocytes of the horse shoe crab Limulus polyphemus,
standardized to detect 0,25 ngml  ^ of reference endotoxin.
All glassware was treated with Toxa-clean (Sigma) to remove
any pyrogen by soaking overnight in a 1 % (w/v) solution and drying in an
oven. Pyrogen-free water (Sigma) was used for sample dilutions and
strict aseptic techniques were employed throughout the assay.
The test sample (200 pi) was added to a vial of lysate, mixed
gently until the contents were in solution and incubated at 37°C for 1 h,
2 0 0  pi of pyrogen-free water was added to another vial of lysate as a
negative control. Positive controls were set up with E. coli endotoxin,
10 ngml  ^ and 1 mgml  ^ (Sigma), Reading of the test after exactly 1 h
incubation was done by gently everting the vials on a flat surface,
A positive test is characterized by the formation of a solid gel, a
negative test shows no gel or clot but may show an increase in turbidity.
Inhibition control vials were supplied. These contain the lysate as in
- 1the test vials but also 1 ngml of E, coli endotoxin. At the end of
the incubation period a positive reaction should be observed with all
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samples in the inhibition control. If the reaction is negative the 
sample is inhibitory and any associated LAL test with this sample is 
invalid. Table 5 shows the possible combination of test results,
5 0 3 Toxin Assay - Intradermal Blueing Test in Rabbits
The animal injections in this assay were done by Dr, D,E,S, 
Stewart-Tull,
New Zealand white rabbits were injected with 0,1 ml of test 
sample intradermally, into an area of skin shaven with Ostler Animal 
Grooming Clippers (Model A-5), After 18-24 h, 3 ml of a 57, (w/v) 
solution of Pontamine Sky Blue 6 XB (Difco) were injected intravenously 
into an ear vein. One hour later the diameter of the zones of blueing 
on the skin were measured. The toxin dose which produced a blueing 
zone of 8  mm in diameter was equivalent to one blueing dose (1 BD).
5,4 Protein Estimations
(i) The method of Warburg and Christian (1941) was used to 
estimate the protein concentration in samples. The extinction of the 
samples at 260 nm and 280 nm was measured on a Pye-Unicam SP500 spectro­
photometer, The ratio of ^280^^260 calculated and from this a
factor is obtained for the calculation of protein concentration.
The protein concentration is given by:
Protein concentration (mgml )^ = x Factor x ^/^,
where d = length of the light path in cm,
(ii) The method as described by Lowry <et al^  (1951) was used 
for protein estimations with bovine serum albumin (Sigma) as the standard 
protein.
______
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TABLE 5
POSSIBLE COMBINATIONS OF TEST RESULTS FROM 
LIMULUS AMOEBOCYTE LYSATE ASSAY
Test Results
(Gel Formation)
Test
Endotoxin
Sample
Inhibitor
Tes t 
Vial
Nego
Con­
trol
Pos. 
Con­
trol
Inhibo
Con­
trol
Acceptable Test
+ + - + + yes
“ - ~ + + yes
_ + - + - no
(inhibitor present)
+ + - « + - no
(inhibitor present)
+ + + + no
(inhibitor present)
+ = gram negative endotoxin present 
= gram negative endotoxin absent
*With high concentrations of endotoxin and an inhibitor present in test 
sample, this combination may occuro
______
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6o2 Gel Filtration
The column (2„5 cm x 55 cm) was filled with a slurry of
Purification of Proteases
6,1 Ammonium sulphate precipitation
The precipitation was carried out as described in section 3,
The ammonium sulphate precipitates were centrifuged at 9,000 rpm (7,000xg) 
for 15 min at 4°C in an MSE 21 High Spin centrifuge. The precipitate 
was dissolved in a minimal amount of distilled water and dialysed for 
48 h at 4°C with several changes of distilled water. The dialysed 
sample was concentrated to about a quarter of its original volume using 
Aquacide IIA (Galbiochem, La Jolla, C,A.), This was termed "crude 
protease", and stored at -20°C until required.
Sephadex GlOO (Sigma) and was equilibrated with borate buffer (0,05M, 
pH 9,0^ by running several litres of this buffer through the gel. The 
crude protease (approximately 10 mg in 5 ml borate buffer) was applied
to the column and was eluted with borate buffer (500 ml, 0,05M, pH 9,0) 
at a rate of 1 mlmin Fractions (3,0 ml) were collected on an LKB
Ultrorac 7000 fraction collector and their absorbance at 280 nm was 
measured in a Unicam SP500 spectrophotometer.
Molecular Weight estimation from gel filtration
The Sephadex GlOO column was equilibrated with borate buffer 
and a sample containing 1 0  mg of each of the following standards in 5  ml 
borate buffer were added to the column;
Cytochrome c, 12,4 k.Dal, (Sigma)
Chymotrypsinogen A, 25 k.Dal, (Sigma)
I
7Ovalbumin 45 k.Dal. (Sigma)
Bovine serum albumin 67 k.Dal, (Sigma),
The column was eluted with borate buffer (500 ml) at a rate of 1 mlmin 
Fractions (3,0 ml) were collected and their absorbance at 280 nm measured 
as before,
A graph was drawn of eluate volume against ^  readings
and from this a graph of eluate volume (V^) against log molecular 
weight of the standard proteins was drawn. From this second graph the 
molecular weight of the protease sample was determined,
6,3 Isoelectric Focussing
Crude protease was dialysed against 17, (w/v) glycine for 24 h 
before electrofocussing. Isoelectric focussing was carried out in a 
step gradient of 0 to 50% (w/v) sucrose containing Ampholine buffers at 
pH 3,5-10.0 (LKB Instruments Inc., Rockville) in a 110 ml LKB electro- 
focussing column (Vesterberg, 1971). The voltage across the column 
(anode at the bottom) was gradually increased to 800V (maximum power, 
2.0W), and the column was kept at 0 to 4°C by circulating ice-cold 
water through the cooling jacket. After 24 h the power supply was 
switched off, and fractions (2 , 0  ml) were collected from the bottom of 
the column using a Hiloflow peristaltic pump (F.A. Hughest and Go,, 
Surrey).
The carrier ampholines were separated from the protein samples 
in each fraction by prolonged dialysis ( 7  days) against borate buffer 
(0.05M, pH 9,0). The fractions were assayed for protein, protease, 
neuraminidase, mucinase and haemagglutinating activity. The reagents 
used for isoelectric focussing are shown in Appendix 4,
78
7,2 Gelatin-PAGE
" I3
7. Polyacrylamide gel electrophoresis (PAGE)
7 0 1 Sodium dodecyl sulphate (SDS)-PAGE
The method used was based on that of Laemmli (1970) as 
modified by Ames (1974), Electrophoresis was done in the presence of 
SDS. Separating and stacking gels contained respectively 11% (w/v) 
and 5% (w/v) acrylamide (Appendix 5),
The test sample was prepared by mixing an equal volume with 
one volume of solubilizing buffer (Appendix 5 ) and heating to 100°C
for 5 min. Samples of 75 p.1 were added to each track in the gel.
Gels were run in 1/10 dilution of running buffer at a constant current 
of 15 mA for approximately 3 h in a Shandon analytical PAGE outfit 
(Shandon Southern Instruments Ltd., Surrey, England). When the tracking 
dye front had reached the bottom of the resolving gel the gels were 
stained for 1 h and destained. The buffers, gels, stain and destain
.are described in Appendix 5, Molecular weight markers, BSA, ovalbumin, 
chymotrypsinogen, trypsin and cytochrome c (Sigma) were used. The 
distance of migration of these standards against log molecular weight 
was plotted to produce a standard curve for the molecular weight 
estimation of other peptides.
The method used was a modified method of Heussen and Dowdle 
(1980), The separating gel contained 1% (w/v) gelatin. The separating
and stacking gels contained 11% (w/v) and 3% (w/v) acrylamide 
respectively. Electrophoresis was done in the presence of SDS. The 
buffers and gels are described in Appendix 6 .
ÏI
7 9
The samples were added to the sample wells in a final volume
destained in 7% acetic acid. The other half was placed on top of a
of 75 pi of solution containing 2,5% (w/v) SDS, 17. (w/v) sucrose and
4 pgral  ^ phenol red. Electrophoresis was performed at a constant
current of 8 mA for approximately 3.5 h in a Shandon analytical PAGE
outfit (Shandon Southern Instruments Ltd., Surrey, England). When the
tracking dye front had reached the bottom of the resolving gel the gel
was removed and shaken gently at room temperature for 1 h in 2.5% (v/v)
Triton X-100 to remove SDS. The gel slabs were transferred to a bath
ocontaining O.lM glycine-NaOH, pH 8.9 and incubated at 37 G for 5 h.
The gels were fixed and stained for 1 h and destained (Appendix 6 ).
Since microbial contamination of electrophoretic buffers and 
other solutions may have added some contaminatory bacterial proteases 
all solutions were autoclaved or sterilized by filtration.
7.3 PAGE gel with gelatin overlay
A PAGE gel was run with no SDS present and a gelatin overlay
:
or Zymogram technique was used to detect the protease bands (Foissey,
1974).
The gels and buffers were prepared as in Appendix 7, the gels 
were run in a horizontal system using a 20 cm x 20 cm gel. The samples 
were all standardized to have approximately 10 EUml  ^ of protease
,.-.3
activity. Each sample (50 pi) was added to the wells and the gels were 
run at 150V in an electrophoresis tank till the tracking dye had reached
1 cm from the end of the gel.
The gel was sliced through the horizontal plane with a wire 
suture; one half was stained in 0.1% (w/v) Amido black for 1 h and
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gelatin agar plate and left at 37^G for 18 h. The PAGE gel was 
removed and the gelatin plate flooded with a mercuric chloride solution
showed where the gelatin was hydrolyzed by the proteases
I
(Appendix 7). This caused precipitation of the gelatin and clear bands
8 o Inhibition Studies
The inhibitors used are shown in Table 6 .
The inhibitor (50 pi) was incubated with 50 pi of protease 
- 1  o(approximately 5 EUml ) at 37 C for 30 min. To this mixture 1.0 ml 
of DMG was added and the DMG protease assay carried out as described 
previously (see page 6 6 ), For each inhibitor a blank was set up 
consisting of 50 pi of inhibitor plus 50 pi borate buffer (0.05M, 
pH 9.0).
In a few cases the inhibitor interfered with the DMG protease 
assay and so the casein plate method (see page 69 ) for measuring 
protease activity was used. In these cases equal volumes of inhibitor 
and pro tease were incubated as before but it was necessary to use
_ Iapproximately 10 EUml of protease to detect a clear zone of precipi­
tation.
The samples (15 pi) were added to the wells in the casein
plates and incubated at 37°G for 18 h. The diameter of the zone of
-,precipitation was measured as mentioned previously.
9. Peptide Digest Analysis
Peptide digest analysis was carried out by the method of 
Schneider, Sigel and Parker (1981).
The protein digestion substrate solution consisted of 4 mg of
s
TABLE 6
PROTEASE INHIBITORS
INHIBITOR SOURCE
Soyabean Trypsin Inhibitor Sigma
ojrA-u"'Eggwhite'TTrypsin Inhibitor
Anti-Trypsin t1
Peps tatin M
2-nitro,4-carboxyphenyI NN-phenylcarbonate n
(NCDG)
Ethylenediaminetetraacetic acid BDH Chemicals Ltd.
(EDTA)
Mercuric Ghioride (HgGl^)
Sodium Fluoride (NaF)
Phenylmethylsulphonyl fluoride Sigma
(PMSF)
N'ethylmaleimide II
Sodium lodoacetate BDH Chemicals Ltd,
8 -Hydroxyquinoline * Sigma
a-2 Macroglobulin * II
*Plate assay used as these inhibitors interfered with DMG assay.
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bovine serum albumin (Sigma) per ml dissolved in a solution of 20% (w/v) 
glycerol, 0.5% (w/v) SDS, 0.1% (w/v) bromophenol blue (Sigma) in 0.05M 
borate buffer, pH 9.0. Tîiis digestion solution was heated for 5 min at 
100°C and stored at -20°C. The solution was warmed to 37^G before the 
addition of the enzyme preparation.
The enzyme preparation was mixed with equal volumes of the
digestion solution and incubated at 37°G for either 30 min or 2 h.
10. IgA Digestion
Human IgA (Sigma) 5 mgml  ^was incubated with an equal volume
After incubation, the enzyme was inactivated by boiling for 5 min after 
the addition of 2-mercaptoethanol and SDS to a final concentration of 10 
and 1%, respectively. These enzyme-treated stocks were stored at -20°C 
until use,
:SDS-PAGE of these digests was carried out as described 
previously.
I;:
-  1of approximately 10 EUml of V. cholerae GlQO/P. These mixtures were.
incubated at 37°C for 1, 9 and 24 h at 37°C. The digestion was stopped 
by freezing the mixtures in liquid nitrogen and the samples stored at 
-20°G. The digests were examined by SDS-PAGE (see page 78 ) and 
Immunoelectrophoresis (see page 84 ).
«
11. Fibronectin Digestion
Fibronectin (Sigma) 1 mgml  ^was incubated with an equal volume 
of Vo cholerae, GlOO/P (approximately 10 EUml ^) for 1, 9 and 24 h at 
37 C. The digestion was stopped by freezing in liquid nitrogen. SDS- 
PAGE (see page 78 ) was used to examine these digests.
12o Lactoferrin Digestion
Vo cholerae GlOO/P (approximately 10 EUml was incubated with 
an equal volume of lactoferrin (Sigma), 1 mgml  ^ for 1, 9 and 24 h at 
37°Co The digestion was stopped and the digests examined by SDS-PAGE, 
(see page 78).
13. Digestion of cholera enterotoxin A-subunit
The A-subunit (1 mgml ^) of cholera enterotoxin (Sigma) was 
incubated with an equal volume of GlOO/P (10 EUml )^ for 1, 9 and 24 h 
at 37°C. The digestion was stopped and SDS-PAGE (see page 78 ) used to 
examine the mixtures.
14o Immunological Techniques
14.1 Ouchterlony double diffusion
Ouchterlony plates were prepared by dissolving 15 g purified 
agar (Oxoid) and 16 g NaCl in 1 litre of distilled water by steaming for 
45 min. Methyl orange (0.12 g) and 50 ml of 10% phenol saline solution 
were added. The molten agar (20 ml) was poured into scratch-free glass 
plates, allowed to set and dried at 37^C. A template was used to cut 
wells in the agar by the method of King (1957). A drop of molten medium 
was added to each well to prevent leakage of reagents under the agar 
layer. Antigen and antiserum were added to the wells and the plate 
incubated in a moist atmosphere at 37°C for 18 h. The appearance of a 
precipitin line between the wells showed the presence of antibody in the 
serum specific to the antigen being tested.
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14.2 Immunoelectrophoresis
Barbitone agar (100 ml; Appendix 8 ) was poured over a glass 
plate (20 X 10 cm) and allowed to set. Troughs and wells were cut with 
a NOo 2 cork borer, according to the template shown in Appendix 9. The 
agar wells were removed and filled with the samples. Electrophoresis 
was carried out in a Shandon electrophoresis tank at 150V for approximately 
2 h using 0.05M barbitone buffer, pH 8.4, Following electrophoresis the 
agar in the troughs was removed and the troughs were filled with antiserum. 
The plate was left in a damp chamber for 24-48 h to allow precipitin
lines to develop. The plate was washed in saline for 48 h, stained in
17. (w/v) Amido Black for 1 h and destained in 77. (v/v) acetic acid,
14.3 Antiserum production
Antisera were produced in collaboration with Dr. D.E.S. 
Stewart-Tull who injected and bled the animals. New Zealand white 
rabbits were vaccinated intramuscularly (i/m) with 2 ml of Freunds 
complete adjuvant containing 1.0 ml Bayol F, 0.4 ml Arlacel A, 1.0 ml 
antigen (containing 100 pg protein) and 250 pg freeze-dried Mycobacterium 
tubercudosis (Appendix 10), Two weeks later the rabbits were given an 
intraperitoneal (i/p) booster injection of Freunds incomplete adjuvant 
(2 ml) containing 1 ml (100 pg) of the same antigen, 1,0 ml Bayol F and 
0.4 ml Arlacel A (Appendix 10). Ten days later blood samples were 
obtained from the rabbit's ear. The blood was allowed to clot and left 
at 4°C overnight. The serum was removed and tested for antibody by the 
Ouchterlony technique. If antibody was present the animal was
exsanguinated by cardiac puncture. The clotted blood was left at 4*^ G
overnight before the serum was removed. Any residual erythrocytes were
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removed from the serum by centrifugation at 900xg for 10 min on an MSE 
bench centrifuge. The sera were stored at -20°C until required.
15. Radio-active adherence assay i
15.1 Radio-labelling of V. cholerae
Vo cholerae was grown overnight at 37°C with shaking in the 
modified Syncase medium. The cells were centrifuged at 900xg for 20 min 
in an MSE minor bench centrifuge and the supernatant fluid was discarded.
The cells were resuspended in the Syncase medium but without the carbon i
source. The cells were resuspended to give an optical density of 0.3 
at 600 nm and 2 pCiml  ^ of ^^C-glucose (Amersham International, Bucking­
hamshire, England) was added. The culture was shaken for a further 5 h 
at 37°G. Subsequently, the cells were washed three times in 0.17. (w/v) 
peptone - 0.857. NaCl and finally resuspended in the peptone-NaCl to give 
an optical density of approximately 0.3 at 600 nm. By a Miles and Misra 
viable count technique, a culture with an optical density of 0.35 was 
found to have 1 . 2  x 1 0  ^  organisms ml
15.2 Preparation of tissue segments
The tissue used throughout these experiments was the ileum from
an adult Wistar rat. The rats were starved of solid food overnight,
killed under GO^ gas and the ileum removed and placed in 1 0  ml of 
physiological saline. Tissue segments were prepared by one of the following 
methods (Figure 9).
Type A - One square centimetre of tissue
The ileum was placed on filter paper and opened longitudinally.
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FIGURE 9
Types of tissue preparation
One square centimetreTYPE A,
serosal
surface
mucosal
surface
One centimetre cylindrical lengthsTYPE B
mucosal
surface
TYPE C Tissue segment mounted on specially prepared syringe
2  ml syringe
serosal
surfacetJSection of 
barrel cut 
off before 
use
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2 2 Segments (1 cm ) or dises (20-113 cm ) were cut using a scalpel or
different sized cork borers respectivelyo 
Type B - One centimetre cylinders of tissue
15.3 Assay Procedure
organisms. After 30 min at 37°C the tissue segments were removed,
1■it:
■;
1 cm lengths of intact ileum were cut and everted to ensure 
that the brush border surface was exposed to the V. cholerae organisms.
Type G - Mucosal disc of tissue
The ileum was opened longitudinally and 1.5 cm lengths cut.
A specially prepared 2 ml syringe was used (Figure 9) to mount the tissue 
segment which ensured that only either the mucosal or serosal surface of 
the ileum was in contact with the V. cholerae organisms.
The tissue segments were pretreated for 30 min at 37 C with 
either saline, as a control, or the enzyme preparation being tested. 
The tissue segments were added to 2 ml of labelled and standardized
washed three times in individual 2 ml aliquots of 0.1% (w/v) peptone - 
0.85% (w/v) NaCl and placed in a scintillation vial for digestion (Mahin 
and Lofberg, 1966), The digestion was carried out by the addition of 
0.25 ml of 707. (v/v) perchloric acid and 0,5 ml of 30% (v/v) hydrogen
peroxide. The vials were sealed and placed in an 80°C water bath for I1-2 h depending on the size of the tissue segment. After cooling 4.5 ml
of scintillation fluid (Appendix 11) was added and the samples were 
counted in a Packard Tri Garb 300C scintillation counter.
The radioactivity present in the three 2 ml washes for each 
tissue segment and in the residual, 2 ml of the suspension of organisms 
originally added to the tissue segment were also measured. This was
   ;   -
done by adding 0.5 ml of each of these samples to 4.5 ml of scintillation 
fluid and counting the radioactivity as previously described. To obtain 
the total counts in the 2 ml washes and the 2 ml of organisms the counts 
obtained for the 0.5 ml that were counted were multiplied by four to give 
the radioactivity present in the 2.0 ml samples.
15.4 Calculation of the number of organisms attached to the tissue 
segment
An example of a worked calculation is shown in Figure 10,
The counts of A, B, C, D and E were added together to give the total
count which is equivalent to the number of organisms in the original 2 ml
sample of V. cholerae added to the tissue segment. In the example shown
10in Figure 10, 30 x 10 organisms were present in the 2 ml sample, which 
gave a total count of 299,659 Cap.m. The c.p.m. in the tissue segment 
were 13,187 which was equivalent to the number of organisms bound to the 
tissue segment. Therefore the number of organisms associated with the 
tissue segment can be calculated by
No. of V. cholerae associated with tissue segment =
13,187 X 30 1.32 x 10^^
------------  X 10 = -----------
299,659
This method was used for the calculation of all adherence assay results 
throughout this study.
15.5 Paraformaldehyde treatment of tissue segments
Paraformaldehyde vapour fixation (Took and Pearce, 1965) was 
used to retain the mucus on the surface of the tissue segments prior to 
the assay procedure.
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FIGURE 10
TYPICAL EXAMPLE OF RESULTS OBTAINED FROM
RADIOACTIVE ADHERENCE ASSAY
Ao Remaining activity of
2 ml V. cholerae culture after 
incubation with tissue segment
273656 c.p.m.
B. Activity in wash 1
C. Activity in wash 2
Do Activity in wash 3
7488 cp.m. 
3400 c.p.m. 
1928 c.p.m.
E, Activity associated with 
tissue segment (Number of 
V. cholerae bound to tissue 
segment)
13187 c.p.m.
By adding A, B, C, D and E 
obtain total count in the original 
2 ml V. cholerae sample added 
to tissue segment.
299,659
Total activity in a 2 ml suspension 
of organisms alone - control 
suspension.
298,867
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Paraformaldehyde, 3 g (BDH Chemicals Ltd., Poole) was placed
oin an evaporating vessel in a desiccator. This was heated to 50 C for
1 h and the desiccator opened carefully in a fume cupboard and the
left at 50°C for 1 h, the tissue segments were used immediately.
solution contained 300 BDml  ^ as 2 mg of toxin is equivalent to 600 BD, 
Dilutions were prepared to give 600, 400, 200, 100 and 20 B,D, 2,0 ml 
in sodium acetate buffer, pH 5,5,
or the enzyme preparation at 37°C, The tissue segments were added to 
2 ml of the toxin solutions for 1 h at 37°C, The tissue segments were
.tissue segments added. The desiccator with the tissue segments was
J
i
16, Toxin Binding to Ileal Segments in vitro --------------------------------------
16,1 Toxin
Cholera toxin, 2 mg (N,I,A,I,D, Cholera Advisory Committee,
Wyeth Laboratories) was added to 2 ml of sodium acetate buffer. This
16.2 Tissue preparation
The method of tissue preparation was identical to type C 
preparation used in the radioactive adherence assay which allowed the 
use of the mucosal surface alone, (see page 86).
16.3 Assay procedure
The tissue segments were incubated for 30 min with 2 ml PBS
removed from the toxin solution and the tissue was discarded as bound 
toxin cannot be detected. The toxin remaining was measured by the intra- 
dermal blueing test in rabbits as described previously (see page 74 ), 
Since the rabbit was injected with 0.1 ml of the toxin solutions the i
expected BDs in the rabbit were 30, 20, 10 5 and 1,0 BD if no toxin had |
bound to the tissue segment. The values of BD obtained from the I
rabbits' back were multiplied by 20 to measure the remaining toxin in I
Ithe 2 ml sample. Therefore the amount of toxin bound to the tissue j
segment was calculated by subtracting the BD of cholera toxin in the I
remaining solution from the expected BD, ie, 600, 400, 200, 100 or 20, :
j
17, Toxin activation i
iICholera toxin (N,I,A,I,D,, Cholera Advisory Committee, Wyeth i
Laboratories) 2 mgml  ^was used, this solution contained 600 BDml  ^ as i
2 mg of toxin is equivalent to 600 BD, I
An equal volume of the toxin solution was incubated with \
-1 !protease (GlOO/P), with an activity of 10,5 EUml for either 5 or 24 h j
at 37^Co An equal volume of distilled water and toxin was also incubated |
for 24 h at 37°C, as a control sample, I
IFollowing incubation the toxin solutions were diluted in |
- 1  Idistilled water to give 30, 20, 10, 5,0 and 1,0 BDml , The intradermal fj 
blueing test (see page 74) was used to measure the toxin activity, |
Since the rabbit was injected with 0.1 ml of the toxin solutions the 
expected BDs in the rabbit were 3,0, 2,0, 1.0, 0.5 and 0.1 BD. Any
increase in toxin activity would be seen by an increase in the blueing
dose of the 0,5 and 0,1 BD samples.
18, Protection Studies
18,1 Animals
Dunkin Hartley guinea-pigs were used for all protection 
experiments.
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18o2o Vaccine components
(i) Protease - GIOO/P prepared during this study,
(ii) Neuraminidase - Galbiochem, La Jolla, California,
(iii) Enterotoxoid - gluteraldehyde treatment of toxin from
N.I.A,I.D, Cholera Advisory Committe, Wyeth 
Laboratories,
18 o 3 Vaccinations
All vaccinations were given in Freunds complete adjuvant 
(FoCoAo), Freunds incomplete adjuvant (F.IoAo) (Freund and Bonanto, 1944) 
or aluminium hydroxide gel (Al(OH)^)o The composition of these 
adjuvants is shown in Appendix 10, This work was done in collaboration 
with Dr, D.E.S. Stewart-Tull who carried out all experiments on living 
animals,
For each vaccine preparation 12 guinea-pigs were used; 3 were 
vaccinated with F.C.A., 3 with F.I.A., 3 with AlOOH)^. Three guinea- 
pigs were unvaccinated controls.
(i) Originally experiments were done by giving a group of guinea-pigs
( D o S - T  1287-1345 ) one 0.5 ml i/m vaccination followed three weeks later
5by ileal loop challenge using approximately 1 x 10 virulent V. cholerae.
(ii) Further experiments involved giving guinea-pigs (D.S-T 1346-1454) 
a 0.5 ml i/m vaccination followed three weeks later with a 0,5 ml i/m 
booster dose. Two weeks later the guinea-pigs were challenged.
(iii) Subsequently, guinea-pigs (D.S-T 1455-1477) were given a 0,5 ml 
i/m vaccination followed three weeks later by an oral boost. The 0.3 ml 
oral dose of each vaccine was administered to each guinea-pig using a
1.0 ml syringe, without a needle, as an applicator and releasing the
I
I
I
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vaccinated i/m with F.C.A. adjuvant were given an oral booster with
tied off after removal of the needle.
mixture at the back of the mouth. In this instance the guinea-pigs
F.I.A, and not F.C.A. The guinea-pigs vaccinated with F.I.A, and 
Al(OH)g were boosted with F.I.A. and Al(OH)^ respectively.
18.4 Ileal loop test
The ileal loop operations were done by Dr. D.E.S. Stewart-Tull.
18.4.1 Preparation of V. cholerae for challenge
V. cholerae was grown overnight in 1% (w/v) protease peptone 
at 37°C without shaking. 5 ml of this culture was added to 20 ml of 
sterile 2% (w/v) protease peptone and left for 5 h at 37°C without 
shaking. This culture was used for the ileal loop challenge. The
j//
control injection was done with 2% (w/v) protease peptone.
18,4,2 Operation procedure
Guinea-pigs were starved of solid food for 24 h as a
'preoperative measure. The animals were anaesthetised by an injection 
of 0.15 ml Valium 20 (Rothe Products Ltd., England) and 0.3 ml of small 
animal Immobilon (Reckitt & Golman, Pharmaceutical Divn., Hull, England),
A length of small intestine above the caecum was lifted out of the 
peritoneal cavity. The intestine was ligated with cotton approximately 
2 cm and 9 cm above the caecum. A third ligature, 7.0 cm above the 
caecum, was tied loosely, resulting in a 5,0 cm long test loop and a 2 cm 
interloop. To prevent leakage from the test loop the sample was 
injected by inserting the hypodermic needle into the 2,0 cm interloop 
and through the loose ligature into the test loop. The ligature was
tightened onto the needle before injection of the sample, and finally
i
Î
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Two 5 cm loops, separated by 2.0 cm interloops, were prepared 
in each animal. One loop was injected with 0.1 ml of the cholera 
culture, the other with 0.1 ml of sterile 2% (w/v) proteose peptone.
The intestine was replaced in the peritoneal cavity and the 
wound was stitched with monofilament nylon (metric 2; Ref. No. V4022; 
Arnolds Veterinary Products Ltd., Reading) and the animal allowed to 
recover from the anaesthetic. After 16-18 h the animal was killed and
the ileal loops were removed. Blood was taken from each animal by
cardiac puncture and antiserum collected as described previously.
18.4.4 Analysis of ileal loop test results
-1In each guinea-pig the mlcm of the protease peptone loop was
fluid accumulation produced solely from the V. cholerae organisms.
These values for the vaccinated and unvaccinated guinea-pigs were compared, 
A 1-tail t-test was used since it was unreasonable to expect a V, cholerae 
culture to produce less fluid accumulation than the culture medium alone. 
An Olivetti model 101 computer was programmed for t-test
I18.4.3 Measurement of ileal loops
Measurement of the length of the loops (cm) were made using 
calipers (Gamlab, Gambridge, type 6921). The accumulated fluid in each 
loop was measured by lowering the loop into a measuring cylinder 
containing dilute Hibitane and noting the volume of fluid displaced (ml). 
The fluid accumulation in the loop was expressed as
ml of fluid displaced (cm length of loop) ^.
— 1subtracted from the mlcm of the V. cholerae loop to give a value of
analysis and the t-value for each group of 3 guinea-pigs compared to the
■
.,^3
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expressed as
significant difference at P = 0.1% level
1% 1eve1
5% level
no significant difference detected
3 unvaccinated control guinea-pigs was obtained* The P-values were 
obtained from statistical tables* The results of these values were I.
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RESULTS
lo Production of protease
Initial experiments were done to find the best growth 
conditions for the extracellular protease production by V, cholerae,
loi Variation in protease production in different media
Vo cholerae was grown at 37°C for 24 h in various growth
media. After 24 h, 1,0 ml samples of the cultures were removed, the
cells centrifuged and the protease activity in the supernatant fluid
measured by the DMG assay. Samples, 1,0 ml, were evaporated to dryness
in an 80°C drying oven and the dry weight of the cells was measured.
The extracellular protease activity in each of the different media was 
“ 1 - 1expressed as EUml mg dry weight of V» cholerae cells (Table 7),
Trypticase soy broth (BBL) yielded the best protease production, 0.73 EUmg  ^
compared with the poorest yield of 0*22 EUmg with the tryptic soy 
broth (Gibco), Consequently the trypticase soy broth (BBL) was used as 
the growth medium for the production of V, cholerae protease,
1,2 Variation in protease production during the growth of V, cholerae
The V, cholerae culture was grown aerobically at 37°C and
3,0 ml samples taken at various time intervals. The growth of V. cholerae 
was measured by the optical density of the culture at 600 nm. The 
samples were centrifuged and the protease activity in the supernatant 
fluids was measured by the DMG assay. Maximum protease activity was 
detected in samples taken between 23-25 h (Figure 11), Consequently,
V, cholerae cultures were grown for 24 h for the production of cholera 
proteases.
TABLE 7
COMPARISON OF GROWTH MEDIA FOR EXTRACELLULAR PROTEASE
PRODUCTION BY V. cholerae
98
.
Ï
MEDIUM PROTEASE ACTIVITY (EoU,ml“ ) per 
mg DRY WEIGHT OF V, cholerae CELLS
Trypticase Soy Broth 
(BBL)
0.73 - 0.15
a
Tryptic Soy Broth 
(Gibco)
27. (w/v) pro tease peptone 
(Difco)
Syncase
(Appendix 2)
0.22 - 0.06
0.56 - 0.08
0.52 - 0.05
The above results are the mean values from three experiments
+ = standard deviation.
1
Ï1
a
I
Ï
s
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FIGURE II
Extracellular protease activity detected in the culture 
fluid during growth of V, cholerae
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2o Stability and Storage
The culture filtrate of a 24 h culture of V, cholerae was 
precipitated with ammonium sulphate to 85% (w/v) saturation. The 
precipitate was stored at 4°C and in this form retained at least 95% of 
its protease activity after three months. This precipitate once 
redissolved and dialysed was termed "crude protease". The stability of 
this "crude protease" at 37, 26, 4, -20 and -70°C was tested over a four 
week period (Table 8). The crude protease was unstable at 37°C and 
26°C as after one day only 56% and 59% of the original protease activity
remained. Storage at 37°C for 7 days resulted in only 2% of the 
original protease activity remaining and at 26°C only 10% of the protease 
activity remained. When the crude protease was stored at 4°C it lost 
nearly 50% of its activity after 28 days, although shorter storage time 
(1 day) did not result in loss of much activity. However, following 
storage for 28 days at -20°C only 6% of the protease activity was lost 
and storage at -70°C for 28 days resulted in the loss of only 5% of the 
protease activity. Subsequently as storage at -70°C had no greater 
effect than storage at -20°C, for convenience all protease samples were 
Stored at -20°C.
3, pH optimum for protease activity
The protease activity of the crude protease was measured over 
a pH range of 1-12, The activity of the pro tease was measured by the 
DMC assay. Maximum activity was found at pH 8,9-9,0 (Figure 12). 
Unfortunately dimethyl casein (DMC) was not soluble in the pH range of
3,5-5,0 so the protease activity could not be measured at this pH,
To try to overcome this problem the azoalbumin assay was used but this
101
TABLE 8
EFFECT OF TEMPERATURE AND TIME OF STORAGE ON PROTEASE STABILITY
TEMPERATURE
(°c)
TIME
(Days)
PROTEASE
BEFORE
STORAGE
ACTIVITY (EUml“ )^
AFTER
STORAGE
PERCENTAGE
PROTEASE
ACTIVITY
REMAINING
1 9,5 5.3 56
37 7 9,8 0,2 2
28 10,1 0 0
1 9.5 5.6 59
26 7 9.8 0.9 10
28 10.1 0 0
1 9,5 9,3 98
4 7 9.8 8.3 85
28 10.1 5.5 55
1 9.5 9.4 99
-20 7 9.8 9,3 95
28 10.1 9.5 94
1 9,5 9,4 99
-70 7 9,8 9,3 95
28 10,1 9,6 95
These results are the average of one experiment done in duplicate.
This experiment has been repeated another twice and similar results 
obtained.
FIGURE 12
pH activity profile of Vo cholerae crude protease
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results from the azoalbumin assay paralleled those of the DMC assay
_pshowing maximum protease activity at pH 9,0 - 0.1,
21.5-31 k.Dal. (Figure 14).
" I
J:';assay was also found to be inactive at pH 3.5-5o0. However, the
.3Partial Purification of the Protease(s) y
4.1 Gel filtration of crude protease
Gel filtration of the crude material on Sephadex GlOO 
eluated with borate buffer (0<,05M, pH 9.0) produced the elution
profile shown in Figure 13. However, only one major peak of protease 
activity, B, measured by the DMC assay, was detected. This peak of 
protease activity did not correspond to the major protein peak
suggesting that a lot of contaminating material had been lost during gel
%
filtration. No neuraminidase activity was detected in any of the k
fractions using the methoxyphenyl neuraminic acid assay. The fractions
in peak B were pooled and termed GlOO protease (GlOO/P). By the use
of appropriate markers the molecular weight of GIOO/P was found to be
4,2 Isoelectric focussing of crude protease
I
Pro teases were also separated from non-enzymatic protein in
:the crude material by isoelectric focussing (IFF) in a pH gradient of y
3.5-10.0. The ^280nm ^^^tion profile is showm with the pH gradient
and the protease activity, measured by the DMC assay, in Figure 15, |
Neuraminidase activity of the fractions was determined using the MPN
assay but no neuraminidase activity was found in any of the fractions, ^IThe elution profile shows three major peaks of protease activity; peak 1 
(protease(s) lEF-1) was focussed as a broad peak with pi values of
104
FIGURE 13
ELUTION PROFILE OF CRUDE PROTEASE ON SEPHADEX GlOO
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FIGURE 14
Standard curve for molecular weight determination by
gel filtration
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FIGURE 15
Elution profile of crude protease from batch %rowTi 
cultures following isoelectric focussing
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4.5-5.5, peak 2 (protease(s) IEF-2) had a pi value of 6,5 and peak 3 
(protease(s) IEF-3) had a pi value of 9,0, The crude protease used 
was from batch-grown cultures of V. cholerae. When crude protease from 
fermenter-grown cultures was subjected to lEF a similar elution profile 
was obtained (Figure 16), Three peaks of protease activity were 
detected with similar pi values to the lEF of the batch-grown production 
of crude protease. The proportions of IEF-1 and IEF-2 varied from those 
obtained in the batch cultures. In the batch-grown cultures IEF-1 was 
present in greater ac-H-olA^ than IEF-2 but with the fermenter-grown 
culture more IEF-2 was present than IEF-1, In both types of culture 
IEF-3 had the maximum protease activity, lEF of GIOO/P also produced 
three peaks of protease activity with a similar elution profile to 
Figure 15, Unless otherwise stated IEF-1, 2 and 3 used throughout this 
study were prepared from crude protease and not GlOO/P,
4.3 Calculation of specific enzyme acrivity of V, cholerae proteases 
during purification
The enzyme activity was calculated (mg protein)  ^ for the 
supernatant fluid, the crude protease, GlOO/P, IEF-1, IEF-2 and IEF-3 
(Table 9), The specific activity increased some 50 times from the 
supernatant fluid to the semi-purified GlOO/P preparation. Isoelectric 
focussing increased the specific activity as compared to gel filtration 
of the crude protease quite markedly,
5, Characterization of V. cholerae proteases
5.1 Polyacrylamide gel electrophoresis (PAGE)
5.1.1 SDS-PAGE
108
FIGURE 16
Elution profile of crude protease from fermenter grown 
cultures following isoelectric focussing
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TABLE 9
SPECIFIC ENZYME ACTIVITY OF V. cholerae PROTEASES DURING 
PURIFICATION PROCEDURES
PROTEASE PREPARATION SPECIFIC ENZYME ACTIVITY
-1(EU,ml mg protein)*
Supernatant Culture Fluid 2,9
Crude Protease** 17,2
GlOO Protease 120,0
IEF-1 Protease*** 178,6
IEF-2 Protease*** 195,0
IEF-3 Protease*** 192,2
* Protease activity measured by DMC assay, protein 
determinations by Lowry method
** Ammonium sulphate precipitate of culture fluid
*** IEF-1, 2 and 3 all prepared from crude protease.
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A 12% polyacrylamide gel was run in the presence of sodium 
dodecyl sulphate (SDS) in a discontinuous buffer system. The samples 
used for the gel were crude protease, GlOO/P, IEF-1, IEF-2, IEF-3 and 
culture medium (TSB) alone (Figure 17), The culture medium alone
Î"
showed no detectable bands when the gel was stained with bromophenol 
blue. The molecular weight markers in lane 1 (Bovine serum albumin,
67 koDal; ovalbumin, 45 k,Dal; chymotrypsinogen, 25 k,Dal; trypsin,
23 koDalo and cytochrome c, 11,7 koDal.) were used to produce a standard 
curve of log molecular weight against migration distance in the PAGE 
gel (Figure IS), From this standard curve the approximate molecular 
weights of other peptide bands was calculated. The GlOO/P, IEF-1, IEF-2 
and IEF-3 all showed the presence of one common band with a molecular 
weight of approximately 42 k.Dal, (Figure 17), IEF-1 (lane 5) also 
showed two other bands with molecular weights of about 45 k.Dal, and 
57 k.Dal., these two bands were not present in IEF-2 or IEF-3 but they 
were present in GIOO/P (lane 6). IEF-3 (lane 3) had one other band 
with a molecular weight of about 75 k.Dal. This was not present in
- :IEF-1 or IEF-2 but was present in GlOO/P. The latter also showed one
other very weak band with a molecular weight of about 82 k.Dal. not 
present in any of the lEF proteases. On comparing GlOO/P and the lEF 
proteases with the crude protease (lane 2) it can be seen that numerous 
contaminating bands have been removed during gel filtration and iso­
electric focussing. On comparing the crude pro tease (lane 2) with any 
of the partially purified proteases (lanes 3-6) during purification 
there was an increase in the staining of low molecular weight material. 
This may have been due to digestion of contaminating proteins by the 
cholera pro teases.
Ill
FIGURE 17
SDS-PAGE of crude protease GIOO/P, IEF-1, IEF-2 and IEF-3
Lane 1 - Molecular weight markers (R.Dal.)
*' 2 - Crude protease
" 3 - IEF-3
" 4 - IEF-2
5 - IEF-1
6 - GIOO/P
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FIGURE 18
Standard for molecular weight determination by SDS-PAGE
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5.1.2 PAGE with gelatin overlay
A polyacrylamide gel containing no SDS was run with samples 
of the crude protease, GlOO/P and the lEF proteases. Following electro­
phoresis a gelatin overlay was placed on the gel and after 18 h the 
gelatin overlay was stained with an acid sublimate solution. Bands of 
clearing were expected where the protease had digested the gelatin. 
However, no distinct bands of clearing were found; instead whole areas 
of clearing were seen ' from the sample wells of the gel to about 4 cm 
from these wells (Figure 19) This resulted in about one third of the gel 
being clear. The only distinct observation from this gel was that the 
crude pro tease gave a larger area of clearing than any of the other 
proteases although each protease preparation was standardized to 
10 EUml As this method was not very informative the following
technique was used,
5.1.3 SDS-PAGE Incorporated with gelatin
A polyacrylamide gel containing 17, (w/v) gelatin was run in 
the presence of SDS in a discontinuous buffer system. Following electro­
phoresis the gels were treated with 2,5% (v/v) Triton X-100, to remove
the SDS, and then incubated for 5 h in buffer. The gelatin protein was
stained black with 17, (w/v) Amido Black, the areas of clearing indicated 
where the protease had digested the gelatin (Figure 20),
All protease preparations showed areas of protease activity
at A and B (Figure 20) and also a more broad area of activity at E, 
However, the intensity of these areas of protease activity varied between 
the different preparations, ie, IEF-2 (lane 2) and IEF-3 (lane 1) showed 
a stronger activity at A than B, whereas IEF-1 (lane 3) showed a stronger
1 14
FIGURE 19
Diagrammatic representation of gelatin agar overlay following 
incubation with PAGE gel of crude protease, GIOO/P, IEF-1,
IEF-2 and IEF-3
Area of clearing indicating 
digestion of gelatin.
Lane I - Crude protease
2 - GIOO/P
3 - IEF-1
4 - IEF-2
5 - IEF-3
All protease samples contained approximately 10 EUml
115
FIGURE 20
SDS-PAGE incorporated with gelatin of crude protease 
GIOO/P, IEF-1, IEF-2 and IEF-3
Lane 1 - IEF-3
" 2 - IEF-2
" 3 - IEF-1
" 4 - GIOO/P
" 5 - Crude protease
-1All samples contained approximately 10 EUml of 
protease activity.
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activity at B, IEF-1 also showed protease activity at C which was 
absent from IEF-2, IEF-3 and GlOO/P but was present in the crude protease. 
The crude protease (lane 5) also had one band of protease activity (area 
D) not present in any of the other preparations,
5.2 Peptide Digest Analysis of BSA digestion by cholera proteases
BSA was used as the standard protein to observe the peptide
patterns obtained after digestion with IEF-1, IEF-2 and IEF-3. The 
three lEF proteases (15 EUml were incubated with BSA for 30 min and 2 h 
and the unique peptides were separated by SDS-PAGE; the patterns obtained 
after the digestion are shown in Figure 21. Lanes 3, 4 and 5 show the 
30 min digestion patterns by IEF-1, 2 and 3 respectively, IEF-1 and 
IEF-2 gave similar patterns but IEF-3 was quite different. The 2 h 
digestion of BSA by IEF-1, 2 and 3 (lanes 6, 7 and 8 respectively) 
showed distinct peptide patterns for each of the lEF proteases, with 
IEF-3 showing most of the BSA in low molecular weight peptides. IEF-1 
and IEF-2 did not show such active digestion of BSA as IEF-3, but their 
peptide patterns were distinct from each other and from the IEF-3 peptide 
pattern. In addition, it was obvious that there was continued protease 
activity, as shown by comparing lanes 3 and 6, with 30 min and 2 h 
digests of BSA by IEF-1.
5.3 Inhibition of protease activity by enzyme inhibitors
Characterization of the lEF proteases was attempted using
enzyme inhibitors. The effect of the inhibitors on the crude protease 
was tested using three different concentrations of each inhibitor. The 
initial concentration of inhibitors tested (Table 10, concentration A) 
was taken from the papers of Young and Broadbent (1982) and Schneider and
FIGURE 21
Peptide Digest Analysis of Bovine Serum Albumin by 
IEF-1, IEF-2 and IEF-3 by SDS-PAGE
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30 min3 4 n 120 min5 6 7 8
Lane I - Molecular weight markers 
2 - BSA
*' 3 - IEF-1 digestion of BSA at 30 min
" 4 - IEF-2
5 - IEF-3
6 - IEF-1
7 - IEF-2
8 - IEF-3
120 min
IEF-1, 2 and 3 had a protease activity of approximately 10 EUml -1
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.1;
Parker (1982), These concentrations were not very effective so two 
higher concentrations of each inhibitor were tested (Table 10, concen­
trations B and G)o Concentration B of the inhibitors was used against 
proteases IEF-1, IEF-2 and IEF-3 to obtain the optimum effect and to 
avoid some of.the solubility problems obtained with concentration C of
the inhibitors. The IFF protease preparations were all standardized
1to approximately 5 EUml except in the cases where the casein plate 
assay was used in which instance the protease was standardized to 
approximately 10 EUml , The protease activity was measured before and
after incubation with the inhibitor and the Inhibition classed on a scale 
from - to -H- for 0 to 100% inhibition.
Table 11 shows the effect of the inhibitors on IEF-1, This 
lEF protease was inhibited by mercuric chloride, the metalloprotease 
inhibitors, EDTA and 8-hydroxyquinoline, the serine protease inhibitors, 
egg white trypsin and anti-trypsin, and by a-2 macroglobulin,
IEF-2 (Table 12) was inhibited by mercuric chloride, the 
metalloprotease inhibitors, EDTA and 8-hydroxyquinoline, the serine 
protease inhibitor anti-trypsin, the thiol pro tease inhibitor 
N-ethylmaleimide and by a-2 macroglobulin,
IEF-3 (Table 13) was inhibited by mercuric chloride, the 
metalloprotease inhibitors, EDTA and 8-hydroxyquinoline, and by a-2 
macroglobulin.
The percentage inhibition by each inhibitor on the protease 
activity of IEF-1, IEF-2 and IEF-3 was calculated and is shown in Table 
14, The figures in boxes represent where the protease was inhibited 
by more than 30%, From this table it is quite clear that all three 
lEF proteases were inhibited by a-1 macroglobulin, mercuric chloride, 
EDTA and 8-hydroxyquinoline,
5
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TABLE 14 SUMMARY OF INHIBITION OF IEF-1, IEF-2 and IEF-3 BY
ENZYME INHIBITORS
INHIBITOR Concen­
tration
Percentage inhibition of 
IEF-1 IEF-2 IEF-3
Soyabean Trypsin 1o 0 mgml ^ 0 7 13—- - -
Eggwh i te[Tryp s in loO 43 4 0
Anti-Trypsin loO 48 m 15
Pepstatin loO 0 3 0
a-2 macroglobulin 1 mgml ^ 69 I \j l 1 I 57
NCDC 4 mM 8 0 17
EDTA 25 100 39 90
8-hydroxyqu inoline 1.0 ” 51 65 69
HgClg 25 " 100 59 84
NaF 250 " 0 0 3
PMSF 40 " 20 17 16
N* ethylmaleimide 25 " 8 L i L 4
Sodium iodoacetate 25 " 24 9 3
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Also noticeable was the inhibition of IEF-1 by egg white i
trypsin and anti-trypsin inhibitors but not by soyabean trypsin inhibitor 
although all three inhibitors belong to the same class of serine protease j
Iinhibitors. This was also true of IEF-2 where only anti-trypsin had |
any effect on the protease activity. Interestingly, IEF-1 and IEF-2 |
I
were both inhibited by more than one class of protease inhibitor. ;
I
ij
6, Activities of the proteases associated with the environment in the
Ismall intestine I
6.1 IgA digestion by cholera proteases |
-1 :Human IgA were incubated with GIOO/P (10 EUml ) for 1, 9 and j
24 h. These digests were examined by SDS-PAGE and immunoelectrophoresis. |
The SDS-PAGE of the digests (Figure 22) showed that after 24 h (lane 1) j
only three specific bands were digested when compared to untreated IgA |
(lanes 4 and 5). The immunoelectrophoresis plate was set up with these |
digests and untreated IgA against goat anti-human IgA serum (Figure 23), !
The antigenicity of the IgA was not destroyed but it was noticed in ;I!repetitive tests that the single precipitin arc was shortened. I
i
6.2 Digestion of Fibronectin by cholera proteases |
Cholera pro teases GlOO/P (9.5 EUml )^ were incubated with 
fibronectin for 1, 9 and 24 h. Fibronectin was digested by cholera 
proteases, as shown by SDS-PAGE of the digests (Figure 24). After only 
1 h (lane 3) fibronectin digestion was noticeable. Further digestion 
occurred as seen in the pattern of the 24 h digest (lane 5).
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FIGURE 22
SDS-PAGE OF IkA DIGESTION BY GlOO/P
Lane 1 - 24 h digestion of IgA with GIOO/P
2 - 9 h It It
3 - 1 h tt It
4 - IgA
5 - IgA
6 - Marker proteins
digestion of these bands has occurred following 
protease treatment.
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FIGURE 23 IMMUNOELECTROPHORESIS OF IgA DIGESTION BY GIOO/P
4r
- ;
L l—
Î 5
to>eL.u. 1 -
2 -
3 -
4 -
5 - 
~ V r o u c >HS> 6
IgA alone
24 h digestion of IgA by GlOO/P
9 h 
1 h 
IgA alone 
Anti-IgA serum
II II II II
II II II II
area digested by protease.
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FIGURE 24 SDS-PAGE OF FIBRONECTIN DIGESTION BY GlOO/P
Lane 1 - Fibronectin
2 - Fibronectin
3 - 1 h digestion of fibronectin by GlOO/P
4 _ 9 h " " " " "
5 - 24 h " " •' Il I»
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6o3 Lack of cholera protease activity on Lactoferrin
“1Lactoferrin was incubated with GlOO/P (9,5 EUml ) for 1, 9 
and 24 h, SDS-PAGE of these digests (Figure 25) showed no digestion 
of the lactoferrin even after 24 h (lane 6),
6,4 Effect of cholera proteases and neuraminidase on toxin binding
Tissue segments were prepared as for type C in the adherence 
assay (see page 86 ), The mucosal surface of the rat ileal segment 
was suspended in PBS, protease, neuraminidase or protease plus neuramini­
dase for 30 min. Subsequently, the tissue segment was added to 2 ml of 
a solution containing 600, 400, 200, 100, 20 BD, in 2.0 ml, of cholera 
toxin for 1 h. The toxin bound to the tissue segment is inactivated 
and cannot be measured directly, therefore the residual toxin was 
measured by the rabbit intradermal blueing dose test. The toxin bound 
to the tissue segment was calculated by subtracting the blueing doses 
of the residual toxin from that originally added to the tissue segment. 
Table 15 shows the results obtained. When tissue segments were added 
to the toxin solution containing 600 BDml the buffer treated segments 
bound 576,4 BD, protease treated 572,4 BD, neuraminidase treated 573,2 BD 
and protease plus neuraminidase treated 573,6 BD of toxin. At the 
other end of the scale, when tissue segments were added to the toxin 
solution containing 100 BD, 2,0 ml 82,8, 88,0, 79,2 and 77,0 BD of 
toxin bound when treated with buffer, protease, neuraminidase and protease 
plus neuraminidase respectively. It is quite clear from these results 
that the enzyme treatment of the tissue segments had no effect on the 
binding of toxin to ileal segments £n vitro. The enzyme preparations 
used for prior treatment of the tissue segments were tested for the 
presence of toxin and found to be negative.
____________ _
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FIGURE 25 SDS-PAGE OF LACTOFERRIN DIGESTION BY GlOO/P
Lane 1 and 2
3
4
5
6
marker proteins 
lactoferrin 
1 h digestion of lactoferrin by GlOO/P
9 h 
24 h
tt II
II II
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TABLE 15 EFFECT OF PROTEASE AND NEURAMINIDASE ON THE BINDING OF 
CHOLERA TOXIN TO RAT ILEAL SEGMENTS in vitro
Tissue Blueing Doses of Cholera Toxin, **
Treatment Added to tissue Remaining after Bound to
segment removal of tissue* tissue segment
600 23.6 576,4
400 20,8 379,2
BUFFER (PBS) 200 22,0 178,0
100 17,2 82.8
20 0,0
600 27,6 572.4
PROTEASE (12.5 EUml"^ 400 26.0 374.0
(Gloo/P) 200 21,4 178.6
100 12,0 88.0
20 0,0 20.0
600 26.8 573,2
400 23,8 376,2
NEURAMINIDASE 200 23.6 176.4
(0.05 lU) 100 20,8 79.2
20 0,0 20.0
PROTEASE 600 26,4 573.6(12,5 EUml" ) (GIOO/P) 400 26.4 373,6
+ 200 25.2 174.8NEURAMINIDASE 100 23.0 77.0(0,05 lU) 20 0.0 20.0
* Average of triplicate results
irk I blueing dose (1 BD) - 8 mm diameter zone of blueing on rabbit back
(see p. 74 )
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6.5 Effect of cholera proteases on toxin activity
Toxin (2 mg ml was incubated with protease (GIOO/P,
10.5 EUml) for 5 and 24 h and with distilled water, as a control, for 
24 h at 37°C, Following incubation the three toxin samples were 
diluted to give expected BD of 3,0, 2,0, 1,0, 0,5 and 0.1, The results 
of the intradermal blueing test of the 15 samples are shown in Figure 26A
It is quite clear from these results that the samples containing 
0,1 and 0,5 BD produced BDs in excess of 1,0 BD, suggesting activation 
of the cholera toxin. However, the control toxin sample which was 
incubated with distilled water for 24 h also showed this increased 
activity which was unexpected. It was therefore decided to assay the 
N,I,A.I,Do toxin for protease activity. The toxin was found to have a 
high protease content of 15 EU of pro tease per mg of toxin. This meant
that in the control samples 30 EU of protease were present, as the toxin
sample was a 2 mgml  ^ solution. The test toxin samples also contained 
this 30 EU of protease plus the 10.5 EU of GlOO/P that were added to the
toxin. These results suggest that proteases may be involved
in toxin activation. The GIOO/P was assayed for toxin activity
and found to be negative. Figure 26B shows the intradermal blueing
dose results of toxin samples not incubated for 24 h before use in the 
assay system. The protease preparations alone showed no BD activity*
6,6 Digestion of the A-subunit of V. cholerae enterotoxin
Cholera toxin, A-subunit (1 mgml ^) was incubated with 
GIOO/P (10 EUml"^) for 1, 9 and 24 h, SDS-PAGE of these digests is 
shown in Figure 27, This gel has not run very well but the A-subunit 
appears to have been split to form two peptides, one with a very low 
molecular weight, indicated by the arrow in Figure 27,
A. Effect of V. cholerae proteases on toxin activity.
1. Control; incubation of toxin with distilled water
2. 24h incubation of toxin with proteases (GIOO/P, 10.5 EU ml ^)
3. 5h incubation of toxin with proteases {6100/P, 10.5 EU ml 1)
B. Titration to find the amount of NIAID cholera toxin equivalent
tolOBD.
1. 0.1 BD
2. 1.0 BD
3. 1.0 BD4. 2.0 BD
5. 4.0 BD6. 8.0 BD
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FIGURE 26
Intradermal blueing test of protease treated toxin samples
3.
Expected BD 3o 20 10 0 5 0 1
B
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FIGURE 27 SDS-PAGE of A-subunit digestion by choiera
proteases (GlOO/P)
1 2 3 4
Lane 1 
2
3
4
5
molecular weight markers 
A-subuni t
1 h digestion of A-subunit by GlOO/P (10 EUml
9 h 
24 h
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mueinase activity.
whole cells grown overnight in syncase medium, the specific activity was 
"* 114.7 EUml . However, some of this protease activity measured may have 
been secreted by the vibrios during the 30 min incubation with the 
dimethylcasein substrate.
6.7 Mucinase activity in protease preparations
The presence of mucinase activity in crude protease, GIOO/P, 
IEF-1, IEF-2 and IEF-3 was measured (Table 16), The crude protease, 
GIOO/P and IEF-3 all showed mucinase activity with values of 16,0,
16,0 and 32,0 respectively. IEF-1 and IEF-2 showed no detectable
6.8 Haemagglutinating activity in protease preparations
Crude protease, GIOO/P, IEF-1, IEF-2 and IEF-3 were tested 
for haemagglutinating activity against sheep and chicken red blood cells 
(Table 17). Haemagglutinating activity was found in crude protease, 
GIOO/P and IEF-3 although the titres were low. No major difference in 
activity was seen between the two types of red blood cells and no 
difference in activity was obtained in the presence of calcium ions. 
IEF-1 and IEF-2 showed no detectable haemagglutinating activity.
6.9 Cell-associated haemagglutinin and protease activity
Haemagglutinin activity with a titre of 8.0 was found by 
assaying whole cells. Protease activity was also found associated with
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TABLE 16 MEASUREMENT OF MUCINASE ACTIVITY IN PROTEASE PREPARATIONS
PROTEASE
SAMPLE (15 EUml" )
MUCINASE 
ACTIVITY *
Crude Protease 16
GIOO/P 16
IEF-1 0
IEF-2 0
IEF-3 32
* The reciprocal of the highest dilution which 
prevented clot formation (see p. 72 )
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TABLE 17
MEASUREMENT OF HAEMAGGLUTINATING ACTIVITY IN PROTEASE
PREPARATIONS
PROTEASE SAMPLE HAEMAGGLUTININ TITRE *
(10 EUml“^) SHEEP rbc CHICKEN rbc
Crude protease 16,0 8.0
GIOO/P 8.0 8.0
IEF-1 0 0
IEF-2 0 0
IEF-3 8.0 8.0
* Reciprocal of highest dilution showing visible 
haemagglutination. 
rbc : red blood cells.
i
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7. Adherence Assay
Initial experiments were done to find the most suitable size 
of tissue segment and the most suitable number of organisms to be used 
in the assay.
(Figure 28) this increase was shown to be exponential,
7o1 One square centimetre of tissue preparation type A
as the number of organisms in the suspension increased over the range
9 90.12 - 120 X 10 (Table 19). When 0,12 x 10 organisms were incubated
y2The size of the ileal segment was increased from 20 mm to
2113 mm by using different sized cork borers to cut the tissue segments. 
By varying the size of the tissue segment it was found that there was 
an increase in the number of organisms associated with the tissue segment
with an increase in tissue area (Table 18). Some 6,4 x 10 V. cholerae
2 8 organisms were associated with a 20 mm tissue segment and 52,8 x 10
2with a 113 mm segment. When these results were shown diagramatically
"
I 
2From the initial experiments it was decided to use 1 cm tissue 
2segments (area of 100 mm ) as these were easy to prepare and a reasonable
number of V, cholerae would adhere to a piece of ileal tissue of this size.
2With the 1 cm tissue segments the number of binding organisms increased ;I1
Iwith the tissue segment 0,2 x 10 organisms adhered to the tissue,
but when 12 x 10^^ organisms were incubated with the tissue segment 
915 X 10 organisms adhered to the tissue segment. These results showed
an increase in the number of organisms associated with the tissue segment 
as more organisms were used in the assay. However, when these results 
were shown diagrammatically (Figure 29) this increase was not exponential.
TABLE 18 COMPARISON OF V„ cholerae ASSOCIATED WITH TISSUE
SEGMENTS OF VARYING SIZE
Area of tissue 2Segment (mm )
Vo cholerae organisms associated with the 
tissue segment, x 10^ *
20 6o4 + 2.3
38 5.2 -h 0.2
50 12,5 + 2.3
78 25.7 + 1.6
95 31.1 + 0.8
100 46.8 4- 3.6
113 52.8 + 0.8
* Calculated from radioactive counts.
These values are the mean of three experiments.
+ : the standard deviation,
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FIGURE 28
Effect of increasing the area of ileal tissue on the number 
of adherent V, cholerae
crLU p-
< o 2
oj LU-51^
100 110 120
AREA of TISSUE SEGMENT (mm^)
The values shown are from three experiments
Mean O Range
140
TABLE 19 Effect of Increasing the number of organisms in the assay
2but keeping the tissue size constant (1 cm ) on the number 
of vibrios adhering to the tissue segment
* Calculated from absorbance at E.„„ nm600
+ Calculated from radioactive counts
These values are the mean of three experiments 
+ : standard deviation.
Number of V, cholerae 
added to tissue 
segment, x 10*^  *
Number of V. cholerae 
associated with tissue 
segment, x 10^ +
0.12 0.2 + 0.03
1.2 1.5 t 0.01
12 5.6 t 0.05
15 6.7 + 0.1
30 9.0 t 0.7
60 10.6 t 2.3
120 15.1 t 0.4
I
Î
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FIGURE 29
Effect of increasing the number of vibrios used in the assay
2system on the number of vibrios that adhered to a I cm
tissue segment
CO 
£T OX 10-
m  8- 51
4-
h-
20 30 40 50 60 70 80 90 100 110 120
No, of V. cho lerae INCUBATED WITH T I S S U E  SEGMENT,
(xIO®)
* Calculated from absorption at 600 nm,
** Calculated from radioactive counts.
The values are the mean from three experiments, 
Mean O Range,
'I
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11It was decided to use approximately 1 x 10 organisms in each
2Tissue segments (1 cm ) were treated with GlOQ/P at concen-
organisms (Table 20), This enzyme treatment had no significant effect
7.
Instead, there was an initial rapid increase followed by a gradual :!
increase in the number of vibrios adhering to the tissue segments as 
more vibrios were added to the assay system.
individual assay as this value is on the slope of the graph and so would 
allow either an increase or decrease in the number of organisms adhering
:■to a tissue segment to be seen.
trations of 1,25 - 20 EU prior to the addition of the radiolabelled
on the number of vibrios binding to the tissue segment (11,8 - 15,7 x 10 )
7when compared to the untreated tissue (12,2 x 10 ).
2The 1 cm tissue segments tended to curl into themselves and
so to overcome this problem and make the assay system more consistent it 
was decided to use a different presentation of the mucosal surface of the 
ileum,
7,2 One centimetre cylindrical lengths of tissue preparation type B
Lengths of ileum (1 cm) were cut and inverted so that the 
brush-border surface of the ileum was the outer surface,
4
%The cylindrical tissue segments were treated with protease, 
protease plus neuraminidase and neuraminidase alone prior to incubation 
with radioactive V, cholerae (Table 21), No effect on the binding of 
V, cholerae organisms to the tissue segments was seen following any of 
the enzyme treatments.
The time of incubation of the tissue segment with the radio­
labelled vibrios was increased from 30 to 60 min. This was done to 
see if a longer incubation time would show differences in the number of
'I
:#
143
TABLE 20 Effect of protease (GlOO/P) on V. cholerae adherence
2to 1 cm tissue segments
Exp to
Vo cholerae associated
Borate Buffer 
(0o05M,pH9„0) 1.25
2with 1 cm tissue segment,
Protease (GlOO/P) EUml 
2.5 5.0 10.0
X 10^ 
1 * 
20.0
1 10,9 12.5 14,5 16.1 13.1 11.5
2 12.5 15.3 16.8 12.5 9,8 12.5
3 11.2 13.8 15.7 15.3 12.2 11,2
4 14.2 14.8 14.6 18.2 12.1 14.2
Mean 12.2 14.1 15.4 15.7 11.8 12.6
* Treatment with enzyme or buffer for 30 min before proceeding with 
assay.
144
TABLE 21 Effect of protease and neuraminidase ou adherence of 
V„ cholerae to 1 cm cylindrical tissue segments
Vocholerae associated with 1 cm cylindrical tissue segments x 10 
E^cpto Borate Buffer Protease Neuraminidase Protease, 10 EUml  ^+
(0o05M,pH9o0) 10EUml 0<,05loUoml  ^ Neuraminidase 0o05 lUml
4.1 3ol 5.0 3.6
3.8 4.3 5.2 4.5
3.9 2.9 4.6 3.6
4,3 4.4 4.3 5.1
Mean 4.0 3.65 4.8 4.2
* Tissue segments were pretreated with the enzyme or buffer preparations 
for 30 rain before assay procedure was continued.
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vibrios adhering to the enzyme treated compared to the untreated 
tissue segments (Table 22). This increase in incubation time caused a 
general 20-fold increase in the number of vibrios binding to the tissue 
segments. This was seen by comparing the buffer-treated segments in 
Table 21 and 22, after 30 min incubation 4.0 x iO^ organisms adhered to 
the tissue segment but after 60 min the numbers adhering to the tissue 
segment had increased to 79.3 x 10^ organisms. However, after a 60 min
I - , ; -incubation there was still no difference between the number of vibrios 
binding to buffer-treated and any of the enzyme-treated tissue segments.
7,3 Presentation of mucosal disc to V. cholerae organisms preparation 
   «  -
type C
To allow only the mucosal or serosal surface of the ileal 
tissue segment to be present during the assay procedure, the tissue
segment was presented to the enzyme preparations and/or the radiolabelled 
organisms at the end of a specially prepared syringe.
Initially experiments were devised to see if the vibrios, 
would actually bind to the serosal surface of the ileum. Table 2 3 shows
8buffer-treated segments of the mucosal and serosal surface with 1.85 x 10
I
vibrios binding to the mucosal surface and 0,45 x 10 vibrios binding to 
the serosal surface. Therefore, of the number of vibrios that will 
bind to the mucosal surface an equivalent 247. will also bind to the 
serosal surface of the ileal segment. Protease treatment (GIOO/P,
-  p6 EUml ) of the mucosal surface (Table 23) caused the number of vibrios
8 8binding to fall from 1.85 x 10 to 0.82 x 10 , a 567. decrease. Protease
treatment of the serosal surface, however, caused a 607. increase in the
number of vibrios binding, increasing the numbers from 0.45 x 10^ to 
81.12 X 10 .
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TABLE 22 EFFECT OF INCREASING THE INCUBATION TIME OF THE ASSAY TO 60 min
ON THE EFFECT OF PROTEASE (GlOO/P) AND NEURAMINIDASE ON THE
ADHERENCE OF V, cholerae TO 1 cm CYLINDRICAL TISSUE SEGMENT 
— — --------------------------------------
Vo cholerae associated with tissue segment 1 cm tube x 10^
Exp to BORATE BUFFER* (0 .05M,pH9o0)
PROTEASE* 
6 EUml“^
NEURAMINIDASE* 
0.05 I.U.ml-t
PROTEASE, 6 EUml"^* + 
NEURAMINIDASE O.OSlUml”^
1 96 98 61 78
2 76 101 82 86
3 71 107 81 108
4 74 84 77 80
Mean 79.3 97.5 75.3 88.0
* Tissue 
before
segments were pretreated with 
being used in the assay.
enzyme or buffer for 30 min at 37°C
:
■I
.1g
I
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TABLE 23 EFFECT OF PROTEASE (GlOQ/P) ON V. cholerae ADHERENCE TO THE 
MUCOSAL OR SEROSAL SURFACE OF THE TISSUE SEGMENT SEPARATELY 
USING MUCOSAL DISC TISSUE PREPARATION
Exp to
Vibrio cholerae organisms associated with the tissue segment (xlO^)
Mucosal surface Serosal surface
Borate Buffer Protease . Borate Buffer Protease
GIOO/P 6EUml” GIOO/P ôEUml"^
1 2.51 0.77 0.43 0.69
2 1.72 0.86 0.56 1.00
3 1.49 1.08 0.46 1.67
4 1.71 0.59 0.35 1.14
Mean 1.85 0.82 0.45 1.12
Tissue segments were pretreated with protease or buffer for 30 min 
before the assay procedure continued.
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Further experiments using 8 and 4 EÜ of protease (Table 24)
showed that with 8 EU the number of vibrios binding to the tissue
8 8segment decreased from 11.2 x 10 to 4.5 x 10 and with 4 EU from
11.2 X 10 to 8.15 X 10 o Therefore, with 8 EU there was a 60% decrease 
in the number of vibrios binding but with 4 EU there was only a 27% 
decrease. Neuraminidase treatment of the mucosal surface had no 
effect on the binding of the vibrios as after neuraminidase treatment
10.2 X 10^ vibrios were associated with the tissue comparable with
11.2 X 10^ vibrios binding to the tissue following buffer treatment 
(Table 24), Protease (8 EU) plus neuraminidase and protease (4 EU) 
plus neuraminidase caused a decrease in the number of vibrios binding 
to 4,9 and 8,4 x 10^ respectively. These figures are comparable to
the protease alone at 8 and 4 EU which gave figures of 4,5 and 8,15 x 10^, 
so protease plus neuraminidase did not enhance the effect of pro tease 
alone.
149
g
S
M-" t - * 1— 11_4 \ 0 4 > 00 OJ
N I e o O i o
4> LOOi o o O l—>
00
MLn
H-* f-*O O O O' CoNi o
CjO O' 4> Ui
\0 \o CjO CO
M
0 0 (_n CO
4 > O ' N i
O'
00
001
g
Irt
O WOO Men piS et(DMOK WvO dMlO MlCDM
CD fx)Mw Oa r+B CDt-* Pi1 en1—*CD
JN >t3MM Og rtg (DH-* pi1 en1—'CD
s:O CDdO Men 833M H*g 0g H*h-* CL1 pi1-^ enCD
% tX)(D 0d OM rtS3 CDg Pen0 CDH*pa ooPien WCD cd3
+
2Î hcto CD Md Oo H rtCn P Pg PM H* eng 0 Pg H-c—■ CL 4 >
t P
M ' en W
CD g
cr"HH*O
yOM(T>Hpi(D
P)coMO0
g"rfmCL
g.
y
1oowPi
endHMlPiOfl)
0Ml
8 "m
cl-H*enend
fD
en
(D
1et
Oo
O
00
1
fMNi
4-
150
8 o Protection Studies
8,1 Parenteral immunization
Initial experiments were done by giving guinea-pigs one i/m 
injection followed later by an ileal loop challenge using virulent
Vo cholerae. The fluid accumulation in the vaccinated and control
-1 -1animals was measured in micm , The mean mlcm for each group of
three guinea-pigs is shown in Table 25, The unvaccinated control 
guinea-pigs had a mean fluid accumulation value of 0,72 mlcm The
fluid accumulation in the guinea-pigs vaccinated with protease, protease 
plus neuraminidase, enterotoxoid plus neuraminidase, protease plus 
enterotoxoid and enterotoxoid alone all showed lower values than the 
controls. However, the neuraminidase alone vaccinated guinea-pigs 
showed no decrease in fluid accumulation.
These results were expressed as histograms (Figure 30) to 
compare the mean fluid accumulation obtained with each vaccine 
preparation containing one of three adjuvants with the mean fluid 
accumulation in the unvaccinated control guinea-pigs. Decreased fluid 
accumulation was noticeable in Figures 30, A, B, G, D and F but not in 
Figure 30E. This suggested that no protection was afforded by the 
neuraminidase vaccination.
To consider whether any of the other vaccine preparations 
afforded significant protection in the guinea-pigs a t-test analysis was 
used. The fluid accumulation in each group of 3 vaccinated guinea-pigs 
was compared to the fluid accumulation in the control guinea-pigs to 
evaluate whether the decrease in fluid accumulation seen with the 
vaccinated guinea-pigs was statistically significant (Table 26), This
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TABLE 25 FLUID ACCUMULATION IN LIGATED ILEAL LOOPS MEASURED AS
mlcm“  ^ FOLLOWING PARENTERAL IMMUNIZATION OF GUINEA-PIGS
Guinea-pig
Numbers
Vaccine** Adjuvant Mean mlcm *
1287-1295 Protease (GlOO/P) F,CoAo 0,513
80 ng F,I,A, 0,453
AloCOH)^ 0,183
1296-1304 Protease (GlOO/P 80 pg FoCoAo 0,186
+ Neuraminidase 60 pg FoI.A, 0,250
AloCOH)^ 0,316
1305-1313 Protease 80 pg + FoCoAo 0.513
Enterotoxoid 80 pg F.IfA^ 0.333
Al.COH)^ 0.456
1314-1322 Enterotoxoid, 80 pg F , C 0 Ao 0.270
P.I.A. 0.393
AloCOH)^ 0,430
1323-1331 Neuraminidase, 60 pg F o C 0 Ao 0,623
F o I o Ao 0.736
Ai.(OH)g 0.670
1332-1340 Enterotoxoid 80 pg + F o Co Ao 0.463
Neuraminidase, 60 pg F o 1 0 Ao 0.493
A1o (0H>3 0.563
1341-1345 Control Animals - no vaccination 0.720
** Concentration that each animal obtained
* Mean o f three values, ie, three guinea-pigs in each group.
FoCoAo - Freunds complete adjuvant 
FoIoAo - Freunds incomplete adjuvant 
AlsCOH)^ - Aluminium hydroxide gel.
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FIGURE 30
HISTOGRAMS OF MEAN FLUID ACCUMULATION IN CONTROL 
GUINEA-PIGS AND GUINEA-PIGS VACCINATED PARENTERALLY
A. Vaccine component - Protease (80 pg)
B. " " - Protease (80 pg) + Neuraminidase (60 pg)
C. " " “ Protease (80 pg) + Enterotoxoid (80 pg)
D. " " - Enterotoxoid (80 pg)
Eo " " - Neuraminidase (60 pg)
F, " " Neuraminidase (60 pg) +
Enterotoxoid (80 pg),
C - control guinea-pigs (unvaccinated)
F.G.A. - Freunds complete adjuvant
FoIoAo - Freunds incomplete adjuvant
Al(0H)„ - Aluminium hydroxide gel.
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TABLE 26 STATISTICAL ANALYSIS OF PARENTERAL IMMUNIZATION OF GUINEA PIGS
Guinea-pig Vaccine component Adjuvant P value Significant
Numbers Protection
1287-1295 Proteinase 80 pg FCA 0.4 + -
FIA 0.6 4
Al(OH)3 0.005 4 4
1296-1304 Proteinase 80 pg + FCA 0,001 4 4 4
Neuraminidase 60 pg FIA 0.001 4 4 4
Al(OH)3 0.001 4 4 4
1305-1313 Proteinase 80 pg + FCA 0,35
Enterotoxoid 80 pg FIA 0.01 4 4
A1(0H)3 0.07 4
1314-1322 Enterotoxoid 80 pg FCA 0.01 4 4
FIA 0.05 4
Al (OH)3 0.7 4 -
1323-1331 Neuraminidase 60 pg FCA 0.38 4
FIA 0.72 4 -
Al (OH)3 0.75 4 —
1332-1340 Neuraminidase 60 pg FCA 0.06 4+ Enterotoxoid 80 pg FIA 0.05 4-
Al(OH)3 0.15 + -
4* not found to be protective
+ protective at P ^  0,05 but >  0.01
-j—j- - protective at P ^0,01 but >  0.001
+++ - protective at P ^  0.001,
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table shows clearly that only protease plus neuraminidase with all 
three adjuvants tested was found to be significantly protective, even 
although decreased fluid accumulation was seen in many other vaccine 
preparations they were not statistically significant.
8.2 Parenteral immunization followed by parenteral booster dose
Subsequently, animals were given an i/m injection of protease
plus neuraminidase, neuraminidase alone or protease alone, followed
three weeks later by an i/m booster dose. Two weeks later they were
challenged with V. cholerae using the ileal loop method. Three
concentrations of each vaccine preparation were used to try to find the
optimal concentration for protective activity. The mean values for
fluid accumulation in the guinea-pigs vaccinated with 20, 40 and 80 pg
of protease are shown in Table 27. On comparing these values to the
“1control value of 0.470 mlcm it was noticed that there was a slight 
decrease in fluid accumulation. Guinea-pigs vaccinated with 0,01,
0,02 and 0.04 I.U, of neuraminidase showed no decrease in fluid accumu­
lation compared to the control guinea-pigs (Table 27), In some 
instances the mean fluid accumulation was higher than the 0.536 mlcm  ^
for the control guinea-pigs. A combination of both protease and 
neuraminidase (Table 27) showed a decrease in fluid accumulation with 
all concentrations tested, although the decrease was less with the lower 
concentration of pro tease (ie. 20 pg protease plus 0.02 I,U,neuraminidase),
These mean values for fluid accumulation in ligated ileal 
loops of guinea-pigs vaccinated with protease, neuraminidase and protease 
plus neuraminidase were displayed as histograms (Figure 31). Protease 
alone (Figure 31A) vaccination and booster dose showed decreased fluid 
accumulation in the guinea-pig ileal loop challenges for all three
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TABLE 27 FLUID ACCUMULATION IN LIGATED ILEAL LOOPS, MEASURED IN mlcm
FOLLOWING PARENTERAL IMMUNIZATION AND PARENTERAL BOOSTER DOSE 
OF PROTEASE (GIOO/P) AND NEURAMINIDASE IN GUINEA-PIGS
Guinea-pig
Numbers
Vaccine * Adjuvant Mean  ^
mlcm
1346-1354 Protease, 80 pg F o C o A. 0.347
F.I.A. 0.210
a K o h )^ 0.250
1355-1363 Protease, 40 pg F o C o Ao 0.457
F o I o Ao 0.317
a K o h )^ 0.247
1364-1372 Protease, 20 pg F o C . A. 0.280
FoIoAo 0.413
A1(0H)3 0.290
1373-1382 Controls - no vaccination 0,470
1383-1391 Protease, 80 pg plus F.CoAo 0.213
Neuraminidase 0.02 I.U. F.IoAo 0.170
a K o h )^ 0.205
1392-1400 Protease 40 pg plus FoC.A. 0.515
Neuraminidase 0,02 I.U, F.I.A. 0.170
A1(0H)3 0.350
1301-1309 Protease 20 pg plus F o C o Ao 0.400
Neuraminidase 0,02 I.U. F.I.A. 0,160
a K o h )^ 0.580
1410-1418 Controls - no vaccination 0,622
1419-1427 Neuraminidase 0.04 I.U. F.C.A. 0.580
F.I.A, 0.730
AlfOH)] 0.670
1428-1436 Neuraminidase 0,02 I.U, F.C.A. 0.410
F.I.A. 0,603
a K o h )^ 0.656
1437-1445 Neuraminidase 0,01 I.U. F.C.A. 0.625
F.I.A. 0,530
Al(OH) 0.653
1446-1454 Controls - no vaccination 0.536
* Concentration that each animal obtained in initial 0.5 ml injection 
and 0,5 ml booster dose.
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FIGURE 31 Histograms showing differences in fluid accumulation
ligated ileal loops of control guinea-pigs and guinea- 
pigs given one parenteral vaccination and one parenteral
booster dose
A (i) - vaccinated and boosted with protease, 80 pg
(ii) - " " " " " 40 pg
(iii) - " " " *• " 20 pg
B (i) - vaccinated and boosted with neuraminidase, 0.04 I.U.
(ii) - " " " " " 0.02 I.U.
(iii) - " " *' " " 0.01 I.U.
G (i) - vaccinated and boosted with protease, 80 pg and
neuraminidase, 0.02 I.U,
(ii) - vaccinated and boosted with protease, 40 pg and
neuraminidase, 0.02 I.U,
(iii) - vaccinated and boosted with protease, 20 pg and
neuraminidase, 0.01 I.U.
G = control guinea-pigs (unvaccinated)
F.C.A. = Freunds complete adjuvant
F.I.A, = Freunds incomplete adjuvant
A1(0H)„ = Aluminium hydroxide gel.
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concentrations used* The neuraminidase vaccination (Figure 31B) showed 
no decrease in fluid accumulation for any of the three concentrations 
tested. The combination vaccine of protease plus neuraminidase (Figure 
3IC) showed decreased fluid accumulation when compared to the mean 
control value, with 80 p,g of protease and 0.02 T,U. of neuraminidase 
(Figure 31C(i)), the decrease in fluid accumulation is greater than for 
the two lower protease concentrations with the neuraminidase (Figure 
31C(ii) and (iii)). This suggested that this combination was providing 
the best protection against V. cholerae challenge.
The results of a t-test analysis of the fluid accumulation in 
each vaccinated guinea-pig compared to the control guinea-pigs are shown 
in Table 28. This table shows quite clearly that neither the protease 
nor neuraminidase alone, used as vaccines, produced significant protection 
although the protease alone was shown to cause a decrease in fluid 
accumulation. The protease plus neuraminidase was, however, protective 
and highly significant protection was obtained with all three adjuvants 
containing 80 |ig of protease and 0.02 I.U. of neuraminidase, 20 |ag of 
protease plus the neuraminidase were found to be less protective than 
80 |dg of pro tease plus 0,02 I.U. of neuraminidase,
8.3 Parenteral immunization followed by an oral booster dose
The effect of an oral booster dose followed three weeks after 
an i/m injection was considered using the 80 jig of protease and 0,02 I.U, 
of neuraminidase and also 80 jUg of protease alone. Two weeks after the 
oral booster dose the guinea-pigs were challenged with V, cholerae using 
the ileal loop method. The mean fluid accumulation in each group of 
guinea-pigs is shown in Table 29, Both the protease plus neuraminidase 
and protease alone showed decreased fluid accumulation when compared to
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TABLE 28 STATISTICAL ANALYSIS OF PARENTERAL PRIMARY PLUS 
PARENTERAL BOOSTER IMMUNIZATION OF GUINEA-PIGS
Guinea-pig
Numbers
Vaccine Component Adjuvant P value Significant
Protection
1346-1354 Proteinase 80 pg FoCoAo 0.50 +
F o 10 Ao 0.15
Al(OH)g 0ol8
1355-1363 Proteinase 40 pg F 0 C o Ao 0o90 at
FoIoAo 0 . 4 5 II
a K o h )^ 0 . 2 0 u
1364-1372 Proteinase 20 pg F.C.A. 0 . 3 0 u
F.I.A. 0 . 7 5 II
A1(0H>3 0 . 3 0 II
1419-1427 Neuraminidase 0.04 lU F.C.A. 0.80 n
F o I o Ao 0 . 1 2 tt
AlCOH)^ 0 . 3 5 II
1428-1436 Neuraminidase 0,02 lU F 0 G o A. 0,40 tt
Fol o Ao 0.60 H
Al (OH)3 0 . 3 0 tt
1437-1445 Neuraminidase 0,01 lU F.C.Ao 0 . 6 0 II
F.I.A. 0 . 9 0 II
Al(OH)2 0.40 U
1383-1391 Proteinase 80 pg + F.C.A. C. 0.001 + + +
Neuraminidase 0,02 lU F.I.A, <  0.001 + + +
Al(OH)3 <  0.001 + + +
1392-1400 Proteinase 40 pg + F.C.A. 0.07 +
Neuraminidase 0,02 lU F.I.A. <  0,001 + 4- i*
Al(OH)3 <  0.001 + + +
1401-1409 Proteinase 20 pg + F oCo Ao 0.10 +
Neuraminidase 0,02 lU Fol o Ao <0.001 + + +■
Al (OH)3 0 . 6 0 +
+ - not found to be protective
protective at P ^  0.05 but ^  0.01
++ - protective at p ^ 0 , 0 1  but ^  0,001
-H4- protective at P ^  0,001,
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TABLE 29 FLUID ACCUMULATED IN LIGATED ILEAL LOOPS MEASURED IN
mlcm"^ FOLLOWING PARENTERAL IMMUNIZATION AND AN ORAL
BOOSTER DOSE OF PROTEASE (GlOO/P) AND NEURAMINIDASE
IN GUINEA-PIGS
Guinea-pig
Numbers
Vaccination Adjuvant mlcm
1455-1453 Protease (80 pg) F.C.A. 0.503
F.I.A. 0.280
AKOH)^ 0.325
1464-1472 Protease (80 pg) F.C.A. 0.293
+ FoIoAo 0.405
Neuraminidase (0.02, I.U.) AlOOH)^ 0.297
1473-1477 Controls - no vaccination 0.752
%
-
i
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the control value of 0,752 mlcm” .^ Histograms of these values showed 
quite clearly this decrease in fluid accumulation (Figure 32), Statist­
ically significant protection was found with all three adjuvants 
containing protease plus neuraminidase (Table 30) and in F.I.A. and 
A 1 (0 H ) 3  containing-protease alone.
The protease and neuraminidase preparations used for the 
vaccines were tested for endotoxin and enterotoxin using the Limulus 
ameobocyte lysate (LAL) assay and the rabbit blueing dose assay respect­
ively. The LAL assay showed that the protease preparation contained 
no detectable endotoxin (Table 31), The neuraminidase gave a positive
result with a 1/10 dilution but a negative result with a 1/100 dilution,
-1Since the vials are standardized to detect 0.25 ngml of endotoxin,
-1the neuraminidase contained somewhere between 2.5 - 25 ngml of
endotoxin.
-1 -1 Protease, 12,5 - 200 pgml and neuraminidase, 0,025 - 0.5 I.U,ml
showed no detectable enterotoxin by using the rabbit blueing dose assay,
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FIGURE 32
Histograms of mean fluid accumulation in control guinea-pigs 
and guinea-pigs vaccinated parenterally followed by an oral
booster dose
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TABLE 30 PARENTERAL PRIMARY PLUS ORAL BOOSTER IMMUNIZATION
OF GUINEA PIGS
Guinea-pig
Numbers
Vaccine component Adjuvant P value Significant
Protection
1455-1463 Proteinase 80 pg F.C.A. 0.2 +
F.I.A, 0.025 4-
A1(0H>3 0,015 •+■ 4"
1464-1472 Proteinase 80 pg 4- F.C.A. 0.01 4" 4-
Neuraminidase F.I.A. 0,005 + 4-
0.02 lU AlCOH)^ 0.001 -t- -p 4-
.1:
i.i.
4- - “ not found to be protective
4- - protective at P ^  0 ,5  but ) ^ 0 . 1
4-4- ” protective at P ^  0 ,1  but ^  0,001
+ 4- + - protective at P ^  0 ,0 0 1 .
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TABLE 31 LIMULUS AMEBOCYTE LYSATE ASSAY ON PROTEASE AND NEURAMINIDASE
USED IN VACCINE PREPARATION
SAMPLE REACTION
Negative Control 
(pyrogen free water) ”
Positive Control 
10 ngml ^ +
1 mgml  ^ * +
Protease 
200 pgml ^
20 pgml ^ H
2 pgml ^ -
Neuraminidase 
0.05 lU +
0,005 lU +
0.0005 lU
Inhibitor Control
+ Protease (200 pg) +
Inhibitor Control **
+ Neuraminidase (0.05 lU)
* E. coll endotoxin
+ = solid gel formed
= no gel or clot formed
îVîV = This must be positive for the assay to be viable.
1;
5:
a;
a
s
I
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DISCUSSION
lo Production of enzymes
The initial aims of the project were directed at the 
production and purification of V. cholerae pro teases, the characterization 
of these enzymes and their role in adherence and as vaccine additives.
In 1981, at the beginning of this study, while there was a 
substantial literature on V, cholerae mucinase (Burnet and Stone, 1947; 
Singer, Wei and Hoa, 1948; Ada and French, 1957; Finkelstein and 
Lankford, 1955; Finkelstein et al, 1966) but almost nothing was 
published on the protease(s) of this organism, Protease activity was 
detected in the culture fluid of V, cholerae in 1970 (Hsieh and Liu, 1970)
and there seems to have been little further interest for a decade. 
However, during the last two years of this research project it became 
apparent that several research groups have been active in this field 
(Schneider and Parker, 1982; Young and Broadbent, 1982; Finkelstein and 
Hanne, 1982; Finkelstein, Boesman— Finkelstein and Hanne, 1983;
Booth, Boesman— Finkelstein and Finkelstein, 1983),
Extracellular protease production milligram  ^ dry weight of
cells was greatest when V. cholerae was grown in trypticase soy broth 
(BBL) (Table 7), When V. cholerae was grown in 2% (w/v) protease peptone 
(Difco) or in the minimal medium, syncase, this resulted in a slightly 
lower yield of protease. However, when the vibrios were grown in
tryptic soy broth (Gibco) there was a 70% reduction in the protease 
-1activity milligram dry weight of cells compared to that produced in 
trypticase soy broth (BBL), Young and Broadbent (1982) confirmed these
_______
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differences in protease production by V, cholerae grown in a variety of 
media, Protease production was greater in nutrient broth than in the 
minimal medium and the addition of glucose, although enhancing the growth 
rate of the organism, decreased the protease production in terms of 
specific enzyme activity. The composition, as stated by the manufacturers 
of trypticase soy broth (BBL) and tryptic soy broth (Gibco) (Appendix 1), 
show no major differences in composition, but in both instances the 
manufacturers state "this is a typical formula; each product lot is 
adjusted to compensate for variables in raw materials or supplemented to 
meet performance criteria". This suggests that there may be subtle 
differences in the two media although these are unknown. Also both 
products contain pancreatic digests of casein and papain digests of 
soyabean protein, the components of which may vary between the two media.
Protease production was detected from the early exponential 
phase of growth and reached a maximum level between 23-25 h (Figure 11). 
Maximum protease production during late stationary phase is not unique 
to V. cholerae. It is also true of Serratia marcescens (Lyerly and 
Kreger, 1979), Pseudomonas aeruginosa (Kreger and Gray, 1978) and 
Streptococcus sanguis (Straus, 1972). This late protease production 
is an vitro characteristic and may not be true of the ini vivo situation. 
It would therefore be interesting to determine when V. cholerae proteases 
are produced im vivo, as the time of protease production during i^ vivo 
colonization would help in understanding the role of proteases in the 
pathogenesis of cholera.
2. Purification of proteases
Gel filtration of the crude material through Sephadex GlOO
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GlOO/P (Figure 12, lanes 2 and 6 respectively) showed the loss of 
numerous bands after gel filtration leaving only five distinct peptide 
bands. Following gel filtration the specific activity of the crude
the pathogenesis of cholera. The mucinase activity is likely to be
increased haemagglutinin titres
activity. Although the titre of haemagglutinating activity obtained
resulted in the loss of a great deal of contaminatory protein material
sas the major peak of protease activity (GIOO/P) did not coincide with %
■■'.Ithe peak (Figure 13), The SDS-PAGE of the crude material and
I
A'
protease increased from 17,2 to 120 EU ml mg protein (Table 9) which
'yindicated that this purification step had increased the specific activity
of the preparation some seven-fold. The GlOO/P was also shown to have
5Imucinase and haemagglutinating activities (Tables 16 and 17 respectively).
The presence of mucinase activity in the protease preparation 
was confirmed by the recent work of Schneider and Parker (1982), who 
found that their mucinase was also a protease. Various authors have Isuggested that mucinase, although not diarrhoeagenic (Burnet and Stone,
1947; Freter, 1955; Lam, Handle and Goodner, 1955) may play a role in
I'"
-important in facilitating vibrio penetration of the mucous layer to Ireach buried epithelial cells on the brush-border surface,
IThe GlOO/P was shown to have low levels of haemagglutinating 
activity with a maximum reciprocal titre of 16,0 obtained with sheep red %
■If.blood cells. Neither the use of chicken red blood cells nor the
!presence of calcium ions enhanced the titre of haemagglutinating 
activity which other workers (Finkelstein and Hanne, 1982) found
A "
Finkelstein and Hanne (1982) purified the "soluble"
haemagglutinin of V, cholerae and found that it had significant protease
___
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with the GlOO/P might be considered to be low it compares favourably 
with the titres obtained by Finkelstein and Hanne (1982) using the same
red blood cells, with the "soluble" haemagglutinin. However, Hanne 
and Finkelstein (1982) found that mixed glycosidase treatment of chicken 
red blood cells made them more responsive to haemagglutination, 
presumably by the creation of more receptors on the cell surface by their 
enzyme action.
Isoelectric focussing of the crude protease produced three 
peaks of protease activity, IEF-1 (pi of 4,5-5.5), IEF-2 (pi of 6,5) and 
IEF-3 (pi of 9,0), Batch and fermenter-grown cultures both produced
good yields of protease. Although their gel filtration elution profiles 
were similar to that shown in Figure 13, it was noticeable that their
isoelectric focussing elution profile showed differences in the 
proportions of IEF-1 and IEF-2, The fermenter-grown cultures showed 
lower levels of IEF-1 than the batch-grown cultures. The only difference 
in the fermenter vessel from the 2 litre flasks used for batch production 
was the aeration rate; the temperature and time of growth were similar,
:This slightly higher aeration rate may have increased the autocatalytic
activity of the protease resulting in the loss of protease activity in
IEF-1. Autodigestion is a common property among proteases (Schroader 
and Shaw, 1968) and is the main reason for their instability at room 
temperature and the need to store the proteases at -20^C (Table 8),
SDS-PAGE of IEF-1, IEF-2 and IEF-3 (Figure 17, lanes 5, 4 and 3 
respectively) showed a considerable degree of purification when compared
■..to the crude protease (Figure 17, lane 2). Purification of the crude
protease following isoelectric focussing was also apparent from the 
levels of specific enzyme activity for the crude protease compared to the
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lEF-proteases ; IEF-1 and IEF-2 both showed a ten-fold increase in 
specific activity and IEF-3 showed a seven-fold increase in specific 
activity.
The IEF-1, IEF-2 and IEF-3 protease fractions were tested for 
mucinase and haemagglutinating activity. Neither activity was detected 
in the IEF-1 and IEF-2 fractions but IEF-3 showed both mucinase and 
haemagglutinating activity. Again, as for GIOO/P, the haemagglutinating 
activity in IEF-3 was low with a titre of 8,0,
IEF-3 possessed protease, mucinase and haemagglutinating 
activities. This fraction appears to be very similar to the "soluble" 
haemagglutinin recently described by Finkelstein and Hanne (1982) since 
this also had haemagglutinating, mucinase and protease activities.
The discovery that a cholera protease had haemagglutinating 
activity is reminiscent of the haemagglutinin-neuraminidase protein 
spikes of paramyxoviruses (Schneid and Ghoppin, 1974) and the haemagglutinin- 
neuraminidase protein of Cl, perfringens (Rood and Wilkinson, 1976a,b).
One can only speculate as to why attachment and enzyme functions are 
present in a single protein in some pathogens. Paramyxoviruses,
Cl, perfringens and V» cholerae share a common feature in that they can 
parasitize epithelial surfaces. Several authors have suggested that 
such parasites use a dual function protein both to hydrolyze the surface 
mucus layer and to interact with it to prevent being cleared from the 
intestine or respiratory trac.b.
Further attempts to purify individual proteases could possibly 
be achieved by raising monoclonal antibodies to each peptide band in the 
SDS-PAGE, These monoclonal antibodies could then be used in an 
immunosorbent column to separate single proteases. Although this would
170 î;
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allow purification of crude material, with no initial purification step 
being necessary, it would be cost inhibitory for large-scale production. 
Therefore, using an immunosorbent column, although useful in basic 
research, would not be as important for vaccine production due to the 
high cost.
Less expensive procedures for the isolation of proteases might 
be considered for vaccine production since the work of this thesis has 
shown that even isoelectric focussing does not yield individual proteases.
As discussed later positive protection was achieved with a mixture of 
proteases (see page 185) and therefore a partially purified preparation 
of proteases may be sufficient.
The "soluble" haemagglutinin isolated by Finkelstein and Hanne
(1982) was shown to exhibit hydrophobic properties similar to other 
microbial adhesins (Robertson, Vincent and Ward, 1977; Smyth et al,
1978; WadstrBm et al, 1979), Since the "soluble" haemagglutinin has
.
similar properties to cholera proteases, especially IEF-3, the use of a 
hydrophobic matrix such as phenylsepharose could also be useful in 
further purification attempts.
Affinity chromatography, using haemaglobin-Sepharose, may be 
useful as this has been used in the purification of wheat proteases and 
proteases of Nocardia brasiliensis (Chua and Bushuk, 1969; Zlotnik,
Schramn and Buckley, 1984).
3, Biochemical Properties of Cholera Proteases
The small intestine has a pH range of 6,5 at the upper end of 
the duodenum to 8,0 at the lower end of the ileum, with an average pH 
of 7,2, The V. cholerae crude protease had an optimum activity at pH
/
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8,9-9.0, markedly higher than the pH of the small intestine. It was 
shown (Figure 12) that the crude protease had an activity of 30 EUml
“ 1at pH 7.2 and 36.5 EUml at pH 9,0. This showed only an 18% decrease
in activity from pH 9.0 to 7.2. Therefore, cholera proteases would 
still be highly active in the small intestine,although not at the 1
experimental optimum pH for the activity.
In view of the variety of protease activities it is often 4'i
difficult to characterize these enzymes biochemically. A single protease
...may display heterogeneity in molecular weight and charge, this may be 
due to autocatalytic degradation during purification. A single enzyme may 
also display multiple enzyme activities which represent catalytically l|
identical but electrophoretically heterogeneous enzymes. =^1
Peptide digest analysis was used to compare the specific
■Acatalytic activities of IEF-1, IEF-2 and IEF-3. The three proteases
were shown to have different peptide patterns after SDS-PAGE of a 2 h
Adigest of BSA by each of the proteases (Figure 21). This suggested that % 
each of the lEF proteases had different catalytic specificities.
The presence of multiple activities in each of the lEF #
proteases, GlOO/P and the crude protease was shown by gelatin-PAGE AA
(Figure 20). Two bands of protease activity, A and B, were present in
:
IEF-2 and IEF-3. IEF-1 also showed these activities plus one other 
protease activity, band G, The crude protease showed activities A, B 
and C plus a protease activity, band D, which was not present in any of 
the semi-purified preparations. The loss of activity D during ■ A
purification may have been due to autocatalytic degradation. The gel 
filtration elution profile of the crude protease (Figure 13) showed one 
major peak of protease activity (peak B, GlOO/P) and one minor peak,
- J,
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peak A, The latter was not investigated as it coincided with the E280nm ‘
:peak which contained a lot of contaminating material» This meant that &
further purification of peak A would have resulted in a very low yield. 
Therefore, the crude preparation of protease contained this peak A
protease which was absent from all semi-purified proteases and so this |
may be equivalent to the band D component which had protease activity shown |
by the gelatin-PAGE.
7The presence of several protease activities in the gelatin-PAGE
imay be due to the presence of several distinct catalytic proteases in
;s,each preparation or a single enzyme has produced multiple protease 
activities which represent a catalytically identical protease that is 
showing electrophoretic heterogeneity due to autocatalytic degradation» #
The use of inhibitors to classify further the lEF proteases
suggested that more than one type of protease was present in each
.preparation. This conclusion was reached as IEF-1 was inhibited by the s
known metalloprotease inhibitors, 8-HQ and EDTA, and also by serine
protease inhibitors. IEF-2 was inhibited by metalloprotease inhibitors,
serine protease inhibitors and a sulphydryl protease inhibitor» IEF-3
was only inhibited by metalloprotease inhibitors (Table 14).
It is not certain that one protease can be inhibited by more
than one class of inhibitor (Dr, Michael North, personal communication).
This suggests that more than one protease is present in IEF-1 and IEF-2,
An unexpected finding was that the three serine protease
inhibitors soyabean trypsin, anti-trypsin and egg-white\trypsin, did not i
cwAi -all inhibit IEF-1 and IEF-2. Eggwhite\trypsin and anti-trypsin inhibited
SIEF-1 but only anti-trypsin inhibited IEF-2. This appears to be a Irather unusual phenomenon and may be due to the different action of the
____________
'ï
173
d
inhibitors on the proteases. Perhaps the optimum concentration of 
inhibitor and protease was not used which may have produced this 
anomaly.
The results from the inhibition studies confirm the presence 
of several proteases in IEF-1 and IEF-2 and disagrees with the idea of 
a single enzyme which produced multiple activity bands due to auto­
catalytic degradation. However, the results obtained for IEF-3 disagree
with this conclusion. IEF-3 has at least three activity bands on gelatin-
PAGE, three peptide bands on SDS-PAGE, but was only inhibited by
inhibitors specific for a metalloprotease. This suggests the presence of
only one catalytic enzyme with electrophoretic heterogeneity or the 
presence of several metalloproteases in IEF-3,
Table 32 was compiled to allow comparison of the biochemical 
properties of the proteases isolated in this study with recently published 
work. This table shows quite clearly the complicated nature of the 
proteases. Comparisons can be made between the proteases although 
different strains and purification procedures were used by each group of 
workers. The most common feature appears to be a protease with an 
alkaline pH optimum and the inhibition by metallo-protease inhibitors.
The number of inhibitors used in this study were three times as 
many as used by Schneider and Parker (1982) or Young and Broadbent (1982) 
which is likely to account for the more complicated inhibition pattern 
seen. Perhaps if the other workers had used more inhibitors they would 
have found the presence of more than one protease in their preparations.
Schneider and Parker (1982) used ammonium sulphate precipitation 
followed by gel filtration for purification of their proteases. They were 
therefore working with a protease preparation similar to GIOO/P used In
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Immunological Properties
li.
this study. It seems probable that their protease preparation contained ;f 
a mixture of proteases which would have been noticed if further 
purification was attempted.
The production of antisera against IEF-2 and IEF-3 appeared not f 
to be successful. Cholera proteases are very unstable in culture 
supernates and may lose virtually all activity in a matter of hours at 
room temperature. The prolonged incubation required for the gel 
filtration technique may result in loss of antigenicity of protease, 
perhaps by autodegradation. This may explain why no antiserum was
detected against IEF-2 and IEF-3.
■ ■In an effort to counteract autodigestion, 25 mM mercuric 
chloride was incorporated into the gel diffusion medium. This however 
had no effect and no reactions to IEF-2 or IEF-3 were detected with
-,immune rabbit sera. Specific antibodies against IEF-1 and crude protease
were detected by this technique which would seem to disagree with the
Iphenomenon of autodigestion causing loss of antigenicity of the #
proteases in IEF-2 and IEF-3,
It is noteworthy that IEF-2 and IEF-3 had higher specific enzyme 
activities than IEF-1 or the crude protease. The sensitivity of the 
gel diffusion technique is not high, therefore, if the protease has a
very high specific activity it may possess equivalent enzymatic activity #■g;
but insufficient antigenicity to react in the Ouchterlony test.
___
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Properties that may be associated with the in vivo colonization 
of V. cholerae
The mucosal secretory immune system is dominated by the 
secretion of antibody of the IgA isotype. lubricating fluids issuing
.from mucous membranes contain relatively large amounts of this immuno­
globulin in comparison to the amounts of IgG and IgM (Tomasi, 1972),
In human beings, approximately 807. of all antibody secreting plasma cells 
within mucosal tissues synthesize IgA, The precise mechanism by which 
antigen disposal at mucosal sites takes place is unclear because 
secretory IgA apparently does not utilize complement for disposal of 
antigens and is not opsonic (Wilson, 1972; Van Epps and Williams, 1976), 
However, it has been suggested that secretory IgA functions by preventing 
adherence of bacteria to relevant tissues (Williams and Gibbons, 1972; 
Brandtzaeg, 1977), Since such adherence is a pre-requisite to 
colonization and disease, in theory, inhibition would be an adequate 
means by which secretory IgA could function in mucosal defence. Poly­
morphonuclear leukocytes and lymphocytes have been shown specifically to 
bind IgA proteins (Lawrence, Weigle and Spiegelberg, 1975), although the 
identification of these cellular receptors has as yet not yielded a 
coherent explanation for the role of cellular elements in the effector 
functions of IgA antibodies.
Many microbial pathogens have been shown to possess a proteo­
lytic activity that can specifically digest IgA, These enzymes have been 
termed IgA proteases (see page 43 ). These typical IgA proteases cleave
IgAl at the hinge region of the molecule leaving intact Fc and Fab 
fragments (Figure 6), The V, cholerae proteases did not appear to yield
4
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|.intact Fc and Fab fragments of IgA by their proteolytic activity as 'ÿ
shown by Immunoelectrophoresis (Figure 23). A typical IgA protease would 
yield fragments which would produce two distinct arcs after immunoelectro~ 
phoresis and interaction with specific antiserum. This was not found in e
this study with the various cholera proteases ard it was concluded that 4
4none of the isolated proteases were typical IgA proteases. However, the
cholera protease did effect some digestion of IgA although this did not
.destroy the antigenicity of the molecule as a single, shortened immuno- 
electrophoretic arc was observed. Previously, when trypsin and chymo- 
trypsin were used to cleave IgA proteins an intact Fc fragment was not 
found as a product of digestion but instead they caused a progressive 
non-specific degradation of the Fc region of IgA, thereby rendering the i;
IIgA antigenically undetectable (Kornfield and Plaut, 1981), The %
I'digestion of IgA by cholera proteases was shown to be a very specific 
event, as shown by SDS-PAGE (Figure 22). The fact that cholera 4;
proteases do digest IgA in a specific manner suggests that this activity I
may be of importance in the evasion of the host mucosal secretory 
immune res p ons e,
A recent paper by Finkelstein, Boesman-r-Finkelstein and Holt
■ '4(1983) has confirmed these conclusions. They demonstrated some 10%
degradation of IgA by their soluble haemagglutinin/protease using 
125 ;;I-labelled IgA, They also concluded that the enzyme was clearly not *
identical to the typical IgA pro teases but it was not clear whether
there may be some effect on the antigenic binding site of IgA. It is
■; ■noteworthy that Schneider and Parker (1982) alluded to the observation e
that Vo cholerae mucinase was also active on immunoglobulins.
 :     _ ,
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Polymorphonuclear leukocytes (PMN) play an important role in 
host defence against many infections. During the process of phagocytosis, 
PMN undergo a remarkable oxidative metabolism, resulting in emission of 
light or chemiluminescence (Allen, Stjernholm and Steel, 1972),
Fs, aeruginosa produces an alkaline protease and an elastase 
which have been shown to be involved in pathogenesis (Holder and Haidaris, 
1979; dagger, Bahner and Warren, 1983), Kharazmi ^  al (1984a) 
demonstrated that both the alkaline protease and the elastase were 
capable of inhibiting neutrophil chemotaxis and also interfering with 
the oxidative metabolism of these cells, Kharazmi ejt ^  (1984b) also 
showed that the alkaline protease and elastase were capable of inhibiting
( V f )
myeloperoxidase-mediated chemiluminescence, / These findings provided 
further evidence for the role of Ps, aeruginosa exoproteases as virulence 
factors.
It would be very interesting to determine if V, cholerae 
proteases have any effect on the PMN chemotaxis or the oxidative 
metabolism of these cells,
Lactoferrin is a host iron-binding protein found in mucosal 
secretions and has been assumed to play a role in host defence by with­
holding essential iron and thus reducing its availability to microbes in 
mucosal secretions (Bullen, 1981), The cholera proteases isolated in 
this study did not degrade lactoferrin (Figure 25) which contradicts the 
recent paper of Finkelstein, Boesman.— Finkelstein and Holt (1983) who 
found their soluble haemagglutinin/protease degraded lactoferrin. They 
suggested that this may be a mechanism to counter iron sequestration by 
lactoferrin, although whether this digestion would have any effect on the 
iron binding capacity of lactoferrin is not known,
(*) (Rosen and Klebanoff, 1976; Webb, Keele and Johnston, 1974; Bender 
and VanEpps, 1983.)
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Fibronectin is an adhesive high molecular weight glycoprotein 
that is present on the surface of mammalian cells (Yamada and Olden,
1978) and was shown to be synthesized by cells of the crypt of 
Lieberkllhn in the intestine (Quaroni, Xsselbacher and Ruaslahti, 1978), 
Whereas fibronectin is believed to facilitate attachment of Gram- 
positive bacteria to host cells and to participate in opsonization 
(Simpson, Courtney and Beachy, 1982), it has been reported to interfere 
with the adherence of Ps. aeruginosa to epithelial cells (Woods e_t al, 
1981), The cholera protease(s) were found to degrade fibronectin after 
only 1 h, and further digestion occurred after 24 h (Figure 24). 
Finkelstein, Boesman^ Finkelstein and Holt (1983) have recently stated 
that their soluble haemagglutinin/protease digested fibronectin, although 
their gel photographs of the digests were not convincing. In the 
published result electrophoretic bands were not readily detectable in the 
untreated fibronectin.
Woods e_t ^  (1981) presented evidence that suggested that 
trypsin-like proteases of Ps. aeruginosa facilitate attachment of these 
organisms to buccal epithelial cells by their action on host cell 
surface fibronectin. The fact that V, cholerae protease(s) have a 
fibronectinase activity does not permit conclusions as to whether the 
fibronectinase (a) is either responsible for the binding of the vibrios 
to the mucosal surface or possibly their subsequent detachment (Nelson, 
Clements and Finkelstein, 1976), (b) enables the vibrios to penetrate 
the fibronectin layer and then attach to another subtrate, or (c) is 
irrelevant to vibrio colonization of the intestinal epithelium. The 
V, cholerae GIOO/P and IEF-3 proteases were shown to have mucinase 
activity and, as has been mentioned, this is likely to be of importance
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in the initial colonization of the small intestine by facilitating 
vibrio penetration of the mucous layer. Antibodies to mucinase have 
been reported in persons convalescing from cholera although formal 
cholera vaccine does not induce antibodies to mucinase. This suggests 
that the protease/mucinase is involved in pathogenesis.
The binding of the B-subunit of cholera enterotoxin to GM 
gangliosides on the epithelial surface is a prerequisite for the 
insertion of the A-subunit into the cell membrane (Figure 3), This 
causes an increase in cyclic AMP by the activation of adenylate cyclase 
(Figure 4), the secretion of chloride ions into the bowel lumen and a 
reduction in the adsorption of sodium which leads to a net fluid deficit 
in the human body. Neuraminidase has been suggested to be involved in 
the binding of enterotoxin to the cell membrane (Durikhin, Popova and 
Korinskii, 1976), In this study neither protease, neuraminidase nor 
protease plus neuraminidase enhanced the binding of cholera toxin to 
ileal segments in vitro (Table 25),
E. coli heat-labile enterotoxin, which is related to cholera 
enterotoxin, was shown to produce two peptide fragments and have 
increased activity following trypsin treatment (Rappaport et al, 1976), 
Finkelstein, Boesman— FinkeIs tein and Holt (1983) found that their soluble 
haemagglutinin/protease was capable of nicking the A-subunit of the heat- 
labile enterotoxin of E, coli. Many authors (Young and Broadbent, 1982; 
Schneider and Parker, 1982; Finkelstein, Boesman:-”Finkelstein and Holt, 
1983) have suggested that cholera enterotoxin may be activated in a 
similar manner to the E, coli enterotoxin but no work has been published 
which either agrees or disagrees with this suggestion.
The intact A-subunit was shown to be susceptible to proteolytic
181
cleavage producing and A^ fragments of 21-24 k.Dal. and 5-7 k.Dal, 
respectively (Gill and Rapport, 1979), The cholera protease(s) were 
found to nick the A-subunit at a specific site producing one polypeptide 
with a very similar molecular weight to the intact A-subunit and one 
very low molecular weight peptide. These were comparable to the A^ and 
A^ fragments described by Gill and Rapport (1979). This proteolytic
action appeared to increase the activity of the toxin but other factors 
present in the crude toxin may have been responsible for this effect.
Hrotease activity of V. cholerae r  an important factor in the pathogenesis
— --J
of cholera. It would be interesting and important to continue this work
in an vivo system. Ileal loops could be treated with the enzyme 
preparations and then injected with a known amount of toxin, any 
differences in fluid accumulation between treated and untreated loops 
could be compared. This vivo approach would give valuable information 
on the involvement of proteases during cholera infection.
Adherence to the intestinal epithelium
Initially, when ileal tissue segments, either one square 
centimetre or cylinders of tissue, were treated with protease, neuramini­
dase or protease plus neuraminidase there was no demonstrable effect on 
the binding of V. cholerae organisms to the surface layer (Tables 19 and 
21), Subsequent experiments showed that this was due to the fact that 
the V, cholerae organisms could bind to both the mucosal and serosal 
surface of the tissue. Vibrio binding to the serosal surface of ileal 
segments was shown by the experimental work with discs of ileal tissue 
exposed at the end of a specially prepared syringe (Table 23).
Of the number of vibrios in a suspension that adhered to the
4:
4;
:
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mucosal surface, an equivalent 24% of this number also adhered to the 
serosal surface. Adherence of vibrios to the serosal surface was 
noticed also by Attridge and Rowley (1983a,b) but they found that some 
vibrio strains were able to adhere equally well to both the mucosal and 
serosal surface of the ileum. The tissue preparation used by Attridge 
and Rowley was the cylinder method initially used in this study,
everted cylinders were used for mucosal adherence and non-everted segments 
were used to measure serosal adherence. This means that in both everted 
and non-everted tissue segments the mucosal and serosal surfaces of the 
tissue were still actually available for vibrio binding. Highly motile 
strains were used by Attridge and Rowley (1983a) and although one tissue 
surface was not always directly available for vibrio binding, it seems 
probable that these highly motile strains would be able to bind to either 
surface. This may be the reason why they found that some vibrio strains 
would adhere equally well to both mucosal and serosal surfaces whereas in
the present study comparatively fewer organisms adhered to the serosal 
surface than the mucosal surface.
Although no difference was determined in the number of vibrios 
directly adhering to the epithelial cells of everted cylindrical tissue 
segments following protease treatment, it was noticed that following 
protease treatment of the tissue segment, the number of vibrios present in 
the washes of the adherence assay were greater than the number of vibrios 
present in the washes used for untreated tissue segments. Since the 
washings remove mucus and loosely bound vibrios, it seems likely that the 
protease treatment facilitated the movement of the vibrios through the 
mucus. This would agree with the finding that the protease had mucinase 
activity which is likely to aid movement of the vibrios through the
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mucous gel apposed to the brush-border surface. To try to consider
this movement through the mucus in more detail, paraformaldehyde vapour
fixation was used to retain the mucus on the epithelial surface.
However, this method of fixation was not used as the tissue segments
were hardened and, although used in iri vitro adherence assays, would be
unrepresentative of the natural state.
Protease treatment caused a decrease in the number of vibrios j
binding to the mucosal surface but a proportional increase in the |
numbers associated with the serosal surface (Table 23), This explains I
!
why the protease produced no overall effect when both the mucosal and i
serosal surfaces were present in the assay system, ie, with one square I
centimetre and cylindrical tissue segments.
It might be argued that it would be disadvantageous to 
V. cholerae as a pathogen to elaborate a soluble protease that blocks 
attachment. Nelson, Clements and Finkelstein (1976) showed that cholera 
vibrios detach from the brush-border surface and suggested that this was 
due to enzyme action. This phenomenon of detachment may be an 
adaptation of V. cholerae to the parasitic mode of life allowing the 
vibrios to multiply and spread. If the cholera protease(s) was 
involved in the detachment from the brush-border surface this would be I
advantageous to the spread of the disease, !
ÎiPartially purified soluble haemagglutinin, or "cholera lectin" 
as it was termed in the study of Finkelstein £t al (1978), was isolated 
from an Inaba serovar. The "cholera lectin" was found to inhibit 
attachment of Ogawa serovars and el. tor biovars in the infant rabbit.
It was presumed that the haemagglutinin acted by occupying, or otherwise 
affecting the receptors on the surface of the epithelium, Finkelstein,
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Boesman— Finkelstein and Holt (1983) also found that soluble haemagglu- 4Itinin/protease inhibited adherence to the intestinal epithelium, §
The cholera protease was isolated from late exponential phase 44
Icultures at a time when significant lysis and release of membrane %
fragments was occurring. To determine if the soluble nature of the
% 
4
protease was a peculiarity of in vitro cultivation, it was decided to
assay V. cholerae cultures for cell-associated protease and also cell- 
associated haemagglutinating activities. Both protease and haemagglutin- 
ating activities were found in a cell-associated form but V, cholerae does 
produce at least four haemagglutinins (Finkelstein and Hanne, 1982), some 
of which would be expected to be present on the vibrio cell surface as 
three are cell-associated haemagglutinins.
It is conceivable that protease (which contains haemagglutinating
4activity) treatment of tissue segments is "masking" receptor sites which 
would otherwise be available for vibrio binding and so a decrease in the 
number of vibrios binding to the brush-border surface following pro tease 
treatment would be expected. The continuation of these adherence
studies in an in vivo system is now necessary and perhaps a time-scale iV'
study of protease production with vibrio adherence in vivo would yield 
some important information.
It seems possible that the cholera protease(s), which has f
mucinase and haemagglutinating activity, serve a dual function of f
indirectly promoting attachment and detachment of V. cholerae to the 
intestinal brush-border surface. The time of production of V. cholerae 
proteases in vivo would confirm this hypothesis.
185 I;
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7» Protective activity of V. cholerae proteases 
The GlOO/P mixture, hereinafter named protease, used in the vaccines 
contained a number of proteases and was-haemagglutinating. e
Active protection tests were initially carried out by giving
one i/m injection of candidate vaccine to guinea-pigs (Table 25). A f
combination of protease plus neuraminidase was in all three adjuvants, /
protective against ileal loop challenge with virulent V. cholerae. This /
was rather unexpected so further experiments were done by giving one i/m
injection followed by an i/m booster dose for protease, neuraminidase
and protease plus neuraminidase at three different concentrations (Table
27), Once again neither protease nor neuraminidase alone elicited
protection in guinea-pigs against ileal loop challenge. However, protease y
plus neuraminidase produced highly significant levels of protection
against challenge with V. cholerae.,with maximum protection in animals
injected with 200 pg of protease and 0.05 I.U. of neuraminidase.
An ideal cholera vaccine would be one which stimulated prolonged
'V-
antibody production at the mucosal surface of the intestine. However,
results have indicated that oral or enteral vaccination is inferior to hi
parenteral administration of vaccines, and requires multiple applications |
k;:;
before a reasonable level of protection is obtained (Holmgren et al, 1975; 
Agarwal and Ganguly, 1972).
It was therefore decided to give guinea-pigs an initial " >
fparenteral immunization followed by an oral booster dose. Protease,
4
200 pg, plus neuraminidase, 0,05 I.U., and protease, 200 pg, alone were Iused for vaccine preparations (Table 31), Protease plus neuraminidase
4
showed highly significant protection and for the first time pro tease alone %  
was found to provide an effective vaccine.
Interestingly, Pierce and Gowans (1975) found that a maximum 
increase in the number of antitoxin-containing cells resulted when oral
  ___
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immunization was preceded by a parenteral Inoculation two weeks earlier.
These workers suggested that the primary inoculation established immuno­
logical memory in the secretory IgA system of the intestine so that 
subsequent oral applications of antigen acted as a "booster".
In vivo, Vo cholerae neuraminidase probably works synergistically
'
with the protease to degrade epithelial mucins. Although neuraminidase was
::absent from culture fluids used for the purification of protease(s), it is 
possible that the protease(s) (mucinase/haemagglutinin) and neuraminidase 
are produced synchronously in vivo to form a "mucinase complex". The
close association between the two enzymes is also shown by the fact that 
90% of pro tease-deficient mutants isolated by Schneider and Parker (1978) 
were also deficient in neuraminidase. Neuraminidase mutants also showed 
a predominance of similar double neuraminidase-protease mutants suggesting 
that expression of protease and neuraminidase is inter-related. This 
may explain the requirement for both enzymes in a protective vaccine.
Active protection, using a protease vaccine, was also shown by
Lyerly and Kreger (1983), They found that vaccination with a serratia
protease stimulated active protection against experimental lethal serratia 
.pneumonia.
It is noteworthy that neither the V. cholerae mucinase described 
by Schneider and Parker (1982) nor the haemagglutinin/protease described 
by Finkelstein and Hanne (1982) have been used in active protection tests. 
However, passive immunization with antibodies against mucinase or 
haemagglutinin/protease have been shown to be protective in the infant 
mouse model. Therefore, for the first time cholera protease(s) (mucinase/ 
haemagglutinin) has been shown to produce active protection against 
Vo cholerae using a guinea-pig ileal loop challenge.
: I;:'
"  :
The present study has shown the relatively cheap production
of an extracellular enzyme capable of eliciting protection against %
2Ve cholerae and so it is worthy of consideration as part of a component 
vaccine. Until genetically engineered mutant strains that are protective 
but avirulent are accepted and production becomes cheap, vaccine work v-
will continue along the lines of whole cell vaccines. Nevertheless,
finding that proteases are protective may be important in understanding 
other infections of mucosal surfaces.
IIIIIThroughout the work on the properties associated with the
■ifin vivo colonization of V, cholerae, adherence and protection all cholera
£protease preparations used were GlOO/P, It is now known that GlOO/P 
contains several proteases and it would be important, once these
■Iproteases were purified, to repeat some of this work using the individual 
protease preparations.
In section (5), for example, it is not known whether only one 
or several proteases are involved in toxin activation. In section 6 
all adherence studies used GlOO/P and it would be interesting to determine 
if individual proteases would have different effects on adherence. Also 
important, although perhaps not cost efficient, would be to determine if 
one single protease would elicit protection or if a combination of 
several, as used in this work are necessary, to provide active protection 
against V. cholerae.
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8, The role of V. cholerae proteases in the pathogenesis of cholera
It will be obvious to the reader that the major portion of the 
work presented in this thesis was done in vitro, summarized in Table 33, 
Therefore, there is more than an element of speculation involved when an 
attempt is made to translate the findings to the in vivo infection. There 
are a number of effects which may be due to the action of proteases 
(Figure 33) either acting alone or in concert with other enzymes in a
"mucinase complex" which contribute to V. cholerae virulence:-
i) evasion of normal host clearance mechanisms 
ii) movement through the mucus 
iii) facilitate colonization 
iv) exposure of receptor sites 
v) activation of enterotoxin 
vi) release of organisms into the lumen.
Positive evidence in this thesis would support the in vivo
protease activities associated with i, ii, iii.
Although the proteases were shown to digest fibronectin (see 
page 127, Figure 24) in vitro, one cannot conclude that this is 
necessarily helping in the exposure of new receptor sites on the epithelial 
surface. In the gut environment it would seem unlikely that the initial 
adherence of V, cholerae would be conditioned by the chance production of 
an extracellular enzyme required to expose a specific receptor for 
attachment. Nevertheless, the exposure of new receptors may aid in the 
lateral spread of the organisms over the epithelial surface once the 
initial colonization has been achieved (Figure 34,a). Similarly, one 
could argue that the proteases aid in the adherence of the organisms to
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TABLE 33
LIST OF ACTIVITIES OF THE V. cholerae MUCINASE COMPLEX
Degrades mucin + + +
Digests fibronectin +
Digests IgA +
Digests enterotoxin A-subunit into two
peptide fragments +
Activates cholera enterotoxin ?
Haemagglutinating activity 4-
Blocks adherence + +
Protective + + +
Detachment ?
+ + + highly active to + weakly active.
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FIGURE 34 Adherence and detachment of V, cholerae to rabbit villi
a.
5 h sample showing large patches of V. cholerae on the adult villus
b.
12 h sample showing almost complete absence of vibrios. 
From Nelson, Clements and Finkelstein (1976).
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,the mucus, shown by Schrank and Verwey (1976) to be the Initial event
.in colonization. However one must remember that this organism produces 
neuraminidase and an endoglycosidase which degrade mucin (R.A, Ollar and 
D.E.So Stewart-Tull, personal communication). Consequently, it is more 
probable that these enzymes function to effect ii, the movement of the 
organisms through the mucus and thus allow contact with the epithelial 
surface. The work of Rozee ^  aj^  (1982) showed that the mucus blanket 
was incomplete (Figure 35). However, in this laboratory histochemical 
staining has shown that mucus tends to be trapped between the villi and 
since V. cholerae organisms migrate into the crypts of LieberkUhn the 
mucinase complex would aid in the positive movement through the mucus.
It does appear that once the organisms have attached themselves to 
receptors the IgA proteases may effect the continued colonization of the 
epithelial surface for a sufficient time to elapse for production of the 
effective exoenterotoxin. In addition, other V. cholerae proteases have 
been shown (see page 132) to activate the enterotoxin vivo.
There is the characteristic phenomenon with infected patients 
on oral hydrotherapy that the disease symptoms regress within some 48 
hours. The precise mechanism for this is still unexplained but may 
involve a) lack of nutrients for the organism to synthesize enterotoxin, 
b) increased water flow in the lumen causing wash-off of the organisms, 
or c) synchronized detachment. It is not possible to discuss a and b in 
relation to proteases but Nelson, Clements and Finkelstein (1976) have 
suggested that enzymes may ultimately be responsible for the synchronized 
detachment of V, cholerae (Figure 34a,b).It is difficult to envisage such 
a role for the proteases when one considers their presence during the 
whole process of adherence, colonization, organism defence and activation
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FIGURE 35
Scanning electron micrograph of ileal epithelium of mouse 
showing fragmentation of mucous blanket
* 3
' J
m
From Rozee et al (1982)
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laboratory findings could be extended to provide an effective and long-
of enterotoxin. The IgG class of immunoglobulin has been shown to be
the important protective antibody (Pierce and Reynolds, 1974; Pierce,
Sack and Sircar, 1977; D.E.S, Stewart-Tull, personal communication) and
?one must also accept that the release of V, cholerae organisms may be due 
to a specific antigen:antibody reaction.
In conclusion it is apparent from this study that V. cholerae 
produces a variety of proteases which play important roles in the disease 
process. In addition, it is significant that the effects of the proteases
can be negated by immune antibodies since experimental vaccines containing y 
the enzymes stimulated protection against virulent challenge in laboratory
animals. Further studies would be warranted to investigate whether such M
lasting immunity in man.
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APPENDICES
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APPENDIX I
Growth Media
Ao Tryptlcase soy broth (BBL)
30 g of powder were dissolved in 1 litre of distilled water
and sterilized by autoclaving for 15 min at 321°C and 15 psi. Final pH,
7.8 - 0.2.
Classical Formula per litre of distilled water:- 
Pancreatic Digest of Casein 17.0 g
Papale Digest of Soybean Meal 3.0
Sodium Chloride 5,0
Dipotassium Phosphate 2,5
Dextrose 2.5
Adjusted and/or supplemented as required to meet 
performance criteria,
B. Tryptic soy broth (Gibco)
30 g of powder were dissolved in 1 litre of distilled water and
sterilized by autoclaving for 15 min at 121°C and 15 psi. Final pH,
7.2 t 0,2.
Classical formula per litre of distilled water 
Ingredients per litre of chemically pure water 
Peptone 140 (Pancreatic Digest of Casein) 17,0 g
Peptone 110 IPapaic Digest of Soy Protein) 3,0 g
Sodium Chloride (NaCl) 5.0 g
Potassium Phsophate Dibasic (K^HPO^) 2.5 g
Dextrose 2,5 g
The above formula is typical, each production lot is adjusted to 
compensate for variables in raw materials.
Typical formula per litre of distilled water:-
Pancreatic digest of casein 15.0 g
Papain digest of soyabean meal 5,0 g
Sodium chloride 5.0 g
Agar 15.0 g
Final pH, 7.3 - 0.2.
 .
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APPENDIX 2
SYNGASE
SYNGAS E MINIMAL MEDIUM
Grams/litre distilled water
Na^HPO^ 5.0
K^HPO^ 5.0
Sucrose 5,0
NH,C14 1,18
Na^SO^ 0.089
MgCl^.bH^O 0.042
MnCl2.4H20 0,004
FeCl^.ôH^O 0.005
Casamino acids 10,0
Final pH 7,2,
As above but substitute glucose for sucrose.
G, As A but with no sucrose present,
The above media were sterilized by autoclaving for 15 min at 121 C 
and 15 psi.
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APPENDIX 3
BUFFERS AND SALINE
1, Physiological Saline (0,15M)
Sodium chloride (34,0 g) was dissolved in distilled water and 
the volume made up to 4,0 litres,
2, Phosphate Buffered Saline (P,B,S,) pH 7,2
(OoOlM phosphate buffer, 0.15M NaCl)
Solution A : 3,58 g Na2HPO^,2H20 were dissolved in litre distilled water. 
Solution B ; 1,56 g NaH2pO^,2H20 were dissolved in 1 litre distilled water,
For use 72,0 ml of solution A and 28 ml of solution B were mixed and the 
volume made up to 200 ml with distilled water to give O.OIM phosphate 
buffer. Sodium chloride (8,766 g) was added to each litre of phosphate 
buffer,
3, Borate Buffer (0.05M, pH 9,0)
50 ml of 0.05M Na2B^0^,IOH2 O were added to 4,6 ml of 0,2M HCl, 
and this diluted to 100 ml with H 2 O.
4, Phosphate buffer (0,1M, pH 5,9)
5.07 ml of O.IM Na2HP0^ were added to 44.92 ml of 0,1M 
NaH2 P0 ^ and this diluted to 100 ml with H 2 O,
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APPENDIX 4c REAGENTS FOR ISOELECTRIC FOCUSSING
1. Anode Solution
Sucrose (B.D.H.) 12,0 g
Distilled water 14,0 ml
Sulphuric acid (Analar) 0,2 ml
Dissolve sucrose in distilled water. Add sulphuric acid dropwise with 
vigorous stirring to prevent caramélisation of the sucrose.
2, Cathode Solution —  -------------
Sodium hydroxide 0,1 g
Distilled water 20,0 ml
3. Diluted Ampholines (10% v/v)
Ampholines 40% (w/v) 2,5 ml
Distilled water 7,5 ml
4, Dense Solution
* This sample can contain up to 1 g of protein.
Sucrose 25,0 g
Ampholine 10% (v/v) 7,5 g
Distilled water 32,0 ml
Total volume 55,0 ml
j 'i
Light Solution
Sample * x ml
Ampho line (10% v/v) 2.5 ml
Distilled water (52,5 - x) ml
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APPENDIX 5 GELS AND BUFFERS FOR SDS-PAGE
(a) STOCK SOLUTIONS
lo Acrylamide (B.D.H.) 30,0 g )
NN'methylenebisacrylamide (NN*bis) 0,8 g )
2, Running buffer (lOx) pH 8,8
Glycine 144,13 g
SDS loO g
tris 30,28 g
3, Solubilizing buffer
0.5M Tris/HCl pH 6.8 25 ml
20% SDS w/v 20 ml
(3 me reap to ethanol 10 ml
glycerol 20 ml
0.1% bromophenol blue w/v 2 ml
H^O 23 ml
) made up to 100 ml
made up to 1 litre
Staining solution
Coomassie Brilliant Blue R (Sigma) 1,25 g 
50% methanol 454 ml
glacial acetic acid 46 ml
Destaining solution 
methanol 
acetic acid
H^ O
50 ml 
75 ml 
875 ml
A8
(b) GEL PREPARATION
(i) Separating gel (11% acrylamide)
Acrylamide/NN'bis 36,7 ml
IM Tris/HCl buffer, pH 8,8 37,5 ml
20% (w/v) SDS 0.5 ml
TEMED 25 pl
Ammonium persulphate 0,8% (w/v)
(freshly prepared) 10 ml
H^O 15,3 ml
(ii) Stacking gel (5% acrylamide)
Acrylamide/NN'bis 16,7 ml
0.5M Tris/HCl buffer, pH 6.8 25 ml
20% w/v SDS 0.5 ml
TEMED 25 pi
Ammonium persulphate, 0,8% w/v 10 ml
H^O 47,8 ml
(c) SAMPLE PREPARATION
Protein samples (approximately 200 pgml ^*) were mixed 1:1
with solubilizing buffer and heated at 100°C for 5 min,
_ 1*with protease samples this value was much lower, ie 50 pgml
APPENDIX 6 GELS AND BUFFERS FOR GELATIN-PAGE
(a) STOCK SOLUTIONS
A9
J:
iv
le Acrylamide
NN*methy1enebisacry1amide
30.0 g )
) made up to 100 ml
0o8 g ) a
Running buffer (l)x), pH 8,8 
glycine
sodium dodecyl sulphate 
tris
144.13 g ))1.0 g ) made up to 1 litre )30.28 g )
3. Staining solution 
Amido Black 
methanol 
acetic acid
H^O
1 g 
300 ml 
100 ml 
600 ml
4» Destaining solution 
methanol 
acetic acid
H^ O
300 ml 
100 ml 
600 ml
(b) GEL PREPARATION
Separating gel
Acrylamide/NN'bis 
1.5M Tris/HCl, pH 8.8 
containing 0.4% (w/v) SDS 
Gelatin, 1% (w/v)
Ammonium persulphate 100 mgml 
(prepared freshly)
TEMED (N,N,N,N'-Tetramethylethylenediamine) 
H^O 14.7 ml
-1
19.8 ml
13.5 ml
5.4 ml 
0.12 ml
50 pl
Stacking gel
Acrylamide/NN'bis 
0.5M Tris/HCl, pH 8.6
containing 0,4% (w/v) SDS 
Aiimonium persulphate, 100 mgml 
TEMED
-1
2.4 ml 
3.0 ml
0.24 ml 
25 pl 
19,0 ml
AlO ;
(c) Sample Preparation
Samples were prepared in solutions containing 2,5% (w/v) SDS,
1% (w/v) sucrose and 4 pgml  ^ phenol red. The samples used all contained
-1approximately 10 EUml of protease activity,
APPENDIX 7
PAGE gel with gelatin overlay
All
) make to 100 ml )
lo PAGE gel
Gyanogum 
Tris
Citric acid 0.08 g )
Add 1 ml of 10% (w/v) ammonium sulphate and 1 ml of 10% (w/v) ammonium 
dime thylaminoethyl cyanide, degas the solution and pour into gel mould,
0o46 g ) with H-O )
Running buffer 
Boric acid 
NaOH (pellets)
18.5 g ) make up to 1 litre )2.0 g )
3. Gelatin gel
Purified agar (Oxoid) 1.2 g
Gelatin (Oxoid) 0.25 g
This was added to 100 ml of 0.2M tris HCl buffer, pH 7*0o The mixture 
was autoclaved (15 psi for 15 min) and then poured into the gel mould.
4. Acid sublimate solution (Mercuric chloride solution)
HgCL
Concentrated HCl
H 02
15 g 
20 ml 
80 ml I
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APPENDIX 8
2o
Reagents for Immunoelectrophoresis
Barbitone buffer, 0.05M, pH 8.4.
Sodium barbitone 10,3 g
Barbitone 1.84 g
H 2 O 1 litre
Barbitone agar
Purified agar 
Barbitone buffer 
Merthiolate
3. Amido Black stain 
Amido Black 
me thano1 
acetic acid
8 S )
1 litre)
0.01 g
) dissolve by steaming
0.5 i 
90 ml 
10 ml
APPENDIX 9
Template for Immunoelectrophoresis Plate
Ai 3
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APPENDIX 10
Adjuvants used in protection studies and for antiserum production
Ao Freunds complete adjuvant (F.C.A.)
1.0 ml Bayol F (Esso: provided by Dr. D.E.S. Stewart-Tull)
0.4 ml Arlacel A (I.Col. America)
1.0 ml Antigen
250 pg freeze-dried Mycobacterium tuberculosis.
B, Freunds incomplete adjuvant (F.I.A.)
1.0 ml Bayol F (Esso: provided by Dr, D.E,S. Stewart-Tull)
0,4 ml Arlacel A (I.C.I. America)
1.0 ml Antigen
C. Aluminium hydroxide gel (Al(0H)2)
1,4 ml Al(0H)2 (prepared by method of Levine and Vaz, 1970)
1.0 ml Antigen
iI
;
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APPENDIX 11
TRITON"TOLUENE SCINTILLANT
Triton X-100 1 litre
Toluene (technical grade) 2 litres
2,5~Diphenyloxazole 8 g
1,4-Di-2-(e-methyl- 0.2 g
5 phenyl oxazolyl benzene)
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1015 Some Characteristics o f  Vibrio cholerae FroteimsesC.R. BLEAKLEY and D.E.S, STEWART-TULL (Department of Microbiology, University oC 
Glasgow) ;
Three specific proteinases were isolated from the culture fluid of K cholerae by isoelectric focuss­
ing. The specificity of these was determined by the use of inhibitors. Their role in adhesion and; 
colonization, examined with ‘'*C-labelled organisms, will be discussed. Protection tests showed 
that one or two injections of proteinase caused a significant reduction in fluid accumulated in 
guinea-pig ileal loops.
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